Updated on 2025/03/27

写真a

 
Kurobe Hirotsugu
 
Organization
Graduate School of Medicine Program for Medical Sciences Associate Professor
Title
Associate Professor
Contact information
メールアドレス
External link

Degree

  • MD ( 2006.3   The University of Tokushima )

  • PhD ( University of TOKUSHIMA )

Research Interests

  • 未熟肺血管床

  • 肺高血圧

  • 肺高血圧症

  • 循環器

  • 肺動脈再構築

  • 急性冠症候群

  • 細胞治療

  • 肺高血圧治療

  • 自然免疫

  • プラーク

  • 動脈硬化

  • 骨髄単核球細胞移植

  • 細胞性免疫

  • サイトカイン

  • 生活習慣病

  • 慢性炎症

  • Medical Device

  • Tissue engineering

  • 心臓手術

  • 胸腺

  • 脱細胞化

  • Hypoxia inducible factor

  • cell transplantation

  • inflammation

  • Regenerative Medicine

  • T cell

  • Vascular remodeling

  • 肺小動脈リモデリング

  • リンパ管新生

  • VEGF-VEGF receptor

  • 低酸素応答

  • 細胞接着因子

  • Macrophage

  • 小口径グラフト

  • 臍帯血

Research Areas

  • Life Science / General surgery and pediatric surgery

  • Life Science / Respiratory surgery

  • Life Science / Cardiovascular surgery

  • Life Science / Cardiology

  • Life Science / Biomedical engineering

  • Life Science / Respiratory surgery  / Cardiovascular Surgery

  • Life Science / Cardiovascular surgery  / Cardiovascular Surgery

  • Life Science / Immunology

  • Life Science / Biomaterials

▼display all

Education

  • The University of Tokushima   Graduate School of Medical Sciences

    2001.4 - 2006.3

      More details

    Country: Japan

    researchmap

  • The University of Tokushima   Faculty of Medicine   School of Medicine

    1994.4 - 2000.3

      More details

    Country: Japan

    researchmap

Research History

  • Ehime University   Department of cardiovascular-Thoracic Surgery, Graduate School of Medicine   Associate Professor   MD, PhD

    2023.1

      More details

    Country:Japan

    Notes:FJCS

    researchmap

  • Ehime University Graduate School of Medicine   Department of Cardiovascular and Thoracic Surgery   Associate Professor

    2019.4 - 2022.12

      More details

  • Tokushima University Hospital   Division of Cardiovascular Surgery   Specially Appointed Associate Professor

    2018.4 - 2019.3

      More details

  • Tokushima University Graduate School   Department of Cardiovascular Surgery, Institute of Biomedical Sciences   Assistant Professor

    2013.8 - 2018.3

      More details

    Country:Japan

    researchmap

  • Yale University   Associate

    2012.11 - 2018.8

      More details

    Country:United States

    researchmap

  • Nationwide Children's Hospital   Postdoctoral fellow

    2012.9 - 2013.8

      More details

    Country:United States

    researchmap

  • Yale University of Medicine   Visiting Assistant Professor

    2011.7 - 2012.8

      More details

  • Tokushima University Hospital   Attending Surgeon

    2008.4 - 2011.6

      More details

  • Institute of Health Bioscience, the University of Tokushima Graduate School   Assistant Professor

    2008.4 - 2011.6

      More details

  • Ehime Prefectural Central Hospital   Fellow

    2006.4 - 2008.3

      More details

  • Tokushima University Hospital   Fellow

    2002.6 - 2006.3

      More details

  • Tokushima University Hospital   Resident

    2002.4 - 2002.6

      More details

  • Tokushima Prefectural Central Hospital   Resident

    2001.10 - 2002.3

      More details

  • Graduate school of Medicine, the University of Tokushima   graduate fellow

    2001.4 - 2006.3

      More details

  • Tokushima University Hospital   Resident

    2000.6 - 2001.9

      More details

▼display all

Professional Memberships

  • Japanese society of regenerative medicine

      More details

  • Japanese Society of Phlebology

      More details

  • JAPANESE CIRCULATION SOCIETY

      More details

  • JAPANESE SOCIETY FOR VASCULAR SURGERY

      More details

  • THE JAPANESE SOCIETY FOR CARDIOVASCULAR SURGERY

      More details

  • The Society of Thoracic Surgeons

      More details

  • THE JAPANESE ASSOCIATION FOR THORACIC SURGERY

      More details

  • JAPAN SURGICAL SOCIETY

      More details

▼display all

Committee Memberships

  • Japanese Society for Therapeutics and Engineering   Councilor  

    2020.4   

      More details

    Committee type:Academic society

    researchmap

  • Shikoku Regional Office of the Japanese Circulation Society   Councilor  

    2016.4   

      More details

    Committee type:Academic society

    researchmap

Qualification acquired

  • 医師免許

Papers

  • Modified Sternum-Closing Procedure with Titanium Cable and a Poly-Lactic Acid (PLA) Mesh Plate—For Improving QOL after Cardiac Surgery in Patient with Sternotomy

    Higaki Tomohide, Kurobe Hirotsugu, Fukunishi Takuma, Sakaue Tomohisa, Nishimura Takashi, Izutani Hironori

    Japanese Journal of Cardiovascular Surgery   53 ( 2 )   56 - 61   2024.3

     More details

    Language:Japanese   Publisher:The Japanese Society for Cardiovascular Surgery  

    <b>Background</b>: Unstable sternal fixation following sternotomy is one of the risk factors that affects postoperative outcomes in cardio-thoracic surgery and is associated with increased risk of infection, bleeding and delayed rehabilitation due to pain associated with sternal movement. Sternal plate systems, which help stabilize fixation, has been limited in use due to patients' comorbidities, such as diabetes mellitus (DM) and obesity. The conventional wire sternal-fixation procedure, which depend on years of physician' experience, raise concerns such as unstable sternal fixation due to uncompleted wire twisting. Therefore, a novel sternal-fixation procedure using both titanium cable and a PLA mesh plate was investigated as a potential improvement for sternal closure. We compared the ability of this new sternum fixation procedure (group N) against the conventional sternal fixation procedure using only a wire (group O) to achieve more stable postoperative sternal fixation. <b>Methods and Results</b>: Among adult open-heart surgeries performed between August 2020 and April 2023, 155 patients who underwent postoperative CT were included, with group N being the combined group and group O being the group using conventional metal wires: group N (86 patients: M 65, F 21) and group O (69 patients: M 50, F 19). Preoperative factors included age at surgery (group N: group O)=68.4±10.6 : 69.6±11.5 years (<i>p</i>=0.25)), BMI (group N: group O=23.0±3.7 : 24.1±7.7 (<i>p</i>=0.16)) and HbA1c (group N: group O=6.3±1.1 : 8.0±10.3% (<i>p</i>=0.10), and no factors were significantly different between the two groups. The CT analysis at the point of hospital discharge after surgery measured postoperative sternal deviation in the third rib position. Transverse displacement was significantly reduced (group N: group O=0.22±0.73: 0.83±1.08 mm (<i>p</i>=0.005)), and longitudinal displacement also showed an improvement but the difference was not statistically significant (group N: group O=0.53±0.86: 0.72±1.14 mm (<i>p</i>=0.13). <b>Conclusion</b>: A novel sternum closing technique using a tension-anchored titanium cable and a PLA mesh plate demonstrated improved postoperative sternal fixation in a controlled study with 155 patients. This new procedure also enables standardized stable sternal closure with a constant force without relying on conventional empirical sensation and without suppressing sternal cutting, thus contributing to the improvement of postoperative quality of life and prevention of complications.

    DOI: 10.4326/jjcvs.53.56

    CiNii Research

    researchmap

    Other Link: https://search.jamas.or.jp/link/ui/2024187899

  • 張力固定型チタンケーブルとメッシュプレートを併用した胸骨固定法の検討

    檜垣 知秀, 黒部 裕嗣, 福西 琢真, 坂上 倫久, 西村 隆, 泉谷 裕則

    日本心臓血管外科学会雑誌   53 ( 2 )   56 - 61   2024.3

     More details

    Language:Japanese   Publisher:(NPO)日本心臓血管外科学会  

    [背景と目的]胸骨正中切開後の不安定な胸骨固定は,感染症・出血のリスク増加や胸骨動揺に伴う疼痛等によるリハビリテーションの遅れなど,術後の経過に影響を与える要因の1つとしてあげられる.従来のワイヤー固定法では,経験年数にも左右されるが,閉胸時の胸骨離断やワイヤーの不完全固定など懸念としてあげられてきた.一方で,近年使用されてきた体内固定用胸骨プレートはその患者適応に制限があり,全例で使うことはむずかしい.今回,より安定した胸骨固定を目的に,チタンケーブルとメッシュプレートを併用した新固定法(N群)の手技を検討し,従来のワイヤーのみを用いた胸骨固定法(O群)と比較検討した.[方法・結果]2020年8月~2023年4月に施行した成人開心術のうち,術後CTを撮影した155例を対象とし,N群(86例:M65,F21),O群(69例:M50,F19)に分類した.術前因子としては,術時年齢(N群:O群=68.4±10.6:69.6±11.5歳(p=0.25)),BMI(N群:O群=23.0±3.7:24.1±7.7(p=0.16)),HbA1c(N群:O群=6.3±1.1:8.0±10.3%(p=0.10))であり,両群間で有意差はなかった.術後CT解析では,第3肋骨位での術後の胸骨のずれを測定した.横ずれ(N群:O群=0.22±0.73:0.83±1.08mm(p=0.005))は有意に減少し,縦ずれ(N群:O群=0.53±0.86:0.72±1.14mm(p=0.13))は統計学的有意差を認めないものの減少傾向を認めた.[結語]チタンケーブルとメッシュプレートを併用した閉胸法は,術後の胸骨ずれを減少させ,その結果,安定した胸骨固定に寄与すると考えられる.チタンケーブルの固定手技は,テンショナーを用いた一定力で胸骨固定できる一方で,胸骨カッティングの懸念を指摘されていた.そのためメッシュプレートを胸骨背面に挿入して固定することにより,胸骨カッティングを防止し,より安定した胸骨固定に繋がると考えられた.(著者抄録)

    researchmap

    Other Link: https://search.jamas.or.jp/default/link?pub_year=2024&ichushi_jid=J01122&link_issn=&doc_id=20240401280002&doc_link_id=10.4326%2Fjjcvs.53.56&url=https%3A%2F%2Fdoi.org%2F10.4326%2Fjjcvs.53.56&type=J-STAGE&icon=https%3A%2F%2Fjk04.jamas.or.jp%2Ficon%2F00007_3.gif

  • 胸部大動脈瘤に対するステントグラフト内挿術後のtype IIエンドリークに対して瘤内直接穿刺による塞栓が有効であった1例

    福西 琢真, 田中 宏明, 本郷 哲央, 八杉 巧, 黒部 裕嗣, 西村 隆, 薦田 宗則, 檜垣 知秀, 坂上 倫久, 泉谷 裕則

    血管外科   42 ( 1 )   82 - 87   2023.11

     More details

    Language:Japanese   Publisher:血管外科症例検討会  

    症例は40歳代の女性。全身性エリテマトーデスによる慢性腎不全で生体腎移植を受けている。経過中に拡大する57mm大の紡錘状下行大動脈瘤を認め、zone3/4に対して胸部ステントグラフト内挿術(TEVAR)を施行した。術後2年でのCT検査で62mmと再度瘤拡大を認め、血管造影を行い下甲状腺動脈等からの側副路を介して気管支動脈から瘤内に血流を認めるtype IIのエンドリーク(EL)と診断した。側副路からのカテーテル挿入は困難と判断し、CTガイド下瘤内直接穿刺で気管支動脈と肋間動脈の選択的にコイル塞栓を行い、さらに瘤内をn-butyl-cyanoacryrate:NBCA、リピオドール、エタノール混合液にて充填した。術後半年のCTでは、瘤径拡大なく経過良好である。(著者抄録)

    researchmap

  • 生体分解性素材を用いた医療デバイスの開発

    黒部 裕嗣, 新岡 俊治, 平田 陽一郎, 福西 琢真, 森谷 友造, 倉田 美恵, 坂上 倫久, 檜垣 高史, 泉谷 裕則

    愛媛医学   42 ( 3 )   119 - 126   2023.9

     More details

    Language:Japanese   Publisher:愛媛医学会  

    researchmap

  • 生体吸収性素材の現状と医用への応用 循環器治療用デバイスへの生体吸収性素材の可能性

    黒部 裕嗣, 新岡 俊治, 中村 日菜美, 花田 幸太郎, 平田 陽一郎, 福西 琢真, 坂上 倫久, 泉谷 裕則, 山内 康治

    人工臓器   51 ( 2 )   S - 91   2022.10

     More details

    Language:Japanese   Publisher:(一社)日本人工臓器学会  

    researchmap

  • 心拍動下MICS弁形成術の工夫

    檜垣 知秀, 黒部 裕嗣, 薦田 宗則, 福西 琢真, 坂上 倫久, 西村 隆, 八杉 巧, 泉谷 裕則

    小切開・鏡視外科学会雑誌   13 ( 1 )   47 - 47   2022.6

     More details

    Language:Japanese   Publisher:(NPO)小切開・鏡視外科学会  

    researchmap

  • モデルマウスを用いた心臓癒着メカニズムの解明

    浪口 謙治, 坂上 倫久, 岡崎 幹生, 菅野 果歩, 薦田 悠平, 鹿田 文昭, 倉田 美恵, 太田 教隆, 久保田 義顕, 黒部 裕嗣, 西村 隆, 増本 純也, 東山 繁樹, 泉谷 裕則

    血管   45 ( 1 )   52 - 52   2022.6

     More details

    Language:Japanese   Publisher:日本心脈管作動物質学会  

    researchmap

  • 心臓手術後に起こる癒着形成のメカニズム

    坂上 倫久, 浪口 謙治, 岡崎 幹生, 菅野 果歩, 薦田 悠平, 倉田 美恵, 太田 教隆, 黒部 裕嗣, 西村 隆, 薦田 宗則, 檜垣 知秀, 八杉 巧, 増本 純也, 泉谷 裕則

    医工学治療   34 ( Suppl. )   102 - 102   2022.5

     More details

    Language:Japanese   Publisher:(NPO)日本医工学治療学会  

    researchmap

  • 心臓手術後に起こる癒着形成のメカニズム

    坂上 倫久, 浪口 謙治, 岡崎 幹生, 菅野 果歩, 薦田 悠平, 倉田 美恵, 太田 教隆, 黒部 裕嗣, 西村 隆, 薦田 宗則, 檜垣 知秀, 八杉 巧, 増本 純也, 泉谷 裕則

    医工学治療   34 ( Suppl. )   102 - 102   2022.5

     More details

    Language:Japanese   Publisher:(NPO)日本医工学治療学会  

    researchmap

  • IMPELLA使用による出血合併症の検討

    檜垣 知秀, 西村 隆, 薦田 宗則, 福西 琢真, 黒部 裕嗣, 坂上 倫久, 八杉 巧, 泉谷 裕則, 三好 徹, 東 晴彦, 山口 修

    医工学治療   34 ( Suppl. )   128 - 128   2022.5

     More details

    Language:Japanese   Publisher:(NPO)日本医工学治療学会  

    researchmap

  • Unique Angiogenesis From Cardiac Arterioles During Pericardial Adhesion Formation. International journal

    Kenji Namiguchi, Tomohisa Sakaue, Mikio Okazaki, Kaho Kanno, Yuhei Komoda, Fumiaki Shikata, Mie Kurata, Noritaka Ota, Yoshiaki Kubota, Hirotsugu Kurobe, Takashi Nishimura, Junya Masumoto, Shigeki Higashiyama, Hironori Izutani

    Frontiers in cardiovascular medicine   8   761591 - 761591   2021

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Objectives: The molecular mechanisms underlying post-operative pericardial adhesions remain poorly understood. We aimed to unveil the temporal molecular and cellular mechanisms underlying tissue dynamics during adhesion formation, including inflammation, angiogenesis, and fibrosis. Methods and Results: We visualized cell-based tissue dynamics during pericardial adhesion using histological evaluations. To determine the molecular mechanism, RNA-seq was performed. Chemical inhibitors were administered to confirm the molecular mechanism underlying adhesion formation. A high degree of adhesion formation was observed during the stages in which collagen production was promoted. Histological analyses showed that arterioles excessively sprouted from pericardial tissues after the accumulation of neutrophils on the heart surface in mice as well as humans. The combination of RNA-seq and histological analyses revealed that hyperproliferative endothelial and smooth muscle cells with dedifferentiation appeared in cytokine-exposed sprouting vessels and adhesion tissue but not in quiescent vessels in the heart. SMAD2/3 and ERK activation was observed in sprouting vessels. The simultaneous abrogation of PI3K/ERK or TGF-β/MMP9 signaling significantly decreased angiogenic sprouting, followed by inhibition of adhesion formation. Depleting MMP9-positive neutrophils shortened mice survival and decreased angiogenic sprouting and fibrosis in the adhesion. Our data suggest that TGF-β/matrix metalloproteinase-dependent tissue remodeling and PI3K/ERK signaling activation might contribute to unique angiogenesis with dedifferentiation of vascular smooth muscle cells from the contractile to the synthetic phenotype for fibrosis in the pericardial cavity. Conclusions: Our findings provide new insights in developing prevention strategies for pericardial adhesions by targeting the recruitment of vascular cells from heart tissues.

    DOI: 10.3389/fcvm.2021.761591

    PubMed

    researchmap

  • 心のう癒着防止剤の開発のためのモデルマウスの作成

    浪口 謙治, 坂上 倫久, 小嶋 愛, 薦田 宗則, 坂本 裕司, 杉浦 純也, 太田 教隆, 黒部 裕嗣, 西村 隆, 打田 俊司, 八杉 巧, 泉谷 裕則, 岡崎 幹生, 鹿田 文昭

    日本心臓血管外科学会学術総会抄録集   50回   O10 - 5   2020.3

     More details

    Language:Japanese   Publisher:(NPO)日本心臓血管外科学会  

    researchmap

  • 当院でのIMPELLAを用いた治療経験

    浪口 謙治, 西村 隆, 坂本 裕司, 薦田 宗則, 杉浦 純也, 太田 教隆, 黒部 裕嗣, 打田 俊司, 八杉 巧, 泉谷 裕則

    人工臓器   48 ( 2 )   S - 185   2019.10

     More details

    Language:Japanese   Publisher:(一社)日本人工臓器学会  

    researchmap

  • Differential outcomes of venous and arterial tissue engineered vascular grafts highlight the importance of coupling long-term implantation studies with computational modeling Reviewed International journal

    Cameron A. Best, Jason M. Szafron, Kevin A. Rocco, Jacob Zbinden, Ethan W. Dean, Mark W. Maxfield, Hirotsugu Kurobe, Shuhei Tara, Paul S. Bagi, Brooks V. Udelsman, Ramak Khosravi, Tai Yi, Toshiharu Shinoka, Jay D. Humphrey, Christopher K. Breuer

    Acta Biomaterialia   94   183 - 194   2019.8

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:ELSEVIER SCI LTD  

    Electrospinning is commonly used to generate polymeric scaffolds for tissue engineering. Using this approach, we developed a small-diameter tissue engineered vascular graft (TEVG) composed of poly-ε-caprolactone-co-L-lactic acid (PCLA) fibers and longitudinally assessed its performance within both the venous and arterial circulations of immunodeficient (SCID/bg) mice. Based on in vitro analysis demonstrating complete loss of graft strength by 12 weeks, we evaluated neovessel formation in vivo over 6-, 12- and 24-week periods. Mid-term observations indicated physiologic graft function, characterized by 100% patency and luminal matching with adjoining native vessel in both the venous and arterial circulations. An active and robust remodeling process was characterized by a confluent endothelial cell monolayer, macrophage infiltrate, and extracellular matrix deposition and remodeling. Long-term follow-up of venous TEVGs at 24 weeks revealed viable neovessel formation beyond graft degradation when implanted in this high flow, low-pressure environment. Arterial TEVGs experienced catastrophic graft failure due to aneurysmal dilatation and rupture after 14 weeks. Scaffold parameters such as porosity, fiber diameter, and degradation rate informed a previously described computational model of vascular growth and remodeling, and simulations predicted the gross differential performance of the venous and arterial TEVGs over the 24-week time course. Taken together, these results highlight the requirement for in vivo implantation studies to extend past the critical time period of polymer degradation, the importance of differential neotissue deposition relative to the mechanical (pressure) environment, and further support the utility of predictive modeling in the design, use, and evaluation of TEVGs in vivo. Statement of Significance: Herein, we apply a biodegradable electrospun vascular graft to the arterial and venous circulations of the mouse and follow recipients beyond the point of polymer degradation. While venous implants formed viable neovessels, arterial grafts experienced catastrophic rupture due to aneurysmal dilation. We then inform a previously developed computational model of tissue engineered vascular graft growth and remodeling with parameters specific to the electrospun scaffolds utilized in this study. Remarkably, model simulations predict the differential performance of the venous and arterial constructs over 24 weeks. We conclude that computational simulations should inform the rational selection of scaffold parameters to fabricate tissue engineered vascular grafts that must be followed in vivo over time courses extending beyond polymer degradation.

    DOI: 10.1016/j.actbio.2019.05.063

    Web of Science

    Scopus

    PubMed

    researchmap

  • A case of nickel allergy after endovascular aortic repair Reviewed International journal

    Yohei Kawatani, Hirotsugu Kurobe, Yoshitsugu Nakamura, Takaki Hori

    Asian Cardiovascular and Thoracic Annals   27 ( 2 )   114 - 117   2019.2

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    A 78-year-old man with no history of allergy, underwent endovascular aortic repair for abdominal aortic aneurysm rupture. Postoperatively, he had low-grade fever and persistently raised white blood cell counts, but tests showed no infection. A skin rash appeared on the trunk and upper arms; we suspected a drug allergy. Despite withdrawal and/or change of medications, the symptoms remained. Finally, a patch test for nickel showed a strongly positive result. Oral prednisone 5 mg·day was started, and the clinical findings resolved thereafter. No recurrence of allergy, infection, or exacerbation of the treated abdominal aortic aneurysm was noted at the 2-year follow-up. −1

    DOI: 10.1177/0218492318784736

    Scopus

    PubMed

    researchmap

  • Inhibition of Atherosclerotic Plaque Development by Oral Administration of α-Glucosyl Hesperidin and Water-Dispersible Hesperetin in Apolipoprotein E Knockout Mice Reviewed International journal

    Noriko Sugasawa, Ayako Katagi, Hirotsugu Kurobe, Taisuke Nakayama, Chika Nishio, Hiroko Takumi, Fumiharu Higashiguchi, Ken ichi Aihara, Michio Shimabukuro, Masataka Sata, Tetsuya Kitagawa

    Journal of the American College of Nutrition   38 ( 1 )   15 - 22   2019.1

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD  

    Objective: Hesperidin, an abundant flavonoid in citrus fruit, and its aglycone, hesperetin, have been reported to possess various physiological activities, including antioxidant, anti-inflammatory, hypolipidemic, and antihypertensive activities. In this study, we investigated whether α-glucosyl hesperidin and water-dispersible hesperetin have protective effects on atherosclerotic progression in apolipoprotein E knockout (Apo-E KO) mice. Methods: Ten-week-old male Apo-E KO mice were randomly assigned a regular high-fat diet, a high-fat diet with 0.5% α-glucosyl hesperidin, or a high-fat diet with 0.1% water-dispersible hesperetin for 12 weeks. Measurement of plasma total cholesterol levels, histological staining of aortic root, and immunohistochemistry for macrophages were performed to evaluate atherosclerotic plaque formation. Vascular reactivity of mouse aortic rings was also measured. Results: Both α-glucosyl hesperidin and water-dispersible hesperetin reduced plasma total cholesterol level. They also reduced plaque formation area, adipose deposition, and macrophage infiltration into atherosclerotic lesion. Vascular-endothelium-dependent relaxation in response to acetylcholine was improved in both experimental diet groups compared to the high-fat diet group. Conclusions: Our study suggests that both α-glucosyl hesperidin and water-dispersible hesperetin exert protective effects on atherosclerotic progression in Apo-E KO mice because they exhibit hypolipidemic activity, reduce inflammation through macrophages, and prevent endothelial dysfunction.

    DOI: 10.1080/07315724.2018.1468831

    Web of Science

    Scopus

    PubMed

    researchmap

  • Appropriate Surgical Treatment of Symptomatic Primary Varicose Veins Decreases Systemic Inflammatory Biomarkers Reviewed

    Hiroki Arase, Noriko Sugasawa, Youhei Kawatani, Mikio Sugano, Hirotsugu Kurobe, Eiki Fujimoto, Takashi Kitaichi, Tetsuya Kitagawa

    ANNALS OF VASCULAR DISEASES   12 ( 3 )   367 - 371   2019

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:ANNALS VASCULAR DISEASES EDITORIAL OFFICE  

    Objective: To evaluate the relationship between systemic inflammatory biomarkers and efficacy of surgical treatment of primary varicose veins of the lower extremities.Methods: Total 12 patients who underwent endovenous laser ablation or stripping of varicose veins and six healthy subjects were enrolled. Structural and molecular changes of varices were assessed by immunohistochemical staining with anti-monocyte chemotactic protein-1 (MCP-1). MCP-1 and interleukin-6 (IL-6) levels in systemic antecubital blood were measured before and at 12 weeks after treatment.Results: Immunohistochemical staining revealed prominent manifestation of MCP-1-positive endothelial cells in the walls of varices. Preoperative serum MCP-1 and IL-6 levels in the patients were significantly higher than those in the control (166 +/- 12 pg/mL vs 99 +/- 10 pg/mL, p=0.003; 5.1 +/- 0.95pg/mL vs 0.0 +/- 0.0 pg/mL, p=0.001, respectively). The values were significantly correlated with the severity of chronic venous insufficiency (CVI). Postoperative serum MCP-1 level significantly decreased compared with the preoperative level (152 +/- 10 pg/mL vs 166 +/- 12 pg/mL, p=0.048). The values after endovenous laser ablation did not significantly decrease compared with those after stripping.Conclusion: Varicose veins with CVI increase inflammatory biomarker levels in the local tissue and systemic blood. Appropriate treatment of symptomatic varicose veins de- creases inflammatory biomarker levels.

    DOI: 10.3400/avd.oa.19-00011

    Web of Science

    PubMed

    researchmap

  • Magnetic resonance imaging of shear stress and wall thickness in tissue-engineered vascular grafts Reviewed International journal

    Mitchel R. Stacy, Cameron A. Best, Mark W. Maxfield, Maolin Qiu, Yuji Naito, Hirotsugu Kurobe, Nathan Mahler, Kevin A. Rocco, Albert J. Sinusas, Toshiharu Shinoka, Smita Sampath, Christopher K. Breuer

    Tissue Engineering - Part C: Methods   24 ( 8 )   465 - 473   2018.8

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:MARY ANN LIEBERT, INC  

    Objectives: Tissue-engineered vascular grafts (TEVGs) have demonstrated potential for treating congenital heart disease (CHD); however, quantitative imaging for tracking functional and structural remodeling of TEVGs has not been applied. Therefore, we evaluated the potential of magnetic resonance (MR) imaging for assessing TEVG wall shear stress (WSS) and wall thickness in a large animal model. Methods: Cell-seeded (n = 3) or unseeded (n = 3) TEVGs were implanted as inferior vena cava interposition grafts in juvenile lambs. Six months following implantation, two-dimensional phase-contrast MR imaging was performed at 3 slice locations (proximal, middle, and distal) to assess normalized WSS (i.e., WSS-to-cross sectional area). T2-weighted MR imaging was performed to assess TEVG wall thickness. Histology was qualitatively assessed, whereas immunohistochemistry was semiquantitatively assessed for smooth muscle cells (αSMA), macrophage lineage cells (CD11b), and matrix metalloproteinase activity (MMP-2 and MMP-9). Picrosirius Red staining was performed to quantify collagen content. Results: TEVG wall thickness was significantly higher for proximal, middle, and distal slices in unseeded versus cell-seeded grafts. Significantly higher WSS values existed for proximal versus distal slice locations for cell-seeded TEVGs, whereas no differences in WSS existed between slices for unseeded TEVGs. Additionally, no differences in WSS existed between cell-seeded and unseeded groups. Both groups demonstrated elastin formation, without vascular calcification. Unseeded TEVGs possessed greater content of smooth muscle cells when compared with cell-seeded TEVGs. No differences in macrophage, MMP activity, or collagen content existed between groups. Conclusion: MR imaging allows for in vivo assessment of functional and anatomical characteristics of TEVGs and may provide a nonionizing approach that is clinically translatable to children undergoing treatment for CHD.

    DOI: 10.1089/ten.tec.2018.0144

    Web of Science

    Scopus

    PubMed

    researchmap

  • The ratio of contrast medium volume to estimated glomerular filtration rate as a predictor of contrast-induced nephropathy after endovascular aortic repair Reviewed

    Yohei Kawatani, Hirotsugu Kurobe, Yoshitsugu Nakamura, Takaki Hori, Tetsuya Kitagawa

    Journal of Medical Investigation   65 ( 1-2 )   116 - 121   2018

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:MOSBY-ELSEVIER  

    Objective: This study aimed to determine the perioperative predictors of contrast medium-induced nephropathy (CIN) after endovascular aortic repair (EVAR). Materials and Methods: The data of 203 consecutive patients who underwent elective EVAR for thoracic and abdominal aortic aneurysm between January 2014 and September 2014 were retrospectively analyzed. CIN was defined according to the diagnostic criteria of the European Society of Urogenital Radiology. Results: Fourteen patients (6.9%) developed CIN after EVAR. Contrast medium volume (CV), preoperative serum creatinine, estimated glomerular filtration rate (eGFR), and the CV/eGFR ratio were significantly related with CIN development after EVAR. The CV/eGFR ratio was significantly higher in patients with CIN than those without CIN. Receiver operator characteristic curve analysis showed that the area under the curve of the CV/eGFR ratio was 0.782, indicating that it was the most important predictor. The appropriate CV/eGFR ratio cutoff was 1.62. Sensitivity and specificity were 85.7% and 65.6%, respectively. Conclusions: The CV/eGFR ratio was a useful predictor of contrast medium-induced nephropathy after EVAR. It is possible that the score can be used in patients when managing the EVAR techniques and contrast medium volume.

    DOI: 10.2152/jmi.65.116

    Web of Science

    Scopus

    PubMed

    researchmap

  • Thoracic Endovascular Aortic Repair for Blunt Thoracic Aortic Injury: A Report of Three Cases in Which Surgeries Were Performed at Different Timings Reviewed International journal

    Yohei Kawatani, Hirotsugu Kurobe, Yoshitsugu Nakamura, Yuji Suda, Takaki Hori

    CASE REPORTS IN SURGERY   2018   7061509 - 7061509   2018

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:HINDAWI LTD  

    Introduction. Blunt thoracic aortic injury (BTAI) is a critical condition. Thoracic endovascular aortic repair (TEVAR) is considered a surgical treatment for BTAI. Reports reveal that some patients benefit from conservative and delayed operation rather than emergency operative therapy. Here, we present three BTAI cases that were treated with TEVAR using different timings. Case Presentation. Case 1 involved a 49-year-old man injured in a car accident and who went into shock. After stabilization with Advanced Trauma Life Support in the emergency room, TEVAR was performed immediately. Case 2 involved a 69-year-old man who was injured after falling. His hemodynamic status was stable and enhanced computed tomography revealed intraluminal hematoma. He underwent TEVAR 15 days after the injury occurred, following conservative therapy. Case 3 involved a 60-year-old man who was injured in a car accident and presented BTAI with subarachnoid hemorrhage and diaphragm tear. A pseudoaneurysm was observed in the distal aortic arch. After open abdominal exploration, diaphragm repair, and observation for subarachnoid hemorrhage, TEVAR was performed 8 hours after arrival. All three patients survived. Conclusions. We treated BTAI successfully. We suggest that TEVAR is useful for BTAI. The timing of the operation and therapeutic option, including conservative therapy, should be decided for each patient.

    DOI: 10.1155/2018/7061509

    Web of Science

    PubMed

    researchmap

  • Novel application and serial evaluation of tissue-engineered portal vein grafts in a murine model Reviewed International journal

    Mark W. Maxfield, Mitchel R. Stacy, Hirotsugu Kurobe, Shuhei Tara, Tai Yi, Muriel A. Cleary, Zhen W. Zhuang, Manuel I. Rodriguez-Davalos, Sukru H. Emre, Yasuko Iwakiri, Toshiharu Shinoka, Christopher K. Breuer

    Regenerative Medicine   12 ( 8 )   929 - 938   2017.12

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:FUTURE MEDICINE LTD  

    Aim: Surgical management of pediatric extrahepatic portal vein obstruction requires meso-Rex bypass using autologous or synthetic grafts. Tissue-engineered vascular grafts (TEVGs) provide an alternative, but no validated animal models using portal TEVGs exist. Herein, we preclinically assess TEVGs as portal vein bypass grafts. Materials & methods: TEVGs were implanted as portal vein interposition conduits in SCID-beige mice, monitored by ultrasound and micro-computed tomography, and histologically assessed postmortem at 12 months. Results: TEVGs remained patent for 12 months. Histologic analysis demonstrated formation of neovessels that resembled native portal veins, with similar content of smooth muscle cells, collagen type III and elastin. Conclusion: TEVGs are feasible portal vein conduits in a murine model. Further preclinical evaluation of TEVGs may facilitate pediatric clinical translation.

    DOI: 10.2217/rme-2017-0021

    Web of Science

    Scopus

    PubMed

    researchmap

  • Acute pancreatitis caused by pancreatic ischemia after TEVAR combined with intentional celiac artery coverage and embolization of the branches of the celiac artery Reviewed International journal

    Yohei Kawatani, Hirotsugu Kurobe, Yoshitsugu Nakamura, Yuji Suda, Yoshinori Okuma, Shinichiro Sato, Toru Hashimoto, Takaki Hori

    JOURNAL OF SURGICAL CASE REPORTS   2017 ( 2 )   rjx029   2017.1

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:OXFORD UNIV PRESS  

    Covering and embolizing the celiac artery has been reported to be a relatively safe procedure, owing to the rich collateral pathway between the celiac artery and superior mesenteric artery. A 69-year-old man presented with an aneurysm on the distal descending aorta. The proximity of the aneurysm to the celiac artery origin necessitated covering the artery with a stent graft. Additionally, the celiac trunk was short, increasing the risk for Type II endoleak. The origin of the celiac artery was covered after embolization of the branches of the celiac artery. Postoperatively, nausea and abdominal pain appeared, and the amylase level and white blood cell count were elevated. Contrast-enhanced computed tomography and abdominal ultrasonography revealed necrosis and cyst formation in the pancreatic tail, resulting in a diagnosis of acute pancreatitis caused by pancreatic ischemia. Conservative treatment was applied. After discharge, although walled-off necrosis remained, the patient was doing well, without any clinical symptoms.

    DOI: 10.1093/jscr/rjx029

    Web of Science

    PubMed

    researchmap

  • Long-term results after open mitral commissurotomy for a one-month-old infant with mitral stenosis Reviewed

    Takashi Kitaichi, Mikio Sugano, Hiroki Arase, Yohei Kawatani, Kanako Kameta, Hirotsugu Kurobe, Eiki Fujimoto, Akemi Ono, Yasunobu Hayabuchi, Hiroshi Fujita, Hitoshi Sogabe, Tetsuya Kitagawa

    Journal of Medical Investigation   64 ( 1-2 )   187 - 191   2017

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:UNIV TOKUSHIMA SCH MEDICINE  

    The strategy for an infant with congenital mitral stenosis should be determined by three important factors: left ventricular volume, the degree of the systemic outflow tract obstruction, and the type of mitral valve dysfunction. A successful staged biventricular repair in early infancy for a patient who had congenital mitral stenosis with short chordae, hypoplastic left ventricle and coarctation of the aorta, and the long-term results are described. There were the following important hemodynamic factors that led to the successful biventricular repair in the patient. Total systemic output was barely supplied through the hypoplastic left ventricle after closure of the ductus arteriosus on admission. The neonate underwent repair of coarctation of the aorta alone as the initial stage at 9 days after birth. Also, spontaneous closure of the foramen ovale following repair of coarctation of the aorta accelerated the progressive left ventricular growth. Open mitral commissurotomy with an interatrial fenestration using the modified Brawley’s approach was performed for a 40-day-old infant. Good left ventricular growth and good mitral valve function have been observed for 18 years after open mitral commissurotomy. Appropriate early augmentation of left ventricular inflow through the mitral valve might be effective for growth of a hypoplastic left ventricle.

    DOI: 10.2152/jmi.64.187

    Web of Science

    Scopus

    PubMed

    researchmap

  • Aortic rupture due to radiation injury successfully treated with thoracic endovascular aortic repair Reviewed International journal

    Yohei Kawatani, Hirotsugu Kurobe, Yoshitsugu Nakamura, Yuji Suda, Takaki Hori

    JOURNAL OF SURGICAL CASE REPORTS   2017 ( 5 )   rjx092   2017

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:OXFORD UNIV PRESS  

    Thoracic endovascular aortic repair (TEVAR) has been reported to be an effective treatment option for aortic emergencies. However, there are few reports about TEVAR for aortic rupture due to radiation injury. A 54-year-old man presented with haemoptysis. He had a history of lung cancer, which had been treated with chemotherapy and radiation therapy (72 Gy/16 times) 3 years previously, and the cancer lesion did not progress. On chest radiography, pneumonia was suspected in the radiated lesion. However, after admission, he presented with back pain, progressive anaemia and hypotension. Enhanced computed tomography revealed extravasation of contrast medium in the distal aortic arch. He was diagnosed with aortic rupture due to radiation injury. TEVAR was performed. He was extubated one day after the operation, and the haemoptysis disappeared. He was discharged from the hospital without any complications. He is well 1 year after the surgery, without aortic disease progression or lung cancer recurrence.

    DOI: 10.1093/jscr/rjx092

    Web of Science

    PubMed

    researchmap

  • Effects of transplanted human cord blood-mononuclear cells on pulmonary hypertension in immunodeficient mice and their distribution Reviewed

    Mikio Sugano, Homare Yoshida, Hirotsugu Kurobe, Hiroki Arase, Hajime Kinoshita, Takashi Kitaichi, Noriko Sugasawa, Soichiro Nakayama, Kazuhisa Maeda, Minoru Irahara, Tetsuya Kitagawa

    Journal of Medical Investigation   64 ( 1-2 )   43 - 49   2017

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:UNIV TOKUSHIMA SCH MEDICINE  

    Objectives: To investigate the effects of human umbilical cord blood-derived mononuclear cell (hUCB-MNC) transplantation on pulmonary hypertension (PH) induced by monocrotaline (MCT) in immunodeficient mice and their distribution. Methods: MCT was administered to BALB/c Slc-nu/nu mice, and PH was induced in mice 4 weeks later. Fresh hUCB-MNCs harvested from a human donor after her delivery were injected intravenously into those PH mice. The medial thickness of pulmonary arterioles, ratio of right ventricular to septum plus left ventricular weight (RV/S+LV), and ratio of acceleration time to ejection time of pulmonary blood flow waveform (AT/ET) were determined 4 weeks after hUCB-MNC transplantation. To reveal the incorporation into the lung, CMTMR-labeled hUCB-MNCs were observed in the lung by fluorescent microscopy. DiR-labeled hUCB-MNCs were detected in the lung and other organs by bioluminescence images. Results: Medial thickness, RV/S+ LV and AT/ET were significantly improved 4 weeks after hUCB-MNC transplantation compared with those in mice without hUCB-MNC transplantation. CMTMR-positive hUCB-MNCs were observed in the lung 3 hours after transplantation. Bioluminescence signals were detected more strongly in the lung than in other organs for 24 hours after transplantation. Conclusions: The results indicate that hUCB-MNCs are incorporated into the lung early after hUCB-MNC transplantation and improve MCT-induced PH.

    DOI: 10.2152/jmi.64.43

    Web of Science

    Scopus

    PubMed

    researchmap

  • Novel Bioresorbable Vascular Graft With Sponge-Type Scaffold as a Small-Diameter Arterial Graft Reviewed International journal

    Tadahisa Sugiura, Shuhei Tara, Hidetaka Nakayama, Hirotsugu Kurobe, Tai Yi, Yong Ung Lee, Avione Y. Lee, Christopher K. Breuer, Toshiharu Shinoka

    Annals of Thoracic Surgery   102 ( 3 )   720 - 727   2016.9

     More details

    Language:English   Publishing type:Research paper (international conference proceedings)   Publisher:ELSEVIER SCIENCE INC  

    Background Current commercialized small-diameter arterial grafts have not shown clinical effectiveness due to their poor patency rates. The present study evaluated the feasibility of an arterial bioresorbable vascular graft, which has a porous sponge-type scaffold, as a small-diameter arterial conduit. Methods The grafts were constructed by a 50:50 poly (1-lactic-co-ε-caprolactone) copolymer (PLCL) scaffold reinforced by a poly (1-lactic acid) (PLA) nanofiber. The pore size of the PLCL scaffold was adjusted to a small size (12.8 ± 1.85 μm) or a large size (28.5 ± 5.25 μm). We compared the difference in cellular infiltration, followed by tissue remodeling, between the groups. The grafts were implanted in 8- to 10-week-old female mice (n = 15 in each group) as infrarenal aortic interposition conduits. Animals were monitored for 8 weeks and euthanized to evaluate neotissue formation. Results No aneurysmal change or graft rupture was observed in either group. Histologic assessment demonstrated favorable cell infiltration into scaffolds, neointimal formation with endothelialization, smooth muscle cell proliferation, and elastin deposition in both groups. No significant difference was observed between the groups. Immunohistochemical characterization with anti-F4/80 antibody demonstrated that macrophage infiltration into the grafts occurred in both groups. Staining for M1 and M2, which are the two major macrophage phenotypes, showed no significant difference between groups. Conclusions Our novel bioresorbable vascular grafts showed well-organized neointimal formation in the high-pressure arterial circulation environment. The large-pore scaffold did not improve cellular infiltration and neotissue formation compared with the small-pore scaffold.

    DOI: 10.1016/j.athoracsur.2016.01.110

    Web of Science

    Scopus

    PubMed

    researchmap

  • The pathophysiological role of oxidized cholesterols in epicardial fat accumulation and cardiac dysfunction: a study in swine fed a high caloric diet with an inhibitor of intestinal cholesterol absorption, ezetimibe Reviewed International journal

    Michio Shimabukuro, Chinami Okawa, Hirotsugu Yamada, Shuhei Yanagi, Etsuko Uematsu, Noriko Sugasawa, Hirotsugu Kurobe, Yoichiro Hirata, Joo ri Kim-Kaneyama, Xiao Feng Lei, Shoichiro Takao, Yasutake Tanaka, Daiju Fukuda, Shusuke Yagi, Takeshi Soeki, Tetsuya Kitagawa, Hiroaki Masuzaki, Masao Sato, Masataka Sata

    Journal of Nutritional Biochemistry   35   66 - 73   2016.9

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:ELSEVIER SCIENCE INC  

    Oxidized cholesterols (oxycholesterols) in food have been recognized as strong atherogenic components, but their tissue distributions and roles in cardiovascular diseases remain unclear. To investigate whether accumulation of oxycholesterols is linked to cardiac morphology and function, and whether reduction of oxycholesterols can improve cardiac performance, domestic male swine were randomized to a control diet (C), high caloric diet (HCD) or HCD + Ezetimibe, an inhibitor of intestinal cholesterol absorption, group (HCD + E) and evaluated for: (1) distribution of oxycholesterol components in serum and tissues, (2) levels of oxycholesterol-related enzymes, (3) paracardial and epicardial coronary fat thickness, and (4) cardiac performance. Ezetimibe treatment for 8 weeks attenuated increases in oxycholesterols in the HCD group almost completely in liver, but reduced only levels of 4β-hydroxycholesterol in left ventricular (LV) myocardium. Ezetimibe treatment altered the expression of genes for cholesterol and fatty acid metabolism and decreased the expression of CYP3A46, which catabolizes cholesterol to 4β-hydroxycholesterol, strongly in liver. An increase in epicardial fat thickness and impaired cardiac performance in the HCD group were improved by ezetimibe treatment, and the improvement was closely related to the reduction in levels of 4β-hydroxycholesterol in LV myocardium. In conclusion, an increase in oxycholesterols in the HCD group was closely related to cardiac hypertrophy and dysfunction, as well as an increase in epicardial fat thickness. Ezetimibe may directly reduce oxycholesterol in liver and LV myocardium, and improve cardiac morphology and function.

    DOI: 10.1016/j.jnutbio.2016.05.010

    Web of Science

    Scopus

    PubMed

    researchmap

  • 糖転移ヘスペリジン 分散ヘスペレチンの動脈硬化病巣進展に対する抑制効果についての検討

    菅澤 典子, 西雄 千佳, 中山 泰介, 黒部 裕嗣, 宅見 央子, 東口 文治, 粟飯原 賢一, 島袋 充生, 佐田 政隆, 北川 哲也

    日本病態栄養学会誌   19 ( 3 )   351 - 360   2016.9

     More details

    Language:Japanese   Publisher:(一社)日本病態栄養学会  

    ヘスペリジン(ビタミンP)はフラボノイドの一種であり、その生理作用は抗酸化作用・血流改善効果・毛細血管の強化・血中コレステロール値の改善効果・抗アレルギー作用など多数報告され、動脈硬化に対しても抑制作用が期待される。ヘスペリジンを酵素処理して配糖化し体内吸収性を高めた糖転移ヘスペリジンと、ヘスペリジンのアグリコンであるヘスペレチンに微粒子化処理を行い水への分散性を高めた分散ヘスペレチンを、動脈硬化モデルである高脂肪食負荷ApoEノックアウトマウスに12週間混餌投与した。大動脈起始部の硬化巣面積は、投与群で有意に減少しており、血中の総コレステロール値においても投与群で有意に低かった。免疫染色を用いて硬化巣におけるマクロファージを検出したところ、投与群で浸潤が減少していることが示唆された。これらの結果より、糖転移ヘスペリジン及び分散ヘスペレチンが動脈硬化進展に対して抑制効果をもつ可能性が示唆された。(著者抄録)

    researchmap

  • Thoracic endovascular aortic repair of a severely angulated aorta using a double-wire technique Reviewed International journal

    Yohei Kawatani, Yoshitsugu Nakamura, Yujiro Hayashi, Tetsuyoshi Taneichi, Yujiro Ito, Hirotsugu Kurobe, Yuji Suda, Takaki Hori

    JOURNAL OF SURGICAL CASE REPORTS   2016 ( 7 )   2016.7

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:OXFORD UNIV PRESS  

    When endovascular treatment is performed, angulation of the access route for a device can make the operative procedure difficult. We encountered a case in which we successfully completed thoracic endovascular aortic repair (TEVAR) in a patient with severely angulated aorta by applying 'double-wire technique'. The patient was an 80-year-old woman. An aneurysm with a 71-mm diameter was observed in the descending aorta. We performed TEVAR. Device delivery could not be achieved by a conventional procedure using one guide wire since the peripheral aorta was severely angulated. Therefore, in addition to a guide wire for main body, a stiff wire and a stiff sheath were introduced to straighten the angulation. The device was successfully introduced and TEVAR was completed. We used the Relay Plus(A (R)) that facilitates tracking through the angulation. The device has a dual structure consisting of a hard sheath and a flexible sheath. We performed TEVAR successfully.

    DOI: 10.1093/jscr/rjw125

    Web of Science

    PubMed

    researchmap

  • Correlations of perioperative coagulopathy, fluid infusion and blood transfusions with survival prognosis in endovascular aortic repair for ruptured abdominal aortic aneurysm Reviewed International journal

    Yohei Kawatani, Yoshitsugu Nakamura, Hirotsugu Kurobe, Yuji Suda, Takaki Hori

    World Journal of Emergency Surgery   11 ( 1 )   29 - 29   2016.6

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:BMC  

    Background: Factors associated with survival prognosis among patients who undergo endovascular aortic repair (EVAR) for ruptured abdominal aortic aneurysms (rAAA) have not been sufficiently investigated. In the present study, we examined correlations between perioperative coagulopathy and 24-h and 30-day postoperative survival. Relationships between coagulopathy and the content of blood transfusions, volumes of crystalloid infusion and survival. Methods: This was a retrospective study of the medical records of all patients who underwent EVAR for rAAA at Chiba-Nishi General Hospital during the period from October 2013 to December 2015. Major coagulopathy was defined using the international normalized ratio or activated partial thromboplastin time (APTT) ratio of at least 1.5, or platelet count less than 50 × 10/l. We quantified the amounts of blood transfusions and crystalloid infusions administered from arrival to the hospital to admission to ICU following operations. Results: Coagulopathy among patients with rAAA was found to progress even after they had presented at the hospital. No statistically significant correlation between preoperative coagulopathy and mortality was found, although a significantly greater degree of postoperative coagulopathy was seen among patients who died both within 24-h and 30 days postoperatively. Among patients with postoperative coagulopathy, lesser quantities of fresh frozen plasma (FFP) compared with red cell concentrate (RCC) were used during the period from hospital arrival to postoperative ICU entry. In both groups of patients who did not survive after 24-h and 30 days, FFP was used less than RCC. Large transfusions of crystalloids administered during the periods from hospital arrival to surgery and from hospital arrival to the end of surgery were associated with postoperative incidence of major coagulopathy, death within 24-h, and death within 30 days. Conclusion: Coagulopathy progressed during care in the emergency outpatient clinic and operations. Postoperative coagulopathy was associated with poorer outcomes. Smaller FFP/RCC ratios and larger volumes of crystalloid infusion were associated with development of coagulopathy and poorer prognosis of survival. Trial registration: This study is retrospectively registered in UMIN Clinical Trials Registry (Registration 19 April 2016, registered number is R000025334 UMIN000021978 ).

    DOI: 10.1186/s13017-016-0087-0

    Web of Science

    Scopus

    PubMed

    researchmap

  • Contrast Medium Induced Nephropathy after Endovascular Stent Graft Placement: An Examination of Its Prevalence and Risk Factors Reviewed International journal

    Yohei Kawatani, Yoshitsugu Nakamura, Yoshihiko Mochida, Naoya Yamauchi, Yujiro Hayashi, Tetsuyoshi Taneichi, Yujiro Ito, Hirotsugu Kurobe, Yuji Suda, Takaki Hori

    RADIOLOGY RESEARCH AND PRACTICE   2016   5950986 - 5950986   2016

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:HINDAWI LTD  

    Endovascular stent graft placement has become a major treatment for thoracic and abdominal aneurysms. While endovascular therapy is less invasive than open surgery, it involves the use of a contrast medium. Contrast media can cause renal impairment, a condition termed as contrast-induced nephropathy (CIN). This study sought to evaluate the incidence and risk factors of CIN following endovascular stent graft placement for aortic aneurysm repair. The study included 167 consecutive patients who underwent endovascular stent graft placement in our hospital from October 2013 to June 2014. CIN was diagnosed using the European Society of Urogenital Radiology criteria. Patients with and without CIN were compared. Chi-squared tests, t -tests, and multivariate logistic regression analyses were performed. Thirteen patients (7.8%) developed CIN. Left ventricular dysfunction and intraoperative blood transfusion were significantly more frequent in the CIN group (P = 0.017 and P = 0.032, resp.). Multivariate analysis showed that left ventricular dysfunction had the strongest influence on CIN development (odds ratio 9.34, P = 0.018, and 95% CI - 1.46-59.7). Patients with CIN also experienced longer ICU and hospital stays. Measures to improve renal perfusion flow should be considered for patients with left ventricular dysfunction who are undergoing endovascular stent graft placement.

    DOI: 10.1155/2016/5950986

    Web of Science

    PubMed

    researchmap

  • PPAR-γ agonist attenuates inflammation in aortic aneurysm patients Reviewed

    Tatsuo Motoki, Hirotsugu Kurobe, Yoichiro Hirata, Taisuke Nakayama, Hajime Kinoshita, Kevin A. Rocco, Hitoshi Sogabe, Takaki Hori, Masataka Sata, Tetsuya Kitagawa

    General Thoracic and Cardiovascular Surgery   63 ( 10 )   565 - 571   2015.10

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:SPRINGER JAPAN KK  

    Background and objective: Peroxisome proliferator-activated receptor (PPAR) -γ agonist, which is an anti-diabetes drug and reduces expression of tumor necrosis factor (TNF)-α, reported to have the effects for anti-inflammation in our body. In cardiovascular fields, this PPAR-γ agonist already reported to suppress progression of coronary atherosclerosis. Various cytokines, which is secreted from fat tissues around artery, promote atherosclerosis and/or aneurysmal changes in aorta/artery. Objective of our study is to clarify whether PPAR-γ agonist has anti-inflammatory effects in aorta of patients with aortic aneurysm (AA). Patients and methods: The medical ethics committee in Tokushima University Hospital approved protocol for this study. Sixteen patients with AA (more than 5 cm in diameter, scheduled open surgery) were divided into two groups; one is PPAR-γ agonist administrating group $$\langle$$⟨n = 6, group P$$\rangle$$⟩, and another is the without group $$\langle$$⟨n = 10, group C$$\rangle$$⟩. PPAR-γ agonist, whose dose was 15 mg/day, was administrated in the group P for more than 2 months before aneurysectomy and grafting (mean; 4.2 ± 3.4 months) (Supplemental Table 1). Biopsy specimens were obtained from abdominal subcutaneous fat, greater omentum, retroperitoneal periaortic fat and aneurysmal wall in surgical procedure. Blood examination also achieved before/after procedure. Harvested specimens were analyzed with histology (HE and EVG), immunohistochemistry (macrophage) and RT-PCR (adiponectin, MCP-1, TNF-α, CD68, matrix metalloprotease (MMP)-2, MMP-9). Results: Macrophage infiltration in aortic wall and retroperitoneal periaortic fat among group P was significantly decreased compared to that among group C. Adiponectin expressions in both subcutaneous fat and retroperitoneal periaortic fat among the group P (adiponectin/β-actin) were significantly increased compared to those among the group C [subcutaneous fat; 16.8 ± 13.9 vs. 5.82 ± 2.94 (P = 0.04), retroperitoneal periaortic fat; 21.3 ± 24.1 vs. 2.12 ± 1.69 (P = 0.04)]. On the other hand, expressions of TNF-α, and MMP-9 in both aortic aneurysmal wall and retroperitoneal periaortic fat among group P were significantly decreased. [(Aortic aneurysmal wall; TNF-α; 0.45 ± 0.15 vs. 5.18 ± 3.49 (P = 0.02), MMP-9; 39.6 ± 69.0 vs. 721 ± 741 (P = 0.04)], [retroperitoneal periaortic fat; TNF-α; 1.14 ± 0.36 vs. 26.4 ± 25.0 (P = 0.048), MMP-9; 0.18 ± 0.21 vs. 50.0 ± 41.8 (P = 0.047)]. Conclusion: These data may indicate that PPAR-γ agonist become the way for preventing or delaying aortic aneurysm progression in patients. More studies will be needed to clarify this drug effects in detail.

    DOI: 10.1007/s11748-015-0576-1

    Web of Science

    Scopus

    PubMed

    researchmap

  • Successful Surgical Repair of Aged Sinus Venosus Atrial Septal Defect with Partial Anomalous Pulmonary Venous Connection: A Case Report Reviewed

    Muneyuki Kadota, Takayuki Ise, Shusuke Yagi, Kenya Kusunose, Hajime Kinoshita, Hirotsugu Kurobe, Hirotsugu Yamada, Takeshi Soeki, Tetsuzo Wakatsuki, Masataka Sata

    JOURNAL OF CARDIAC FAILURE   21 ( 10 )   S185 - S185   2015.10

     More details

    Language:English   Publisher:CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS  

    DOI: 10.1016/j.cardfail.2015.08.233

    Web of Science

    researchmap

  • Cilostazol, not aspirin, prevents stenosis of bioresorbable vascular grafts in a venous model Reviewed International journal

    Shuhei Tara, Hirotsugu Kurobe, Juan De Dios Ruiz Rosado, Cameron A. Best, Toshihiro Shoji, Nathan Mahler, Tai Yi, Yong Ung Lee, Tadahisa Sugiura, Narutoshi Hibino, Santiago Partida-Sanchez, Christopher K. Breuer, Toshiharu Shinoka

    Arteriosclerosis, Thrombosis, and Vascular Biology   35 ( 9 )   2003 - 2010   2015.9

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:LIPPINCOTT WILLIAMS & WILKINS  

    Objective - Despite successful translation of bioresorbable vascular grafts for the repair of congenital heart disease, stenosis remains the primary cause of graft failure. In this study, we investigated the efficacy of long-term treatment with the antiplatelet drugs, aspirin and cilostazol, in preventing stenosis and evaluated the effect of these drugs on the acute phase of inflammation and tissue remodeling. Approach and Results - C57BL/6 mice were fed a drug-mixed diet of aspirin, cilostazol, or normal chow during the course of follow-up. Bioresorbable vascular grafts, composed of poly(glycolic acid) mesh sealed with poly(l-lactide-co-ε-caprolactone), were implanted as inferior vena cava interposition conduits and followed up for 2 weeks (n=10 per group) or 24 weeks (n=15 per group). Both aspirin and cilostazol suppressed platelet activation and attachment onto the grafts. On explant at 24 weeks, well-organized neotissue had developed, and cilostazol treatment resulted in 100% graft patency followed by the aspirin (67%) and no-treatment (60%) groups (P<0.05). Wall thickness and smooth muscle cell proliferation in the neotissue of the cilostazol group were decreased when compared with that of the no-treatment group at 24 weeks. In addition, cilostazol was shown to have an anti-inflammatory effect on neotissue at 2 weeks by regulating the recruitment and activation of monocytes. Conclusions - Cilostazol prevents stenosis of bioresorbable vascular graft in a mouse inferior vena cava implantation model up to 24 weeks and is accompanied by reduction of smooth muscle cell proliferation and acute inflammation.

    DOI: 10.1161/ATVBAHA.115.306027

    Web of Science

    Scopus

    PubMed

    researchmap

  • Evaluation of remodeling process in small-diameter cell-free tissue-engineered arterial graft Reviewed International journal

    Shuhei Tara, Hirotsugu Kurobe, Mark W. Maxfield, Kevin A. Rocco, Tai Yi, Yuji Naito, Christopher K. Breuer, Toshiharu Shinoka

    Journal of Vascular Surgery   62 ( 3 )   734 - 743   2015.9

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:MOSBY-ELSEVIER  

    Objective Autologous grafts are used to repair atherosclerotic cardiovascular diseases; however, many patients lack suitable donor graft tissue. Recently, tissue engineering techniques have emerged to make biologically active blood vessels. We applied this technique to produce arterial grafts using established biodegradable materials without cell seeding. The grafts were evaluated in vivo for vessel remodeling during 12 months. Methods Poly(l-lactide-co-ε-caprolactone) scaffolds reinforced by poly(lactic acid) (PLA) fiber were prepared as arterial grafts. Twenty-eight cell-free grafts were implanted as infrarenal aortic interposition grafts in 8-week-old female SCID/Bg mice. Serial ultrasound and micro computed tomography angiography were used to monitor grafts after implantation. Five grafts were harvested for histologic assessments and reverse transcription-quantitative polymerase chain reaction analysis at time points ranging from 4 months to 1 year after implantation. Results Micro computed tomography indicated that most implanted mice displayed aneurysmal changes (three of five mice at 4 months, four of five mice at 8 months, and two of five mice at 12 months). Histologic assessments demonstrated extensive tissue remodeling leading to the development of well-circumscribed neovessels with an endothelial inner lining, a neointima containing smooth muscle cells and elastin, and a collagen-rich extracellular matrix. There were a few observed calcified deposits, located around residual PLA fibers at 12 months after implantation. Macrophage infiltration into the scaffold, as evaluated by F4/80 immunohistochemical staining, remained after 12 months and was focused mostly around residual PLA fibers. Reverse transcription-quantitative polymerase chain reaction analysis revealed that gene expression of Itgam, a marker for macrophages, and of matrix metalloproteinase 9 was higher than in native aorta during the course of 12 months, indicating prolonged inflammation (Itgam at 8 months: 11.75 ± 0.99 vs native aorta, P <.01; matrix metalloproteinase 9 at 4 months: 4.35 ± 3.05 vs native aorta, P <.05). Conclusions In this study, we demonstrated well-organized neotissue of cell-free biodegradable arterial grafts. Although most grafts experienced aneurysmal change, such findings provide insight into the process of tissue-engineered vascular graft remodeling and should allow informed rational design of the next generation of arterial grafts.

    DOI: 10.1016/j.jvs.2014.03.011

    Web of Science

    Scopus

    PubMed

    researchmap

  • Comparison of the Biological Equivalence of Two Methods for Isolating Bone Marrow Mononuclear Cells for Fabricating Tissue-Engineered Vascular Grafts Reviewed International journal

    Hirotsugu Kurobe, Shuhei Tara, Mark W. Maxfield, Kevin A. Rocco, Paul S. Bagi, Tai Yi, Brooks V. Udelsman, Ethan W. Dean, Ramak Khosravi, Heather M. Powell, Toshiharu Shinoka, Christopher K. Breuer

    Tissue Engineering - Part C: Methods   21 ( 6 )   597 - 604   2015.6

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:MARY ANN LIEBERT, INC  

    Our approach for fabricating tissue-engineered vascular grafts (TEVG), applied in the surgical management of congenital heart disease, is accomplished by seeding isolated bone marrow-derived mononuclear cells (BM-MNCs) onto biodegradable scaffolds. The current method used for isolation of BM-MNCs is density centrifugation in Ficoll. This is a time-consuming, labor-intensive, and operator-dependent method. We previously demonstrated that a simpler, faster, and operator-independent method for isolating BM-MNCs using a filter elution technique was feasible. In this study, we compare the use of each technique to determine if the BM-MNCs isolated by the filtration elution method are biologically equivalent to BM-MNCs isolated using density centrifugation. Scaffolds were constructed from a nonwoven poly(glycolic acid) fiber mesh coated with 50:50 poly(l-lactide-co-ε-caprolactone) sealant. BM-MNCs were isolated from the bone marrow of syngeneic C57BL/6 mice by either density centrifugation with Ficoll or filtration (Ficoll vs. Filter), then statically seeded onto scaffolds, and incubated overnight. The TEVG were implanted in 10-week-old C57BL/6 mice (n=23 for each group) as inferior vena cava interposition grafts and explanted at 14 days for analysis. At 14 days after implantation, there were no significant differences in graft patency between groups (Ficoll: 87% vs. Filter: 78%, p=0.45). Morphometric analysis by hematoxylin and eosin staining showed no difference of graft luminal diameter or neointimal thickness between groups (luminal diameter, Ficoll: 620.3±82.9 μm vs. Filter: 633.3±131.0 μm, p=0.72; neointimal thickness, Ficoll: 37.9±7.8 μm vs. Filter: 37.9±11.2 μm, p=0.99). Histologic examination demonstrated similar degrees of cellular infiltration and extracellular matrix deposition, and endothelial cell coverage on the luminal surface, in either group. Macrophage infiltration showed no difference in the number of F4/80-positive cells or macrophage phenotypes between the two experimental groups (Ficoll: 2041±1048 cells/mm<sup>2</sup> vs. Filter: 1887±907.7 cells/mm<sup>2</sup>, p=0.18). We confirmed the biological equivalence of BM-MNCs, isolated using either density centrifugation or filtration, for making TEVG.

    DOI: 10.1089/ten.tec.2014.0442

    Web of Science

    Scopus

    PubMed

    researchmap

  • Development of small diameter nanofiber tissue engineered arterial grafts Reviewed International journal

    Hirotsugu Kurobe, Mark W. Maxfield, Shuhei Tara, Kevin A. Rocco, Paul S. Bagi, Tai Yi, Brooks Udelsman, Zhen W. Zhuang, Muriel Cleary, Yasuko Iwakiri, Christopher K. Breuer, Toshiharu Shinoka

    PLoS ONE   10 ( 4 )   e0120328   2015.4

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:PUBLIC LIBRARY SCIENCE  

    The surgical repair of heart and vascular disease often requires implanting synthetic grafts. While synthetic grafts have been successfully used for medium-to-large sized arteries, applications for small diameter arteries (<6 mm) is limited due to high rates of occlusion by thrombosis. Our objective was to develop a tissue engineered vascular graft (TEVG) for small diameter arteries. TEVGs composed of polylactic acid nanofibers with inner luminal diameter between 0.5 and 0.6 mm were surgically implanted as infra-renal aortic interposition conduits in 25 female C17SCID/bg mice. Twelve mice were given sham operations. Survival of mice with TEVG grafts was 91.6%at 12 months post-implantation (sham group: 83.3%). No instances of graft stenosis or aneurysmal dilatation were observed over 12 months post-implantation, assessed by Doppler ultrasound and microCT. Histologic analysis of explanted TEVG grafts showed presence of CD31-positive endothelial monolayer and F4/80-positive macrophages after 4, 8, and 12 months in vivo . Cells positive for innodataalpha-smooth muscle actin were observed within TEVG, demonstrating presence of smooth muscle cells (SMCs). Neo-extracellular matrix consisting mostly of collagen types I and III were observed at 12 months post-implantation. PCR analysis supports histological observations. TEVG group showed significant increases in expressions of SMC marker, collagen-I and III, matrix metalloproteinases-2 and 9, and itgam (a macrophage marker), when compared to sham group. Overall, patency rates were excellent at 12 months after implantation, as structural integrity of these TEVG. Tissue analysis also demonstrated vessel remodeling by autologous cell.

    DOI: 10.1371/journal.pone.0120328

    Web of Science

    Scopus

    PubMed

    researchmap

  • TGFβR1 inhibition blocks the formation of stenosis in tissue-engineered vascular grafts Reviewed International journal

    Daniel R. Duncan, Pei Yu Chen, Joseph T. Patterson, Yong Ung Lee, Narutoshi Hibino, Muriel Cleary, Yuji Naito, Tai Yi, Thomas Gilliland, Hirotsugu Kurobe, Spencer N. Church, Toshiharu Shinoka, Tarek M. Fahmy, Michael Simons, Christopher K. Breuer

    Journal of the American College of Cardiology   65 ( 5 )   512 - 514   2015.2

     More details

    Language:English   Publisher:ELSEVIER SCIENCE INC  

    DOI: 10.1016/j.jacc.2014.08.057

    Web of Science

    Scopus

    PubMed

    researchmap

  • Comparison of a closed system to a standard open technique for preparing tissue-engineered vascular grafts Reviewed International journal

    Hirotsugu Kurobe, Mark W. Maxfield, Yuji Naito, Muriel Cleary, Mitchel R. Stacy, Daniel Solomon, Kevin A. Rocco, Shuhei Tara, Avione Y. Lee, Albert J. Sinusas, Edward L. Snyder, Toshiharu Shinoka, Christopher K. Breuer

    Tissue Engineering - Part C: Methods   21 ( 1 )   88 - 93   2015.1

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:MARY ANN LIEBERT, INC  

    We developed a prototype for a closed apparatus for assembling tissue-engineered vascular grafts (TEVGs) with the goal of creating a simple operator-independent method for making TEVGs to optimize safety and enable widespread application of this technology. The TEVG is made by seeding autologous bone marrow-derived mononuclear cells onto a biodegradable tubular scaffold and is the first man-made vascular graft to be successfully used in humans. A critical barrier, which has prevented the widespread clinical adoption of the TEVG, is that cell isolation, scaffold seeding, and incubation are performed using an open method. To reduce the risk of contamination, the TEVG is assembled in a clean room. Clean rooms are expensive to build, complex to operate, and are not available in most hospitals. In this investigation, we used an ovine model to compare the safety and efficacy of TEVGs created using either a standard density centrifugation-based open method or the new filter-based closed system. We demonstrated no graft-related complications and maintenance of growth capacity in TEVGs created using the closed apparatus. In addition, the use of the closed system reduced the amount of time needed to assemble the TEVG by ∼50%. Adaptation of similar methodologies may facilitate the safe translation and the widespread use of other tissue engineering technologies.

    DOI: 10.1089/ten.tec.2014.0160

    Web of Science

    Scopus

    PubMed

    researchmap

  • Development of Delirium in the Intensive Care Unit in Patients after Endovascular Aortic Repair: A Retrospective Evaluation of the Prevalence and Risk Factors Reviewed International journal

    Yohei Kawatani, Yoshitsugu Nakamura, Yujiro Hayashi, Tetsuyoshi Taneichi, Yujiro Ito, Hirotsugu Kurobe, Yuji Suda, Takaki Hori

    CRITICAL CARE RESEARCH AND PRACTICE   2015   405817 - 405817   2015

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:HINDAWI LTD  

    Delirium is an acute form of nervous system dysfunction often observed in patients in the intensive care unit. Endovascular aortic repair (EVAR) is considered a minimally invasive surgical treatment for abdominal aortic aneurysm. Although the operation method is widely used, there are few investigations of the rate and risk factors of delirium development after the operation. In this study, we retrospectively examined the rate of delirium development in the intensive care unit (ICU) after EVAR, as well as the associated preoperative risk factors and effects on the lengths of ICU and hospital stays. We examined the 81 consecutive patients who underwent elective EVAR between November 2013 and August 2014. The Intensive Care Delirium Screening Checklist was used to diagnose delirium. Twenty patients (24.7%) were diagnosed with delirium in this study. The ICU and hospital length of stays of patients with delirium were 3.3 +/- 2.4 days and 14.5 +/- 11.9 days, respectively, the latter of which was significantly longer than that of patients without delirium (p = 0.019). Additionally, renal dysfunction, preoperative benzodiazepine use, and intraoperative transfusion were found to be risk factors for the development of delirium after elective EVAR.

    DOI: 10.1155/2015/405817

    Web of Science

    PubMed

    researchmap

  • Development of delirium in the intensive care unit in patients after endovascular aortic repair: A retrospective evaluation of the prevalence and risk factors Reviewed

    Yohei Kawatani, Yoshitsugu Nakamura, Yujiro Hayashi, Tetsuyoshi Taneichi, Yujiro Ito, Hirotsugu Kurobe, Yuji Suda, Takaki Hori

    Critical Care Research and Practice   2015   2015

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:HINDAWI PUBLISHING CORP  

    Delirium is an acute form of nervous system dysfunction often observed in patients in the intensive care unit. Endovascular aortic repair (EVAR) is considered a minimally invasive surgical treatment for abdominal aortic aneurysm. Although the operation method is widely used, there are few investigations of the rate and risk factors of delirium development after the operation. In this study, we retrospectively examined the rate of delirium development in the intensive care unit (ICU) after EVAR, as well as the associated preoperative risk factors and effects on the lengths of ICU and hospital stays. We examined the 81 consecutive patients who underwent elective EVAR between November 2013 and August 2014. The Intensive Care Delirium Screening Checklist was used to diagnose delirium. Twenty patients (24.7%) were diagnosed with delirium in this study. The ICU and hospital length of stays of patients with delirium were 3.3 ± 2.4 days and 14.5 ± 11.9 days, respectively, the latter of which was significantly longer than that of patients without delirium (p= 0.019). Additionally, renal dysfunction, preoperative benzodiazepine use, and intraoperative transfusion were found to be risk factors for the development of delirium after elective EVAR.

    DOI: 10.1155/2015/405817

    Web of Science

    Scopus

    researchmap

  • A Case Report on the Successful Treatment of Streptococcus pneumoniae-Induced Infectious Abdominal Aortic Aneurysm Initially Presenting with Meningitis Reviewed International journal

    Yohei Kawatani, Yoshitsugu Nakamura, Yujiro Hayashi, Tetsuyoshi Taneichi, Yujiro Ito, Hirotsugu Kurobe, Yuji Suda, Takaki Hori

    CASE REPORTS IN SURGERY   2015   825069 - 825069   2015

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:HINDAWI LTD  

    Infectious abdominal aortic aneurysms often present with abdominal and lower back pain, but prolonged fever may be the only symptom. Infectious abdominal aortic aneurysms initially presenting with meningitis are extremely rare; there are no reports of their successful treatment. Cases with Streptococcus pneumoniae as the causative bacteria are even rarer with a higher mortality rate than those caused by other bacteria. We present the case of a 65-year-old man with lower limb weakness and back pain. Examination revealed fever and neck stiffness. Cerebrospinal fluid showed leukocytosis and low glucose levels. The patient was diagnosed with meningitis and bacteremia caused by Streptococcus pneumoniae and treated with antibiotics. Fever, inflammatory response, and neurologic findings showed improvement. However, abdominal computed tomography revealed an aneurysm not present on admission. Antibiotics were continued, and a rifampicin soaked artificial vascular graft was implanted. Tissue cultures showed no bacteria, and histological findings indicated inflammation with high leukocyte levels. There were no postoperative complications or neurologic abnormalities. Physical examination, blood tests, and computed tomography confirmed there was no relapse over the following 13 months. This is the first reported case of survival of a patient with an infectious abdominal aortic aneurysm initially presenting with meningitis caused by Streptococcus pneumoniae.

    DOI: 10.1155/2015/825069

    Web of Science

    PubMed

    researchmap

  • A Case of Ruptured Aortic Arch Aneurysm Successfully Treated by Thoracic Endovascular Aneurysm Repair with Chimney Graft Reviewed International journal

    Yohei Kawatani, Yujiro Hayashi, Yujiro Ito, Hirotsugu Kurobe, Yoshitsugu Nakamura, Yuji Suda, Takaki Hori

    CASE REPORTS IN SURGERY   2015   780147 - 780147   2015

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:HINDAWI LTD  

    We report the case of aortic arch aneurysm rupture treated successfully with thoracic endovascular aneurysm repair ( TEVAR) accompanied by aortic arch debranching using the chimney graft technique. A 94-year-old man was transported to the hospital after complaining of chest pain for one day. Contrast-enhanced computed tomographic ( CT) images revealed an aortic arch aneurysm rupture. Considering the patient's age and postoperative activities of daily living, TEVAR was used. In order to place an indwelling stent graft from the ascending aorta to the periphery, the chimney graft technique was used to debranch the brachiocephalic artery. Hemodynamics was stabilized postsurgically. Plain CT performed 20 days postoperatively confirmed that the intrathoracic hematoma had decreased in size. Although respiratory failure was persistent, there were improvements and the patient was extubated 34 days postoperatively and discharged from the intensive care unit 37 days postoperatively. On postoperative day 75, he was discharged from the hospital toanelder care facility. Few reports have focused on stent grafting for treating aortic arch aneurysm rupture. TEVAR using the chimney graft technique could be an effective treatment option for patients with a decreased ability to tolerate surgery.

    DOI: 10.1155/2015/780147

    Web of Science

    PubMed

    researchmap

  • Efficacy and Optimal Timing of Endovascular Treatment for Type B Aortic Dissection. Reviewed

    Hajime Kinoshita, Eiki Fujimoto, Hiroki Arase, Hirotsugu Kurobe, Fumio Chikugo, Hitoshi Sogabe, Takashi Kitaichi, Tetsuya Kitagawa

    Annals of vascular diseases   8 ( 4 )   307 - 13   2015

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    OBJECTIVES: To determine the efficacy and the optimal timing of thoracic endovascular aortic repair (TEVAR) for closing the primary entry in uncomplicated patients with chronic type B aortic dissection and a patent false lumen (FL). METHODS: Thirteen patients underwent TEVAR for aortic dissection between 2008 and 2012. These patients had chronic dissection with a patent FL and expansion of the aorta. Early TEVAR was performed for five patients within 1-7 months from the index dissection (TEVAR-EC group) and delayed TEVAR was performed for eight patients within 1-16 years (TEVAR-DC group). Changes in the diameters and volumes of the true lumen (TL) and FL and the aortic remodeling were assessed by multidetector computed tomography for 3 years after TEVAR. RESULTS: The reduction rate of FL in the thoracic aorta was notably higher in the TEVAR-EC group than in the TEVAR-DC group regardless of the presence or absence of distal retrograde flow. There was a significant TL expansion despite different timings of TEVAR. CONCLUSIONS: Early TEVAR resulted in good prognosis and preferable aortic remodeling in uncomplicated patients with chronic type B aortic dissection and a patent FL, and we recommend early TEVAR within seven months after the index dissection.

    DOI: 10.3400/avd.oa.15-00069

    PubMed

    researchmap

  • Treatment with Aortic Stent Graft Placement for Stanford B-Type Aortic Dissection in a Patient with an Aberrant Right Subclavian Artery. Reviewed International journal

    Yohei Kawatani, Yujiro Hayashi, Yujiro Ito, Hirotsugu Kurobe, Yoshitsugu Nakamura, Yuji Suda, Takaki Hori

    Case reports in vascular medicine   2015   746354 - 746354   2015

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    A 71-year-old man visited our hospital with the chief complaint of back pain and was diagnosed with acute aortic dissection (Debakey type III, Stanford type B). He was found to have a variant branching pattern in which the right subclavian artery was the fourth branch of the aorta. We performed conservative management for uncomplicated Stanford type B aortic dissection, and the patient was discharged. An ulcer-like projection (ULP) was discovered during outpatient follow-up. Complicated type B aortic dissection was suspected, and we performed thoracic endovascular aortic repair (TEVAR). The aim of operative treatment was ULP closure; thus we placed two stent grafts in the descending aorta from the distal portion of the right subclavian artery. The patient was released without complications on postoperative day 5. Deliberate sizing and examination of placement location were necessary when placing the stent graft, but operative techniques allowed the procedure to be safely completed.

    DOI: 10.1155/2015/746354

    PubMed

    researchmap

  • Well-organized neointima of large-pore poly(l-lactic acid) vascular graft coated with poly(l-lactic-co-ε-caprolactone) prevents calcific deposition compared to small-pore electrospun poly(l-lactic acid) graft in a mouse aortic implantation model Reviewed International journal

    Shuhei Tara, Hirotsugu Kurobe, Kevin A. Rocco, Mark W. Maxfield, Cameron A. Best, Tai Yi, Yuji Naito, Christopher K. Breuer, Toshiharu Shinoka

    Atherosclerosis   237 ( 2 )   684 - 691   2014.12

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:ELSEVIER IRELAND LTD  

    Objective: Tissue engineering techniques have emerged that allow bioresorbable grafts to be implanted that restore function and transform into biologically active arteries. However, these implants are susceptible to calcification during the remodeling process. The objective of this study was to evaluate the role of pore size of bioabsorbable grafts in the development of calcification. Methods: Two types of grafts were prepared: a large-pore graft constructed of poly(l-lactic acid) (PLA) fibers coated with poly(l-lactide-co-ε-caprolactone) (PLCL) (PLA-PLCL), and a small-pore graft made of electrospun PLA nanofibers (PLA-nano). Twenty-eight PLA-PLCL grafts and twenty-five PLA-nano grafts were implanted as infra-renal aortic interposition conduits in 8-week-old female SCID/Bg mice, and followed for 12 months after implantation. Results: Large-pore PLA-PLCL grafts induced a well-organized neointima after 12 months, and Alizarin Red S staining showed neointimal calcification only in the thin neointima of small-pore PLA-nano grafts. At 12 months, macrophage infiltration, evaluated by F4/80 staining, was observed in the thin neointima of the PLA-nano graft, and there were few vascular smooth muscle cells (VSMCs) in this layer. On the other hand, the neointima of the PLA-PLCL graft was composed of abundant VSMCs, and a lower density of macrophages (F4/80 positive cells, PLA-PLCL; 68.1±41.4/mm vs PLA-nano; 188.3±41.9/mm , p=0.007). The VSMCs of PLA-PLCL graft expressed transcription factors of both osteoblasts and osteoclasts. Conclusion: These findings demonstrate that in mouse arterial circulation, large-pore PLA-PLCL grafts created a well-organized neointima and prevented calcific deposition compared to small-pore, electrospun PLA-nano grafts. 2 2

    DOI: 10.1016/j.atherosclerosis.2014.09.030

    Web of Science

    Scopus

    PubMed

    researchmap

  • Targeted imaging of matrix metalloproteinase activity in the evaluation of remodeling tissue-engineered vascular grafts implanted in a growing lamb model Reviewed International journal

    Mitchel R. Stacy, Yuji Naito, Mark W. Maxfield, Hirotsugu Kurobe, Shuhei Tara, Chung Chan, Kevin A. Rocco, Toshiharu Shinoka, Albert J. Sinusas, Christopher K. Breuer

    Journal of Thoracic and Cardiovascular Surgery   148 ( 5 )   2227 - 2233   2014.11

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:MOSBY-ELSEVIER  

    Results The seeded grafts demonstrated significant luminal and longitudinal growth from 2 to 6 months. In vivo imaging revealed subjectively greater matrix metalloproteinase activity in grafts versus native tissue. Ex vivo imaging confirmed a quantitative increase in matrix metalloproteinase activity and demonstrated greater activity in unseeded versus seeded grafts. The glycosaminoglycan content was increased in seeded grafts versus unseeded grafts, without significant differences in collagen content.

    DOI: 10.1016/j.jtcvs.2014.05.037

    Web of Science

    Scopus

    PubMed

    researchmap

  • [Reconstruction of pulmonary blood flow in the Norwood procedure; Blalock-Taussig shunt; from bench to surgery] Reviewed

    Takashi Kitaichi, Mikio Sugano, Hajime Kinoshita, Taisuke Nakayama, Hirotsugu Kurobe, Tamotsu Kanbara, Eiki Fujimoto, Tetsuya Kitagawa

    Kyobu geka. The Japanese journal of thoracic surgery   67 ( 4 )   274 - 277   2014.4

     More details

    Language:Japanese   Publishing type:Research paper (scientific journal)  

    Although the right-ventricle to pulmonary artery( RV-PA) shunt as a source of pulmonary blood supply of Norwood procedure has improved early outcomes, disadvantages including right ventricular dysfunction or arrhythmias have been reported. So it has been still remained controversial whether BT shunt or RV-PA conduit should be selected. We examined the influence of Blalock-Taussig( BT) shunt size on regulation of the pulmonary blood flow in experimental model of a univentricular heart to determine the specific guidelines regarding suitable shunt size in the Norwood procedure. The canine univentricular heart model with the ratio of shunt size to body weight (SS/BW) of 0.8 to 1.1 showed significant negative correlation between the pulmonary/systemic blood flow ratio( Qp/Qs)and arterial PCo2, but those with SS/BW of 1.1 to 1.4 did not. Similar phenomena were shown with the grouped data on relationship between the Qp/Qs and inspired oxygen fraction. These findings imply that when SS/BW is 0.8 to 1.1, the Qp/Qs is controllable by physiologic respiratory manipulations. In the context of our clinical experiences, SS/BW of 0.9 to 1.0 is considered a useful index for suitable BT shunt in the Norwood procedure.

    Scopus

    PubMed

    researchmap

  • Stem cells in tissue-engineered blood vessels for cardiac repair

    H. Kurobe, M. W. Maxfield, Y. Naito, C. Breuer, T. Shinoka

    Cardiac Regeneration and Repair: Biomaterials and Tissue Engineering   389 - 409   2014.2

     More details

    Publishing type:Part of collection (book)  

    In surgical repair for heart disease, it is often necessary to implant conduits or correct tissue defects. Commonly used graft materials include artificial grafts, autologous tissues, allografts and xenografts. However, none of these offer growth potential, and all are associated with varying levels of thrombogenicity and susceptibility to infection. Lack of growth potential of these four options is particularly important in pediatric cardiac surgery, where patients will often outgrow their grafts and require additional operations. Vascular tissue engineering offers a solution that produces neovessels and neo-organs from autologous cells that can grow, remodel, rebuild and respond to injury. © 2014 Woodhead Publishing Limited All rights reserved.

    DOI: 10.1533/9780857096715.3.389

    Scopus

    researchmap

  • Tissue engineering in the vasculature Reviewed International journal

    Yuji Naito, Kevin Rocco, Hirotsugu Kurobe, Mark Maxfield, Christopher Breuer, Toshiharu Shinoka

    Anatomical Record   297 ( 1 )   83 - 97   2014.1

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:WILEY  

    Tissue engineering holds great promise to address complications and limitations encountered with the use of traditional prosthetic materials, such as thrombogenicity, infection, and future degeneration which represent the major morbidity and mortality after device implant surgery. The general concept of tissue engineering consists of three main components: a scaffold material, a cell type for seeding the scaffold, and biochemical, physio-chemical signaling and remodeling process. This remodeling process is guided by cell signals derived from both seeded cells and host inflammatory cells that infiltrate the scaffold and deposit extracellular matrix, forming the neotissue. Vascular tissue engineering is at the forefront in the translation of this technology to clinical practice, as tissue engineered vascular grafts (TEVGs) have now been successfully implanted in children with congenital heart disease. In this report, we review the history, advances, and state of the art in TEVGs. © 2013 Wiley Periodicals, Inc.

    DOI: 10.1002/ar.22838

    Web of Science

    Scopus

    PubMed

    researchmap

  • Iliac access conduit facilitates endovascular aortic aneurysm repair and ipsilateral iliofemoral bypass Reviewed

    Hajime Kinoshita, Eiki Fujimoto, Hitoshi Sogabe, Hiroshi Fujita, Taisuke Nakayama, Mikio Sugano, Hirotsugu Kurobe, Tamotsu Kanbara, Takashi Kitaichi, Tetsuya Kitagawa

    Journal of Medical Investigation   61 ( 1-2 )   204 - 207   2014

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    It may be difficult to access a route to deliver a stent-graft for abdominal aortic aneurysm in high-risk patients with bilateral iliofemoral occlusive disease. These two patients underwent both endovascular aortic aneurysm repair by a modified iliac access conduit technique and sequential ipsilateral iliofemoral artery bypass using the conduit, which provided excellent results. The iliac access conduit facilitates endovascular aortic aneurysm repair and ipsilateral iliofemoral bypass of high-risk patients with abdominal aortic aneurysm and bilateral iliofemoral occlusive disease.

    DOI: 10.2152/jmi.61.204

    Scopus

    PubMed

    researchmap

  • Vessel bioengineering - Development of small-diameter arterial grafts - Reviewed

    Shuhei Tara, Kevin A. Rocco, Narutoshi Hibino, Tadahisa Sugiura, Hirotsugu Kurobe, Christopher K. Breuer, Toshiharu Shinoka

    Circulation Journal   78 ( 1 )   12 - 19   2014

     More details

    Language:English   Publisher:JAPANESE CIRCULATION SOC  

    The development of vascular bioengineering has led to a variety of novel treatment strategies for patients with cardiovascular isease. Notably, combining biodegradable scaffolds with autologous cell seeding to create tissue-engineered ascular grafts (TEVG) allows for in situ formation of organized neovascular tissue and we have demonstrated he clinical viability of this technique in patients with congenital heart defects. The role of the scaffold is to rovide a temporary 3-dimensional structure for cells, but applying TEVG strategy to the arterial system requires caffolds that can also endure arterial pressure. Both biodegradable synthetic polymers and extracellular matrixbased atural materials can be used to generate arterial scaffolds that satisfy these requirements. Furthermore, the ole of specific cell types in tissue remodeling is crucial and as a result many different cell sources, from matured omatic cells to stem cells, are now used in a variety of arterial TEVG techniques. However, despite great progress n the field over the past decade, clinical effectiveness of small-diameter arterial TEVG (<6 mm) has remained elusive. o achieve successful translation of this complex multidisciplinary technology to the clinic, active participation f biologists, engineers, and clinicians is required.

    DOI: 10.1253/circj.CJ-13-1440

    Web of Science

    Scopus

    PubMed

    researchmap

  • Vessel Regeneration and Bioengineering

    Shuhei Tara, Ethan W. Dean, Kevin A. Rocco, Brooks V. Udelsman, Hirotsugu Kurobe, Toshiharu Shinoka, Christopher K. Breuer

    Regenerative Medicine Applications in Organ Transplantation   811 - 827   2014

     More details

    Publishing type:Part of collection (book)  

    Over the last decade, advancements in the field of vascular tissue engineering have generated a variety of novel treatment strategies for patients with cardiac defects and vascular disease. Notably, the technique of seeding cells onto biodegradable polymeric scaffolds to create tissue-engineered vascular grafts (TEVGs) allows for the formation of organized neovascular tissue and enables the implanted construct to grow with the patient. Studies in animal models have resulted in a greater understanding of the complex and dynamic processes behind neovessel development and enabled the creation of a TEVG seeded with bone marrow-derived mononuclear cells for use in a pilot clinical trial. Current research indicates that this tissue engineering approach is safe and effective, and the ongoing translation of this technology holds great promise. In this text, we review the scaffold materials, cell types, and seeding methods for TEVG creation, and we introduce our clinical application of TEVGs. © 2014 Elsevier Inc. All rights reserved.

    DOI: 10.1016/B978-0-12-398523-1.00058-6

    Scopus

    researchmap

  • Azelnidipine suppresses the progression of aortic aneurysm in wild mice model through anti-inflammatory effects Reviewed International journal

    Hirotsugu Kurobe, Yuki Matsuoka, Yoichiro Hirata, Noriko Sugasawa, Mark W. Maxfield, Masataka Sata, Tetsuya Kitagawa

    Journal of Thoracic and Cardiovascular Surgery   146 ( 6 )   1501 - 1508   2013.12

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:MOSBY-ELSEVIER  

    Background: Although systemic hypertension is closely associated with aortic aneurysm (AA) formation, there are many patients with AA without hypertension. In these patients, an inflammation-mediated progression of aneurysmal disease is likely responsible for AA growth and eventual rupture. Unfortunately, there remains no reproducible and durable small animal model of aortic aneurysmal disease, the development of which would enable the investigation of the pathophysiology of this vexing condition. The first aim was to establish a useful wild-type mouse model of AA with low mortality. The second aim was to use this model to assess the protective effect of azelnidipine, a new calcium channel blocker, against the progression of the AA independent of its antihypertensive effect. Methods: Angiotensin II and β-aminopropionitrile (a lysyl oxidase inhibitor) were administrated subcutaneously in 7-week-old C57BL/6J mice using an osmotic minipump for 4 weeks to generate a wild-type mouse model of AA. Concurrently, azelnidipine (a calcium channel blocker) or a placebo was administrated orally for 4 weeks. Mice were humanely killed and assessed at the end of the 4 weeks of pharmacologic manipulation. Results: The combined infusion of angiotensin II and β-aminopropionitrile induced degenerative aneurysm of the thoracic and/or abdominal aorta (11/12; 92%). The majority of aneurysms were located in the distal aortic arch and suprarenal abdominal aorta. Although there was no difference in systolic blood pressure between the control and azelnidipine-treated groups, azelnidipine significantly reduced the incidence of AA (2/11; 18%). Azelnidipine treatment reduced the pathologic findings normally associated with aneurysm formation within the aortic wall. Azelnidipine also reduced the number of macrophage antigen-3 (MAC-3)-positive cells in the periaortic adipose tissue and reduced the gene expression levels of tumor necrosis factor-alpha and matrix metalloproteinase-2 and -9 within the aortic wall. Conclusions: This study demonstrates that combined treatment with angiotensin II and β-aminopropionitrile induces degenerative AAs in wild-type mice, and azelnidipine prevents aneurysm progression via its anti-inflammatory effect. Copyright © 2013 by The American Association for Thoracic Surgery.

    DOI: 10.1016/j.jtcvs.2013.02.073

    Web of Science

    Scopus

    PubMed

    J-GLOBAL

    researchmap

  • HMGB1 plays a critical role in vascular inflammation and lesion formation via toll-like receptor 9 Reviewed International journal

    Yoichiro Hirata, Hirotsugu Kurobe, Mayuko Higashida, Daiju Fukuda, Michio Shimabukuro, Kimie Tanaka, Yasutomi Higashikuni, Tetsuya Kitagawa, Masataka Sata

    Atherosclerosis   231 ( 2 )   227 - 233   2013.12

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:ELSEVIER IRELAND LTD  

    Objective: Endogenous ligands such as high-mobility group box 1 (HMGB1) and nucleic acids are released by dying cells and bind to Toll-like receptors (TLRs). As TLR9 is involved in both microbial and sterile inflammation by detecting both bacterial and endogenous DNA, we investigated its role in inflammation and lesion formation in a mouse model of vascular injury. Methods and results: C57BL/6 (WT) and TLR9 KO mice were subjected to wire-mediated vascular injury. Anti-HMGB1 antibody and purified HMGB1 protein were chronically delivered around the injured arteries by gelatin hydrogel, and neointima formation at 4 weeks after injury was evaluated. In addition, the same vascular injury was performed in bone-marrow chimeric mice (WT bone marrow into TLR KO mice; TLR9 KO bone marrow into WT mice). We also evaluated the production of inflammatory cytokines by mouse macrophages in response to HMGB1 and CpG-ODN. In wild-type mice after vascular injury, anti-HMGB1 antibody significantly reduced neointima formation and HMGB1 protein accelerated neointima hyperplasia. HMGB1 failed to accelerate lesion formation in TLR9 KO mice. The bone marrow transplantation study revealed that TLR9 in bone marrow-derived cells played a fundamental role in neointima formation. Invitro, HMGB1 and CpG-ODN synergistically induced the production of inflammatory cytokines by macrophages. Conclusions: HMGB1 serves as an endogenous mediator of inflammation and lesion formation via the TLR9 pathway in response to vascular injury. Blockade of HMGB1 and/or TLR9 may represent a novel approach to treating atherosclerosis. © 2013 Elsevier Ireland Ltd.

    DOI: 10.1016/j.atherosclerosis.2013.09.010

    Web of Science

    Scopus

    PubMed

    researchmap

  • Protective effects of selective mineralocorticoid receptor antagonist against aortic aneurysm progression in a novel murine model Reviewed International journal

    Hirotsugu Kurobe, Yoichiro Hirata, Yuki Matsuoka, Noriko Sugasawa, Mayuko Higashida, Taisuke Nakayama, Mark Webster Maxfield, Yasushi Yoshida, Michio Shimabukuro, Tetsuya Kitagawa, Masataka Sata

    Journal of Surgical Research   185 ( 1 )   455 - 462   2013.11

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:ACADEMIC PRESS INC ELSEVIER SCIENCE  

    Background: The optimal medical management to delay the progression of aortic aneurysms has not been fully clarified, and the only standard treatment at present is antihypertensive therapy. Previous studies have shown beneficial effects of selective mineralocorticoid receptor (MR) antagonists on cardiovascular remodeling. The aim of the present study was to investigate the effect of a selective MR antagonist on aortic aneurysm progression. Methods: Seven-week-old C57BL/6J male mice were administered with angiotensin II and β-aminopropionitrile for 4 weeks. The mice received either vehicle or eplerenone, a selective MR antagonist (100 mg/kg daily) every day by gavage, starting at 7 weeks of age. The production of inflammatory cytokines in cultures of high mobility group box-1-stimulated macrophages with or without a MR antagonist was also analyzed using an enzyme-linked immunosorbent assay. Results: Although no differences were found in the peak systolic blood pressure between the experimental groups, the mice in the eplerenone group showed a significant reduction in aneurysm development. On histologic analysis, coarse and stretched elastic fibers were markedly improved in the aortic wall in the eplerenone group. Real-time polymerase chain reaction of both aortic wall and perivascular adipose tissue demonstrated the expression of tumor necrosis factor-α, interleukin-6, and matrix metalloproteinase-2 was significantly decreased in eplerenone group, and that of monocyte chemoattractant protein-1 in the aortic wall was also significantly decreased. Macrophage infiltration in the aortic wall and perivascular adipose tissue in the eplerenone group was also significantly decreased. The production of tumor necrosis factor-α and interleukin-6 in macrophage culture, which was stimulated by high mobility group box-1 and CpG oligodeoxynucleotides, was also significantly decreased in the eplerenone group. Conclusions: Eprelenone suppressed aortic aneurysm progression through an anti-inflammatory effect. Thus, selective MR antagonists might be effective in preventing the progression of aortic aneurysms. © 2013 Elsevier Inc. All rights reserved.

    DOI: 10.1016/j.jss.2013.05.002

    Web of Science

    Scopus

    PubMed

    J-GLOBAL

    researchmap

  • Macrophage-Specific Hypoxia-Inducible Factor (HIF)-1a-Deficient Mice Suppress the Vascular Remodeling and Regulate M2 Macrophage Polarization Reviewed

    Taisuke Nakayama, Hirotsugu Kurobe, Noriko Sugasawa, Hajime Kinoshita, Yasushi Yoshida, Yoichiro Hirata Hirata, Mie Sakata, Mark W. Maxfield, Michio Shimabukuro, Yousuke Takahama, Masataka Sata, Toshiaki Tamaki, Tetsuya Kitagawa, Shuhei Tomita

    CIRCULATION   128 ( 22 )   2013.11

     More details

    Language:English   Publisher:LIPPINCOTT WILLIAMS & WILKINS  

    Web of Science

    researchmap

  • Biaxial mechanical properties of the inferior vena cava in C57BL/6 and CB-17 SCID/bg mice

    Y. U. Lee, Y. Naito, H. Kurobe, C. K. Breuer, J. D. Humphrey

    Journal of Biomechanics   46 ( 13 )   2277 - 2282   2013.9

     More details

    Publishing type:Research paper (scientific journal)  

    Multiple murine models have proven useful in studying the natural history of neovessel development in the tissue engineering of vascular grafts. Nevertheless, to better understand longitudinal changes in the biomechanics of such neovessels, we must first quantify native tissue structure and properties. In this paper, we present the first biaxial mechanical data for, and nonlinear constitutive modeling of, &QJ;the inferior vena cava from two models used in tissue engineering: wild-type C57BL/6 and immunodeficient CB-17 SCID/bg mice. Results show that inferior vena cava from the latter are significantly stiffer in the circumferential direction, both materially (as assessed by a stored energy function) and structurally (as assessed by the compliance), despite a lower intramural content of fibrillar collagen and similar wall thickness. Quantifying the natural history of neovessel development in different hosts could lead to increased insight into the mechanisms by which cells fashion and maintain extracellular matrix in order to match best the host stiffness while ensuring sufficient vascular integrity. © 2013.

    DOI: 10.1016/j.jbiomech.2013.06.013

    Scopus

    researchmap

  • Role of macrophage-derived hypoxia-inducible factor (HIF)-1α as a mediator of vascular remodelling Reviewed International journal

    Taisuke Nakayama, Hirotsugu Kurobe, Noriko Sugasawa, Hajime Kinoshita, Mayuko Higashida, Yuki Matsuoka, Yasushi Yoshida, Yoichiro Hirata, Mie Sakata, Mark W. Maxfield, Michio Shimabukuro, Yousuke Takahama, Masataka Sata, Toshiaki Tamaki, Tetsuya Kitagawa, Shuhei Tomita

    Cardiovascular Research   99 ( 4 )   705 - 715   2013.9

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:OXFORD UNIV PRESS  

    AimsExcessive vascular remodelling leads to progression of a wide range of vasculopathies, and the immune response to intimal injuries is crucial in this process. This vascular remodelling occurs in the hypoxic microenvironment and is closely related to the immune system. Macrophages play a key role in immunological-cell-mediated arterial remodelling. In this study, we clarified the role of macrophage-derived hypoxia-inducible factor (HIF-1α) in vascular remodelling.Methods and resultsWire-induced femoral arterial injury was inflicted in mice lacking the macrophage-specific HIF-1α gene and in their wild-type counterparts. The mutant mice showed both suppressed wire-induced neointimal thickening and decreased infiltration of inflammatory cells in the adventitia, compared with wild-type mice. Studies to clarify the mechanism of restrained vascular remodelling in the mutant mice revealed decreased production of pro-inflammatory cytokines by the activated macrophages and suppressed macrophage migration activity in the mutant mice. Gene expressions of the HIF-1α-deficient macrophages positively correlated with the phenotypic profile of M2 macrophages and negatively correlated with that of M1 macrophages.ConclusionOur results show that HIF-1α in macrophages plays a crucial role in promoting vascular inflammation and remodelling. As decreasing HIF-1α activity in macrophages may prevent the progression of vascular remodelling, HIF-1α may be a possible therapeutic target in vascular diseases. © 2013 The Author.

    DOI: 10.1093/cvr/cvt146

    Web of Science

    Scopus

    PubMed

    J-GLOBAL

    researchmap

  • Techniques and results in the management of multiple muscular trabecular ventricular septal defects Reviewed

    Tetsuya Kitagawa, Takashi Kitaichi, Mikio Sugano, Hirotsugu Kurobe

    General Thoracic and Cardiovascular Surgery   61 ( 7 )   367 - 375   2013.7

     More details

    Language:English   Publisher:7  

    The management of patients with multiple muscular trabecular ventricular septal defects (VSDs) remains controversial. In the past two decades, innovative techniques including a right ventricular apical infundibulotomy and transcatheter, intraoperative and perventricular device closure have been exploited, and essential right atrial approach and limited apical left ventriculotomy have also been refined. However, specific management guidelines for this difficult disease have not been established. In this article, the benefits and drawbacks of each technique are reviewed and discussed. Primary repair for infants with multiple muscular trabecular VSDs was associated with good late outcomes. The right atrial approach was satisfactory for all muscular VSDs, excluding apical defects that were well seen through a limited apical ventriculotomy. Surgical closure of apical defects could be achieved safely and completely in early infancy through a limited apical left ventriculotomy or a right ventricular apical infundibulotomy. Further follow-up and prudent evaluations of ventriculotomy-associated morbidities are needed. Pulmonary artery banding should be limited to a small infant with complex associated defects. Percutaneous device closure, the most desirable option, is impractical due to limitations between the delivery system and access route. Intraoperative device closure appears less successful than device closure in the catheterization laboratory. Perventricular device closure has a significant advantage of being a non-bypass procedure approach. A less invasive strategy for "true" Swiss cheese septum is needed. All may have an important role, and results obtained by using these techniques are encouraging. These hybrid approaches will promise future success on management guidelines of multiple muscular trabecular VSDs. © 2013 The Japanese Association for Thoracic Surgery.

    DOI: 10.1007/s11748-013-0267-8

    Scopus

    PubMed

    J-GLOBAL

    researchmap

  • Epicardial adipose tissue volume and adipocytokine imbalance are strongly linked to human coronary atherosclerosis Reviewed International journal

    Michio Shimabukuro, Yoichiro Hirata, Minoru Tabata, Munkhbaatar Dagvasumberel, Hiromi Sato, Hirotsugu Kurobe, Daiju Fukuda, Takeshi Soeki, Tetsuya Kitagawa, Shuichiro Takanashi, Masataka Sata

    Arteriosclerosis, Thrombosis, and Vascular Biology   33 ( 5 )   1077 - 1084   2013.5

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:LIPPINCOTT WILLIAMS & WILKINS  

    OBJECTIVE - : The impact of epicardial adipose tissue (EAT) over abdominal or overall adiposity on coronary artery disease (CAD) is currently unknown. We compared the association among EAT volume (EATV), cytokine/adipocytokine profiles in EAT and subcutaneous fat, and atherogenic CAD. APPROACH AND RESULTS - : Paired samples were obtained from EAT and subcutaneous adipose tissue during elective cardiac surgery for CAD (n=50) or non-CAD (n=50). EATV was the sum of cross-sectional EAT areas, and visceral and subcutaneous fat areas were determined at the umbilicus level on computed tomography scans. CD68, CD11c, and CD206 cells were counted using immunohistochemical staining. Cytokine/adipocytokine expression was evaluated using quantitative real-time polymerase chain reaction. Multivariate analysis indicated that male sex, age, diabetes mellitus, high triglycerides, and low high-density lipoprotein cholesterol, and EATV index (EATV/body surface area, cm/m) were significant CAD predictors (corrected R=0.401; P<0.001); visceral fat area, hypertension, smoking, low-density lipoprotein cholesterol (140 mg/dL [3.63 mmol/L]) or statin use were not predictors. The EATV index positively correlated with the CD68 and CD11c cell numbers and nucleotide-binding domain, leucine-rich-containing family, pyrin domain-containing-3 (NLRP3), interleukin-1β, and interleukin-1R expression; and negatively correlated with adiponectin expression in EAT. A multivariate analysis model, including CD68 cells and interleukin-1β, and adiponectin expression in EAT strongly predicted CAD (corrected R=0.756; P<0.001). CONCLUSIONS - : EATV and macrophage and cytokine/adipocytokine signals in EAT strongly correlated with CAD. Our findings suggest that EATV and adipocytokine imbalance are strongly linked to human coronary atherosclerosis. © 2013 American Heart Association, Inc.

    DOI: 10.1161/ATVBAHA.112.300829

    Web of Science

    Scopus

    PubMed

    J-GLOBAL

    researchmap

  • Complete but not partial thymectomy in early infancy reduces T-cell-mediated immune response: Three-year tracing study after pediatric cardiac surgery Reviewed International journal

    Hirotsugu Kurobe, Takashi Tominaga, Mikio Sugano, Yasunobu Hayabuchi, Yoshiyasu Egawa, Yousuke Takahama, Tetsuya Kitagawa

    Journal of Thoracic and Cardiovascular Surgery   145 ( 3 )   656 - +   2013.3

     More details

    Language:English   Publishing type:Research paper (international conference proceedings)   Publisher:MOSBY-ELSEVIER  

    Objective: Thymectomy is often performed to secure an operative field in surgery for congenital heart defects in early infancy. However, how neonatal thymectomy affects the subsequent development of the immune system in humans remains unclear. We monitored patients for 3 years from the time of thymectomy that was performed during cardiac surgery in early infancy. Methods: For up to 3 years, we monitored the number of circulating lymphocytes and the clinical course of the children who underwent complete (n = 17), partial, and no (n = 15) thymectomy during congenital heart defect surgery performed at less than 3 months of age. The titers of immunoglobulin-G produced in response to vaccinated viruses and phytohemagglutinin responses were also measured. Results: Six months after surgery, the number of T cells, including CD4 and CD8 subpopulations, decreased in patients with complete but not partial thymectomy. The reduction in T-cell number persisted for 3 years, whereas the number of B cells did not change. In patients with complete thymectomy, the titers of immunoglobulin-G produced in response to vaccinated measles and rubella viruses were reduced, whereas the phytohemagglutinin-induced proliferation of T cells was not impaired. In addition, hospitalization frequency associated with infectious diseases increased in patients with complete but not partial thymectomy. Conclusions: The results revealed that complete thymectomy in early infancy reduces the number of circulating T cells and T-cell-mediated immune responses for at least 3 years, suggesting that the thymus should be at least partially preserved during surgery in early infancy to maintain protective immunity. Copyright © 2013 by The American Association for Thoracic Surgery. + +

    DOI: 10.1016/j.jtcvs.2012.12.015

    Web of Science

    Scopus

    PubMed

    J-GLOBAL

    researchmap

  • Beneficial effect of a synthetic prostacyclin agonist, ONO-1301, in rat autoimmune myocarditis model Reviewed International journal

    Yoichiro Hirata, Hirotsugu Kurobe, Etsuko Uematsu, Shusuke Yagi, Takeshi Soeki, Hirotsugu Yamada, Daiju Fukuda, Michio Shimabukuro, Mizuho Nakayama, Kunio Matsumoto, Yoshiki Sakai, Tetsuya Kitagawa, Masataka Sata

    European Journal of Pharmacology   699 ( 1-3 )   81 - 87   2013.1

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:ELSEVIER SCIENCE BV  

    Injury to the heart can result in cardiomyocyte hypertrophy, fibrosis, and cell death. Myocarditis sometimes progresses to dilated cardiomyopathy. We previously reported that ONO-1301, a synthetic prostacyclin agonist with thromboxane-synthase inhibitory activity, promotes production of hepatocyte growth factor (HGF) from various cell types and ameliorates ischemia-induced left ventricle dysfunction in the mouse, rat and pig. Here, we investigated the therapeutic efficacy of ONO-1301 in a rat model of myosin-induced experimental autoimmune myocarditis, in which the heart transits from an acute inflammatory phase to a chronic dilated cardiomyopathy phase. Four weeks after myosin injection to Lewis rats, ONO-1301 (6 mg/kg/day) was orally administered for 4 weeks (ONO-1301 group). Hemodynamic parameters and plasma brain natriuretic peptide (BNP) level were significantly improved by ONO-1301. Histological analysis revealed that capillary density in the myocardium was significantly increased by ONO-1301. ONO-1301 increased circulating endothelial progenitor cells (EPC) as determined by FACS analysis. These beneficial effects of ONO-1301 were partially abrogated by a neutralizing anti-HGF antibody (8 mg/kg/dose). These findings indicate beneficial effects of ONO-1301 in a rat experimental autoimmune myocarditis model. © 2012 Elsevier B.V. All rights reserved.

    DOI: 10.1016/j.ejphar.2012.11.045

    Web of Science

    Scopus

    PubMed

    J-GLOBAL

    researchmap

  • Exendin-4, a glucagon-like peptide-1 receptor agonist, attenuates neointimal hyperplasia after vascular injury Reviewed International journal

    Yoichiro Hirata, Hirotsugu Kurobe, Chika Nishio, Kimie Tanaka, Daiju Fukuda, Etsuko Uematsu, Sachiko Nishimoto, Takeshi Soeki, Nagakatsu Harada, Hiroshi Sakaue, Tetsuya Kitagawa, Michio Shimabukuro, Yutaka Nakaya, Masataka Sata

    European Journal of Pharmacology   699 ( 1-3 )   106 - 111   2013.1

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:ELSEVIER SCIENCE BV  

    Exendin-4 is a glucagon-like peptide-1 receptor agonist that has been used as a drug for treatment of type 2 diabetes. To investigate the effect of exendin-4 on the cardiovascular system, we investigated the impact of exendin-4 on neointimal hyperplasia of the femoral artery after vascular injury. We performed wire-mediated endovascular injury in C57BL/6 mice, followed by administration of exendin-4 24 nmol/kg/day via infusion pump. Four weeks after the injury, exendin-4 treatment significantly attenuated neointimal hyperplasia of the injured artery, although it did not affect glucose metabolism and lipid profile in wild-type mice. Immunofluorescence study revealed abundant expression of GLP-1 receptor on α-smooth muscle actin-positive cells in the injured vessel. Cell proliferation assay using rat aortic smooth muscle cells showed that exendin-4 reduced PDGF-BB induced smooth muscle cell proliferation through the cAMP/PKA pathway. Exendin-4 also inhibited TNFα production by peritoneal macrophages in response to inflammatory stimulus. Our findings indicate that a GLP-1 receptor agonist attenuated neointimal formation after vascular injury. GLP-1 receptor agonists or drugs that raise endogenous GLP-1 level might be effective in the treatment of vascular diseases. © 2012 Elsevier B.V. All rights reserved.

    DOI: 10.1016/j.ejphar.2012.11.057

    Web of Science

    Scopus

    PubMed

    J-GLOBAL

    researchmap

  • Delayed-onset severe heparin-induced thrombocytopenia after total arch replacement under cardiopulmonary bypass Reviewed

    Taisuke Nakayama, Hajime Kinoshita, Mikio Sugano, Hirotsugu Kurobe, Tamotsu Kanbara, Eiki Fujimoto, Takashi Kitaichi, Hiroshi Fujita, Hitoshi Sogabe, Tetsuya Kitagawa

    Journal of Medical Investigation   60 ( 1-2 )   154 - 158   2013

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:1-2  

    An extremely rare case with delayed-onset heparin-induced thrombocytopenia (HIT) is described. A 46-year-old man underwent arch replacement for aortic dissection under cardiopulmonary bypass and initial exposure of unfractionated heparin. In post operative 7 days, persistent atrial fibrillation was occurred, so a continuous infusion of heparin (10000 IU/day) and Vitamine K antagonist (Warfarin) taking was started for preventing thrombosis. By 32 days after the operation, his platelet count had fallen (3 103 /μL) and oral hematoma and ecchymoma of bilateral lower legs were occurred. The value of HIT antibodies and the IgG antibody was 2.485 and 1.586 on 32-postoperative day, respectively. Heparin was immediately discontinued, and argatroban administrated. Platelet exceeded above 100 103/μL on 12 days of the therapy. To our knowledge, few cases of delayed-onset severe HIT associated with CPB surgery have been reported in Japan.

    DOI: 10.2152/jmi.60.154

    Scopus

    PubMed

    J-GLOBAL

    researchmap

  • Telmisartan ameliorates insulin sensitivity by activating the AMPK/SIRT1 pathway in skeletal muscle of obese db/db mice Reviewed International journal

    Asuka Shiota, Michio Shimabukuro, Daiju Fukuda, Takeshi Soeki, Hiromi Sato, Etsuko Uematsu, Yoichiro Hirata, Hirotsugu Kurobe, Norikazu Maeda, Hiroshi Sakaue, Hiroaki Masuzaki, Iichiro Shimomura, Masataka Sata

    Cardiovascular Diabetology   11   139 - 139   2012.11

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:BIOMED CENTRAL LTD  

    Background: Telmisartan is a well-established angiotensin II type 1 receptor blocker that improves insulin sensitivity in animal models of obesity and insulin resistance, as well as in humans. Telmisartan has been reported to function as a partial agonist of the peroxisome proliferator-activated receptor (PPAR) γ, which is also targeted by the nicotinamide adenine dinucleotide (NAD)-dependent deacetylase (SIRT1). Here, we investigated the pathways through which telmisartan acts on skeletal muscle, in vitro as well as in vivo.Methods: Nine-week-old male db/db mice were fed a 60% high-fat diet, with orally administrated either vehicle (carboxymethyl-cellulose, CMC), 5 mg/kg telmisartan, or 5 mg/kg telmisartan and 1 mg/kg GW9662, a selective irreversible antagonist of PPARγ, for 5 weeks. Effects of telmisartan on Sirt1 mRNA, AMPK phosphorylation, and NAD+/NADH ratio were determined in C2C12 cultured myocytes.Results and discussion: Telmisartan treatment improved insulin sensitivity in obese db/db mice fed a high-fat diet and led to reduction in the size of hypertrophic pancreatic islets in these mice. Moreover, in vitro treatment with telmisartan led to increased expression of Sirt1 mRNA in C2C12 skeletal muscle cells; the increase in Sirt1 mRNA in telmisartan-treated C2C12 myoblasts occurred concomitantly with an increase in AMPK phosphorylation, an increase in NAD+/NADH ratio, and increases in the mRNA levels of PGC1α, FATP1, ACO, and GLUT4.Conclusions: Our results indicate that telmisartan acts through a PPARγ-independent pathway, but at least partially exerts its effects by acting directly on skeletal muscle AMPK/SIRT1 pathways. © 2012 Shiota et al.; licensee BioMed Central Ltd.

    DOI: 10.1186/1475-2840-11-139

    Web of Science

    Scopus

    PubMed

    J-GLOBAL

    researchmap

  • Role of Macrophage-derived Hif-1 alpha as a Mediator of Vascular Remodeling Reviewed

    Taisuke Nakayama, Hirotsugu Kurobe, Noriko Sugasawa, Hajime Kinoshita, Mayuko Higashida, Yuki Matsuoka, Yasushi Yoshida, Yoichiro Hirata, Mie Sakata, Mark W. Maxfield, Yousuke Takahama, Masataka Sata, Toshiaki Tamaki, Tetsuya Kitagawa, Shuhei Tomita

    CIRCULATION   126 ( 21 )   2012.11

     More details

    Language:English   Publisher:LIPPINCOTT WILLIAMS & WILKINS  

    Web of Science

    researchmap

  • The Innate Immune System, Nlrp3 Inflammasome is Intensified in Epicardial Adipose Tissue around Coronary Arterial Lesions: Evidence from Biopsied Adipose Tissue in Coronary Artery Bypass Surgery Reviewed

    Hiromi Sato, Michio Shimabukuro, Yoichiro Hirata, Minoru Tahata, Dagvasumberel Munkhbaatar, Daiju Fukuda, Hirotsugu Kurobe, Takeshi Soeki, Shuichiro Takanashi, Tetsuya Kitagawa, Masataka Sata

    CIRCULATION   126 ( 21 )   2012.11

     More details

    Language:English   Publisher:LIPPINCOTT WILLIAMS & WILKINS  

    Web of Science

    researchmap

  • Activation of AMPK-Sirt1 pathway by telmisartan in white adipose tissue: A possible link to anti-metabolic effects Reviewed International journal

    Asuka Shiota, Michio Shimabukuro, Daiju Fukuda, Takeshi Soeki, Hiromi Sato, Etsuko Uematsu, Yoichiro Hirata, Hirotsugu Kurobe, Hiroshi Sakaue, Yutaka Nakaya, Hiroaki Masuzaki, Masataka Sata

    European Journal of Pharmacology   692 ( 1-3 )   84 - 90   2012.10

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:ELSEVIER SCIENCE BV  

    Telmisartan exerts anti-metabolic effects beyond its angiotensin receptor blockade activities, but the mechanisms have hitherto remained elusive. We sought to elucidate the peroxisome proliferator-activated receptor-γ (PPAR-γ)-dependent and PPAR-γ-independent mechanisms underlying the anti-metabolic effects of telmisartan in white adipose tissue. Nine-week-old male C57BL/6 mice were fed with a 60% high-fat diet for 6 weeks, with 1 mg/kg telmisartan or vehicle administrated orally during the last 3 weeks. 3T3-L1 adipocytes were cultured with telmisartan either with 2-chloro-5-nitro-N- phenylbenzamide (GW9662), a selective irreversible antagonist of PPAR-γ, or compound C, an ATP-competitive inhibitor of AMPK. Western blotting and semiquantitative RT-PCR analysis were used to assess adiponectin, Sirt1, and AMPK levels. Lipid accumulation was assessed by Oil red O staining. The activation of transcription factor PPAR-γ2 was evaluated by using a luciferase reporter assay for mPPAR-γ2 expression plasmid vector. Treatment with telmisartan increased serum adiponectin levels in high-fat diet-fed mice concomitantly with an upregulation of adiponectin mRNA in visceral adipose tissue. In vitro telmisartan treatment dose-dependently increased adiponectin mRNA in 3T3-L1 cells; the increase was inhibited by compound C, but not by GW9662. Telmisartan increased expression of Sirt1 mRNA and Sirt1 protein as well as the phosphorylation of AMPK in 3T3-L1 cells. Telmisartan can increase adiponectin production in white adipose tissue partly via a PPAR-γ2-independent mechanism. Precise understanding of this molecular mechanism will require further investigation. © 2012 Elsevier B.V.

    DOI: 10.1016/j.ejphar.2012.07.026

    Web of Science

    Scopus

    PubMed

    J-GLOBAL

    researchmap

  • Gender disparities in the association between epicardial adipose tissue volume and coronary atherosclerosis: A 3-dimensional cardiac computed tomography imaging study in Japanese subjects Reviewed International journal

    Munkhbaatar Dagvasumberel, Michio Shimabukuro, Takeshi Nishiuchi, Junji Ueno, Shoichiro Takao, Daiju Fukuda, Yoichiro Hirata, Hirotsugu Kurobe, Takeshi Soeki, Takashi Iwase, Kenya Kusunose, Toshiyuki Niki, Koji Yamaguchi, Yoshio Taketani, Shusuke Yagi, Noriko Tomita, Hirotsugu Yamada, Tetsuzo Wakatsuki, Masafumi Harada, Tetsuya Kitagawa, Masataka Sata

    Cardiovascular Diabetology   11   106 - 106   2012.9

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:BIOMED CENTRAL LTD  

    Background: Growing evidence suggests that epicardial adipose tissue (EAT) may contribute to the development of coronary artery disease (CAD). In this study, we explored gender disparities in EAT volume (EATV) and its impact on coronary atherosclerosis.Methods: The study population consisted of 90 consecutive subjects (age: 63 ± 12 years; men: 47, women: 43) who underwent 256-slice multi-detector computed tomography (MDCT) coronary angiography. EATV was measured as the sum of cross-sectional epicardial fat area on CT images, from the lower surface of the left pulmonary artery origin to the apex. Subjects were segregated into the CAD group (coronary luminal narrowing > 50%) and non-CAD group.Results: EATV/body surface area (BSA) was higher among men in the CAD group than in the non-CAD group (62 ± 13 vs. 33 ± 10 cm /m , p < 0.0001), but did not differ significantly among women in the 2 groups (49 ± 18 vs. 42 ± 9 cm /m , not significant). Multivariate logistic analysis showed that EATV/BSA was the single predictor for >50% coronary luminal narrowing in men (p < 0.0001). Predictors excluded were age, body mass index, hypertension, diabetes mellitus, and hyperlipidemia.Conclusions: Increased EATV is strongly associated with coronary atherosclerosis in men. © 2012 Dagvasumberel et al.; licensee BioMed Central Ltd. 3 2 3 2

    DOI: 10.1186/1475-2840-11-106

    Web of Science

    Scopus

    PubMed

    J-GLOBAL

    researchmap

  • Systemic preconditioning by a prolyl hydroxylase inhibitor promotes prevention of skin flap necrosis via HIF-1-induced bone marrow-derived cells Reviewed International journal

    Mitsuru Takaku, Shuhei Tomita, Hirotsugu Kurobe, Yoshitaka Kihira, Atsushi Morimoto, Mayuko Higashida, Yasumasa Ikeda, Akira Ushiyama, Ichiro Hashimoto, Hideki Nakanishi, Toshiaki Tamaki

    PLoS ONE   7 ( 8 )   e42964   2012.8

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:PUBLIC LIBRARY SCIENCE  

    Background: Local skin flaps often present with flap necrosis caused by critical disruption of the blood supply. Although animal studies demonstrate enhanced angiogenesis in ischemic tissue, no strategy for clinical application of this phenomenon has yet been defined. Hypoxia-inducible factor 1 (HIF-1) plays a pivotal role in ischemic vascular responses, and its expression is induced by the prolyl hydroxylase inhibitor dimethyloxalylglycine (DMOG). We assessed whether preoperative stabilization of HIF-1 by systemic introduction of DMOG improves skin flap survival. Methods and Results: Mice with ischemic skin flaps on the dorsum were treated intraperitoneally with DMOG 48 hr prior to surgery. The surviving area with neovascularization of the ischemic flaps was significantly greater in the DMOG-treated mice. Significantly fewer apoptotic cells were present in the ischemic flaps of DMOG-treated mice. Interestingly, marked increases in circulating endothelial progenitor cells (EPCs) and bone marrow proliferative progenitor cells were observed within 48 hr after DMOG treatment. Furthermore, heterozygous HIF-1α-deficient mice exhibited smaller surviving flap areas, fewer circulating EPCs, and larger numbers of apoptotic cells than did wild-type mice, while DMOG pretreatment of the mutant mice completely restored these parameters. Finally, reconstitution of wild-type mice with the heterozygous deficient bone marrow cells significantly decreased skin flap survival. Conclusion: We demonstrated that transient activation of the HIF signaling pathway by a single systemic DMOG treatment upregulates not only anti-apoptotic pathways but also enhances neovascularization with concomitant increase in the numbers of bone marrow-derived progenitor cells. © 2012 Takaku et al.

    DOI: 10.1371/journal.pone.0042964

    Web of Science

    Scopus

    PubMed

    J-GLOBAL

    researchmap

  • Autologous peripheral blood-derived mononuclear cells induced by erythropoietin improve critical ischemic limbs. Reviewed

    Tamotsu Kanbara, Hirotsugu Kurobe, Takashi Kitaichi, Mikio Sugano, Taisuke Nakayama, Hajime Kinoshita, Takashi Iwase, Masafumi Akaike, Masahiro Abe, Masataka Sata, Toshio Matsumoto, Tetsuya Kitagawa

    Annals of vascular diseases   5 ( 1 )   52 - 60   2012

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:1  

    PURPOSE: Efficient and secure collection of CD34+ cells are crucial for the angiogenic therapies. We have developed autologous peripheral blood-mononuclear cell (MNC) transplantation induced by erythropoietin (rhEPO) for critical ischemic limbs. METHODS: Seven patients, including five with arteriosclerosis obliterans, one with Buerger's disease and one with progressive systemic sclerosis, underwent ten cell therapies. The first administration of rhEPO was performed two weeks before apheresis, and the second administration and blood donation were performed one week before apheresis to activate bone marrow. MNCs including CD34+ cells, isolated from peripheral blood by apheresis, were immediately injected intramuscularly into ischemic limbs. RESULTS: The number of peripheral blood-CD34 + cells had significantly increased from 1.32 ± 0.83/microL, before the rhEPO induction, to 1.86 ± 0.94/microL, before the apheresis. The number of transplanted MNCs ranged between 0.5 × 10(9) and 16.5 × 10(9), and that of CD34+ cells, between 0.1 × 10(6) and 12.7 × 10(6), accounting for 0.02%-0.1% of MNCs. There were no serious complications. Finger ulcers with Buerger's disease were significantly improved one month after the transplantations, but the same or other ulcer(s) appeared 2-6 months later. Three patients had an improvement in rest pain, and one patient extended maximum pain-free walking distance. CONCLUSIONS: Erythropoietin-induced autologous peripheral blood-MNC transplantation is a useful and safe alternative for ischemic limbs.

    DOI: 10.3400/avd.oa.11.00070

    PubMed

    J-GLOBAL

    researchmap

  • Concise review: Tissue-engineered vascular grafts for cardiac surgery: Past, present, and Future Reviewed International journal

    Hirotsugu Kurobe, Mark W. Maxfield, Christopher K. Breuer, Toshiharu Shinoka

    Stem Cells Translational Medicine   1 ( 7 )   566 - 571   2012

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:WILEY  

    In surgical repair for heart or vascular disease, it is often necessary to implant conduits or correct tissue defects. The most commonly used graft materials to date are (a) artificial grafts; (b) autologous tissues, such as pericardium and saphenous vein; (c) allografts; and (d) xenografts. However, none of these four options offer growth potential, and all are associated with varying levels of thrombogenicity and susceptibility to infection. The lack of growth potential of these four options is particularly important in pediatric cardiac surgery, where patients will often outgrow their vascular grafts and require additional operations. Thus, developing a material with sufficient durability and growth potential that will function as the child grows older will eliminate the need for reoperation and significantly reduce morbidity and mortality of some types of congenital heart defects. Vascular tissue engineering is a relatively new field that has undergone enormous growth over the last decade. The goal of vascular tissue engineering is to produce neovessels and neo-organ tissue from autologous cells using a biodegradable polymer as a scaffold. The most important advantage of tissue-engineered implants is that these tissues can grow, remodel, rebuild, and respond to injury. Once the seeded autologous cells have deposited an extracellular matrix and the original scaffold is biodegraded, the tissue resembles and behaves as native tissue. When tissue-engineered vascular grafts are eventually put to use in the clinical arena, the quality of life in patients after surgery will be drastically improved. © AlphaMed Press.

    DOI: 10.5966/sctm.2012-0044

    Web of Science

    Scopus

    PubMed

    J-GLOBAL

    researchmap

  • Ezetimibe monotherapy ameliorates vascular function in patients with hypercholesterolemia through decreasing oxidative stress Reviewed

    Hirotsugu Kurobe, Ken Ichi Aihara, Mayuko Higashida, Yoichiro Hirata, Masako Nishiya, Yuki Matsuoka, Tamotsu Kanbara, Taisuke Nakayama, Hajime Kinoshita, Mikio Sugano, Eiki Fujimoto, Ayako Kurobe, Noriko Sugasawa, Takashi Kitaichi, Masashi Akaike, Masataka Sata, Toshio Matsumoto, Tetsuya Kitagawa

    Journal of Atherosclerosis and Thrombosis   18 ( 12 )   1080 - 1089   2011.12

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:JAPAN ATHEROSCLEROSIS SOC  

    Aim: Ezetimibe, an inhibitor of cholesterol intestinal absorption, is a lipid lowering agent. However, anti-atherogenic effects of ezetimibe have not been fully elucidated. Therefore, the objective in this study was to clarify the vascular protective effects of ezetimibe in patients with hypercholesterolemia. Methods: Ezetimibe was administered to 20 patients with hypercholesterolemia (group E), and 20 age- and sex-matched patients with hypercholesterolemia were followed as controls (group C). Difference in metabolic profiles and cardiovascular surrogate markers before ezetimibe treatment and after 12 weeks of ezetimibe treatment were statistically evaluated. Results: Ezetimibe treatment significantly reduced serum levels of low-density lipoprotein cholesterol (LDL-C) and malondialdehyde-modified low-density lipoprotein (MDA-LDL). In addition, the values of body mass index, body weight, waist circumference, plasma HbA1c and urinary albumin were significantly decreased in group E compared to those in group C. On the other hand, high-density lipoprotein cholesterol (HDL-C) and adiponectin levels were significantly increased in group E compared to those in group C. The values of brachial-ankle pulse wave velocity (ba-PWV), mean arterial blood pressure (m-ABP), and % of flow-mediated dilation (FMD) were significantly improved in group E. Furthermore, ultrasonic studies demonstrated amelioration of the vascular stiffness of common carotid arteries in group E but not in group C. These vascular protective effects of ezetimibe were statistically correlated with the decreased values of MDA-LDL and MDA-LDL-to-LDL-C ratio but not with those of LDL-C. Conclusion: Ezetimibe has a lipid lowering-independent vascular protective effect in patients with hypercholesterolemia through decreasing oxidative stress.

    DOI: 10.5551/jat.9548

    Web of Science

    Scopus

    PubMed

    J-GLOBAL

    researchmap

  • Preconditioning of Mice with a Prolyl Hydroxylase Inhibitor, Dimethyloxalylglycine, Prevents Skin Flap Necrosis Reviewed

    Mitsuru Takaku, Shuhei Tomita, Hirotsugu Kurobe, Akira Ushiyama, Ichiro Hashimoto, Hideki Nakanishi, Toshiaki Tamaki

    CIRCULATION   124 ( 21 )   2011.11

     More details

    Language:English   Publisher:LIPPINCOTT WILLIAMS & WILKINS  

    Web of Science

    researchmap

  • Hmgb-1 Signal Via Tlr-9 Plays Critical Role iIn Vascular Remodeling Reviewed

    Mayuko Higashida, Yoichiro Hirata, Hirotsugu Kurobe, Yutaka Nakaya, Tetsuya Kitagawa, Masataka Sata

    CIRCULATION   124 ( 21 )   2011.11

     More details

    Language:English   Publisher:LIPPINCOTT WILLIAMS & WILKINS  

    Web of Science

    researchmap

  • Coronary atherosclerosis is associated with macrophage polarization in epicardial adipose tissue Reviewed International journal

    Yoichiro Hirata, Minoru Tabata, Hirotsugu Kurobe, Tatsuo Motoki, Masashi Akaike, Chika Nishio, Mayuko Higashida, Hiroaki Mikasa, Yutaka Nakaya, Shuichiro Takanashi, Takashi Igarashi, Tetsuya Kitagawa, Masataka Sata

    Journal of the American College of Cardiology   58 ( 3 )   248 - 255   2011.7

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:ELSEVIER SCIENCE INC  

    Objectives: The purpose of this report was to assess the link between macrophage polarization in epicardial adipose tissue and atherosclerosis in patients with coronary artery disease (CAD). Background: Macrophage accumulation enhances chronic inflammation in adipose tissue, but macrophage phenotypic change in human epicardial adipose tissue and its role in atherogenesis are unknown. Methods: Samples were obtained from epicardial and subcutaneous adipose tissue during elective cardiac surgery (CAD, n = 38; non-CAD, n = 40). Infiltration of M1/M2 macrophages was investigated by immunohistochemical staining with antibodies against CD11c and CD206, respectively. Expression of pro- and anti-inflammatory adipocytokines in adipose tissue was evaluated by real-time quantitative polymerase chain reaction. Results: Infiltration of macrophages and expression of pro- and anti-inflammatory cytokines were enhanced in epicardial fat of patients with CAD compared with that in non-CAD patients (p < 0.05). The ratio of M1/M2 macrophages was positively correlated with the severity of CAD (r = 0.312, p = 0.039). Furthermore, the expression of pro-inflammatory cytokines was positively correlated, and the expression of anti-inflammatory cytokines was negatively correlated with the ratio of M1/M2 macrophages in epicardial adipose tissue of CAD patients. By contrast, there was no significant difference in macrophage infiltration and cytokine expression in subcutaneous adipose tissue between the CAD and non-CAD groups. Conclusions: The ratio of M1/M2 macrophages in epicardial adipose tissue of CAD patients is changed compared with that in non-CAD patients. Human coronary atherosclerosis is associated with macrophage polarization in epicardial adipose tissue. © 2011 American College of Cardiology Foundation.

    DOI: 10.1016/j.jacc.2011.01.048

    Web of Science

    Scopus

    PubMed

    J-GLOBAL

    researchmap

  • Functional restoration of endothelial cells of the cryopreserved heart valve Reviewed

    Eiki Fujimoto, Masanori Yoshizumi, Tamotsu Kanbara, Hirotsugu Kurobe, Tatsuo Motoki, Mikio Sugano, Taisuke Nakayama, Takashi Kitaichi, Tetsuya Kitagawa

    General Thoracic and Cardiovascular Surgery   59 ( 3 )   169 - 174   2011.3

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:3  

    Purpose: Although several approaches have been tried to improve the durability of cryopreserved valves, cellular restoration after thawing remains to be investigated. The aim of our study was to assess the functional restoration of endothelial cells of cryopreserved heart valves by in vitro culture for an alternative step to improving longevity. Methods: Cryopreserved human umbilical vein endothelial cells (HUVECs) and porcine aortic cusps were cultivated for 14 days after thawing. Then the cellular activity of the enzymes cytosolic esterase and mitochondrial dehydrogenase was measured. The cellular viability of cryopreserved cusps was also assessed using confocal laser scanning microscopy. Results: The number of viable HUVECs decreased markedly after cryopreservation and thawing but recovered to pre-cryopreservation level after 14 days of culture. In contrast, the enzyme activity of the cryopreserved porcine aortic cusps showed recovery at 7 days of in vitro tissue culture after thawing. Confocal laser scanning microscopy findings showed that the cellular cytosolic esterase activity of cryopreserved cusps deteriorated after thawing but displayed considerable recovery by day 14 of culture. Conclusion: The functional recovery of endothelial cells in cryopreserved heart valves seems to require tissue culture of at least 14 days. Ex vivo endothelial restoration of cryopreserved heart valves may add to heart valve durability. © 2011 The Japanese Association for Thoracic Surgery.

    DOI: 10.1007/s11748-010-0711-y

    Scopus

    PubMed

    CiNii Books

    researchmap

  • Successful early resection of cardiac papillary fibroelastomas Reviewed

    Hirotsugu Kurobe, Tamotsu Kanbara, Homare Yoshida, Tatsuo Motoki, Mikio Sugano, Taisuke Nakayama, Takashi Kitaichi, Tetsuya Kitagawa

    General Thoracic and Cardiovascular Surgery   59 ( 3 )   191 - 194   2011.3

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:3  

    Two adult patients with previous transient cerebral ischemic attacks (TIAs) or chest oppression were referred for further investigation. A swaying pedicled tumor was detected in the left atrium of the former patient and in the left coronary cusp of the latter by echocardiography. The TIA, or angina-like attack, was anticipated to be caused by thromboembolism of the tumor. Both patients underwent tumor extirpation. The histological findings demonstrated that both tumors were benign papillary fibroelastoma limited to the endocardium/ endothelium layer. In conclusion, early surgical resection of a cardiac papillary fibroelastoma should be performed. © 2011 The Japanese Association for Thoracic Surgery.

    DOI: 10.1007/s11748-010-0654-3

    Scopus

    PubMed

    CiNii Books

    researchmap

  • Enhanced inflammation in epicardial fat in patients with coronary artery disease Reviewed

    Yoichiro Hirata, Hirotsugu Kurobe, Masashi Akaike, Fumio Chikugo, Takaki Hori, Yoshimi Bando, Chika Nishio, Mayuko Higashida, Yutaka Nakaya, Tetsuya Kitagawa, Masataka Sata

    International Heart Journal   52 ( 3 )   139 - 142   2011

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:SPRINGER  

    It has been hypothesized that epicardial fat, a local visceral fat depot with close proximity to coronary arteries, may serve as a source of inflammatory cytokines and cells in coronary atherosclerotic lesions. Here, we characterized infiltration of inflammatory cells and expression of adipocytokines in epicardial adipose tissue in patients with and without coronary artery disease (CAD). Pare samples were obtained from epicardial and subcutaneous adipose tissue during elective cardiac surgery (CAD, n = 8; non-CAD, n = 9). Inflammatory cell infiltration was investigated by immunohistochemical staining using antibodies against CD3, CD4, CD8 and CD68. Expression of adipocytokines was evaluated by real-time quantitative reverse transcription-polymerase chain reaction. Infiltration of macrophages and CD8-positive T cells in the epicardial adipose tissue in the CAD group was greater than that in the non-CAD group. In contrast, there was no significant difference between the two groups in the number of inflammatory cells in subcutaneous adipose tissue. No statistical difference could be found between the CAD group and the non-CAD group in the expression levels of adiponectin and inflammatory cytokines in epicardial adipose tissue. Our findings suggest that inflammatory cell infiltration is enhanced in epicardial adipose tissue, but not in subcutaneous fat, in patients with coronary artery disease. Chronic inflammation in epicardial fat may influence the pathogenesis of coronary atherosclerosis.

    DOI: 10.1536/ihj.52.139

    Web of Science

    Scopus

    PubMed

    J-GLOBAL

    researchmap

  • [Preferable surgical approaches to the aortic root-arch in patients with functioning tracheostomy]. Reviewed

    Taisuke Nakayama, Masashi Kanou, Shingo Isshiki, Hideki Sasaki, Takashi Tominaga, Hiroshi Ishitoya, Hirotsugu Kurobe, Tetsuya Kitagawa, Katsuhiko Hiratani, Takaki Hori

    Kyobu geka. The Japanese journal of thoracic surgery   63 ( 13 )   1113 - 1118   2010.12

     More details

    Language:Japanese   Publishing type:Research paper (scientific journal)   Publisher:13  

    Preferable surgical approaches to aortic diseases occurring between the aortic root and the arch in patients with functioning tracheotomy or permanent tracheostomy are described for securing adequate exposure and avoiding postoperative mediastinitis. Case 1: A 41-year-old man with Marfan syndrome presented with chronic type A thrombosed aortic dissection and severe aortic valve regurgitation. He had had a functional tracheostomy for managing respiratory function due to traumatic spinal cord damage. The heart and the ascending aorta were shifted to the right side of the chest and showed a significant counterclockwise rotation. Therefore, the reverse L-figure approach of a right-sided 3rd intercostal anterior thoracostomy and lower midline sternotomy was performed for Bentall operation. Case 2: A 76-year-old woman presented with thoracic aortic aneurysm of 11 cm in diameter. She had had a permanent tracheostomy with total laryngectomy. Therefore, cram shell approach was performed for total arch replacement. The 2 cases had no postoperative mediastinitis. These approaches are recommended for aortic diseases occurring in the ascending aorta or the aortic arch in patients with functioning tracheotomy.

    Scopus

    PubMed

    researchmap

  • Macrophage Polarization in Epicardial Adipose Tissue is Correlated with Severity of Human Coronary Artery Disease Reviewed

    Yoichiro Hirata, Tatsuo Motoki, Hirotsugu Kurobe, Masashi Akaike, Minoru Tabata, Shuichiro Takanashi, Takashi Igarashi, Tetsuya Kitagawa, Masataka Sata

    CIRCULATION   122 ( 21 )   2010.11

     More details

    Language:English   Publisher:LIPPINCOTT WILLIAMS & WILKINS  

    Web of Science

    researchmap

  • Pioglitazone Attenuates Inflammatory Changes in Abdominal Aortic Aneurysm Reviewed

    Tatsuo Motoki, Hirotsugu Kurobe, Yoichiro Hirata, Yuta Arai, Atsuko Terahashi, Mikio Sugano, Homare Yoshida, Tamotsu Kanbara, Takashi Kitaichi, Masataka Sata, Tetsuya Kitagawa

    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY   30 ( 11 )   E270 - E270   2010.11

     More details

    Language:English   Publisher:LIPPINCOTT WILLIAMS & WILKINS  

    Web of Science

    researchmap

  • Undiminished regulatory T cells in the thymus of patients with myasthenia gravis Reviewed

    N. Matsui, S. Nakane, F. Saito, I. Ohigashi, Y. Nakagawa, H. Kurobe, H. Takizawa, T. Mitsui, K. Kondo, T. Kitagawa, Y. Takahama, R. Kaji

    Neurology   74 ( 10 )   816 - 820   2010.3

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:LIPPINCOTT WILLIAMS & WILKINS  

    Objective: The thymus has been implicated as a possible site of origin that triggers autoimmunity in myasthenia gravis (MG). Although several groups have suggested that the decrease in the number of regulatory T (Treg) cells contributes to the onset of MG, the exact role of Treg cells in MG remains unclear. To address this point, we examined the number and distribution of Treg cells in a large number of patients with MG. Methods: Immunohistofluorescence analysis of Foxp3 along with CD4 and CD8 was performed in thymic sections of MG (+) (n = 24) and MG (-) patients (n = 27). Circulating CD4CD25 cells in the peripheral blood of patients with MG (n = 15) and age-matched healthy subjects (n = 15) were also analyzed. RESULTS: Foxp CD CD cells were predominantly found in the thymic medulla and their number declined with age. There was no significant difference in the number or the distribution of Foxp CD CD cells in the thymus between MG (+) and MG (-) patients. The number of circulating CD CD25 cells in the peripheral blood of patients with MG was not significantly altered compared to that in healthy subjects. Conclusion: The cellularity of Treg cells in the thymus and circulation is not diminished in patients with myasthenia gravis. Copyright © 2010 by AAN Enterprises, Inc. 3+ 4+ 8- 3+ 4+ 8- 4+ +

    DOI: 10.1212/WNL.0b013e3181d31e47

    Web of Science

    Scopus

    researchmap

  • Role of hypoxia-inducible factor 1α in T cells as a negative regulator in development of vascular remodeling Reviewed International journal

    Hirotsugu Kurobe, Masahisa Urata, Masaki Ueno, Masaaki Ueki, Shiro Ono, Yuki Izawa-Ishizawa, Yayoi Fukuhara, Yu Lei, Adiratna Mat Ripen, Tamotsu Kanbara, Ken Ichi Aihara, Keisuke Ishizawa, Masashi Akaike, Frank J. Gonzalez, Toshiaki Tamaki, Yousuke Takahama, Masanori Yoshizumi, Tetsuya Kitagawa, Shuhei Tomita

    Arteriosclerosis, Thrombosis, and Vascular Biology   30 ( 2 )   210 - 217   2010.2

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:LIPPINCOTT WILLIAMS & WILKINS  

    BACKGROUND AND PURPOSE-: Recent studies have shown that the cellular immune response in the development of vascular remodeling modulates the resulting pathological alterations. We show that hypoxia-inducible factor 1 (Hif-1) (specifically expressed in T cells) is involved in the immune response to vascular remodeling that accompanies arteriosclerosis. METHODS AND RESULTS-: To study the role of T cells in the development of vascular remodeling, femoral arterial injury induced by an external vascular polyethylene cuff was examined in mice lacking Hif-1 (specifically in T cells). We found that cuff placement caused prominent neointimal hyperplasia of the femoral artery in Hif-1-(T-cell)-deficient mice compared with that in control mice and that infiltration of inflammatory cells at the adventitia was markedly increased in the mutant mice. Studies to clarify the mechanism of augmented vascular remodeling in the mutant mice showed enhanced production of cytokines by activated T cells and augmented antibody production in response to a T-dependent antigen in the mutant mice. CONCLUSIONS-: The results of this study revealed that Hif-1α in T cells plays a crucial role in vascular inflammation and remodeling in response to cuff injury as a negative regulator of T cell-mediated immune response. Potential new therapeutic strategies that target Hif-1α are described. © 2010 American Heart Association, Inc.

    DOI: 10.1161/ATVBAHA.109.192666

    Web of Science

    Scopus

    PubMed

    J-GLOBAL

    researchmap

  • Undiminished regulatory T cells in the thymus of patients with myasthenia gravis Reviewed

    N. Matsui, S. Nakane, F. Saito, I. Ohigashi, Y. Nakagawa, H. Kurobe, H. Takizawa, T. Mitsui, K. Kondo, T. Kitagawa, Y. Takahama, R. Kaji

    Neurology   74 ( 10 )   816 - 820   2010

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:Lippincott Williams and Wilkins  

    Objective: The thymus has been implicated as a possible site of origin that triggers autoimmunity in myasthenia gravis (MG). Although several groups have suggested that the decrease in the number of regulatory T (Treg) cells contributes to the onset of MG, the exact role of Treg cells in MG remains unclear. To address this point, we examined the number and distribution of Treg cells in a large number of patients with MG. Methods: Immunohistofluorescence analysis of Foxp3 along with CD4 and CD8 was performed in thymic sections of MG (+) (n = 24) and MG (-) patients (n = 27). Circulating CD4CD25 cells in the peripheral blood of patients with MG (n = 15) and age-matched healthy subjects (n = 15) were also analyzed. RESULTS: Foxp3+CD4+CD 8- cells were predominantly found in the thymic medulla and their number declined with age. There was no significant difference in the number or the distribution of Foxp3+CD4+CD8- cells in the thymus between MG (+) and MG (-) patients. The number of circulating CD 4+CD25+ cells in the peripheral blood of patients with MG was not significantly altered compared to that in healthy subjects. Conclusion: The cellularity of Treg cells in the thymus and circulation is not diminished in patients with myasthenia gravis. Copyright © 2010 by AAN Enterprises, Inc.

    DOI: 10.1212/WNL.0b013e3181d31e47

    Scopus

    PubMed

    researchmap

  • Syngeneic Bone Marrow Mononuclear Cells Improve Pulmonary Arterial Hypertension Through Vascular Endothelial Growth Factor Upregulation Reviewed International journal

    Homare Yoshida, Takashi Kitaichi, Masahisa Urata, Hirotsugu Kurobe, Tamotsu Kanbara, Tatsuo Motoki, Tetsuya Kitagawa

    Annals of Thoracic Surgery   88 ( 2 )   418 - 424   2009.8

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:ELSEVIER SCIENCE INC  

    Background: We investigated the effects and possible mechanism of syngeneic bone marrow mononuclear cell (BM-MNC) transplantation on pulmonary arterial hypertension induced by monocrotaline. Methods: Monocrotaline (80 mg/kg body weight) was administrated to C57BL/6 mice, and pulmonary arterial hypertension was induced 4 weeks later. Bone marrow mononuclear cells harvested from syngeneic donor mice were injected intravenously into those mice 4 weeks after monocrotaline administration. The ratio of right ventricular to septum plus left ventricular weight, the number of small pulmonary arteries, and medial thickness of pulmonary arteries were measured. Western immunoblotting of the lung tissue was performed to observe vascular endothelial growth factor and its receptor expression 1 week after BM-MNC transplantation. Vascular endothelial growth factor receptor-2 inhibitor was administered to pulmonary arterial hypertension mice simultaneously with BM-MNC transplantation. Results: The ratio of right ventricular to septum plus left ventricular weight increased, the number of pulmonary arteries decreased, and medial thickness increased significantly 4 weeks after monocrotaline injection compared with those of vehicle-injected mice. These indices of monocrotaline-injected mice improved significantly 4 weeks after BM-MNC transplantation compared with those of mice at 8 weeks after monocrotaline injection (0.22 ± 0.02 versus 0.31 ± 0.02; 17.1 ± 2.6 versus 8.2 ± 1.7; 7.7% ± 2.2% versus 20% ± 2.1%, respectively; p < 0.01). However, BM-MNCs were not incorporated into the lung at 1 week after transplantation, and significant vascular endothelial growth factor upregulation and without receptor expression was observed in lung tissue 1 week after transplantation. Improvement of pulmonary arterial hypertension was inhibited by simultaneous administration of vascular endothelial growth factor receptor-2 inhibitor with BM-MNC transplantation. Conclusions: These results indicate that syngeneic BM-MNC transplantation improves monocrotaline-induced pulmonary arterial hypertension by favorable pulmonary artery remodeling through vascular endothelial growth factor upregulation. © 2009 The Society of Thoracic Surgeons.

    DOI: 10.1016/j.athoracsur.2009.04.105

    Web of Science

    Scopus

    PubMed

    J-GLOBAL

    researchmap

  • ENHANCED MACROPHAGE INFILTRATION IN EPICARDIAL ADIPOSE TISSUE IN PATIENTS WITH CORONARY ARTERY DISEASE. Reviewed

    Yoichiro Hirata, Toshiyuki Niki, Kenya Kusunose, Koji Yamaguchi, Shusuke Yagi, Kunihiko Koshiba, Takashi Iwase, Hirotsugu Yamada, Takeshi Soeki, Tetsuzo Wakatsuki, Masashi Akaike, Hirotsugu Kurobe, Humio Chikugo, Takaki Hori, Tetsuya Kitagawa, Masataka Sata

    JOURNAL OF VASCULAR RESEARCH   46   166 - 166   2009

     More details

    Language:English   Publisher:KARGER  

    Web of Science

    researchmap

  • Heparin cofactor II is an independent protective factor against peripheral arterial disease in elderly subjects with cardiovascular risk factors

    Ken Ichi Aihara, Hiroyuki Azuma, Masashi Akaike, Hirotsugu Kurobe, Nobuyuki Takamori, Yasumasa Ikeda, Yuka Sumitomo, Sumiko Yoshida, Shusuke Yagi, Takashi Iwase, Kazue Ishikawa, Masataka Sata, Tetsuya Kitagawa, Toshio Matsumoto

    Journal of Atherosclerosis and Thrombosis   16 ( 2 )   127 - 134   2009

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:JAPAN ATHEROSCLEROSIS SOC  

    Aim: Heparin cofactor (HC) specifically inactivates thrombin action at the injured vascular wall. We have reported that HC is a protective factor against coronary in-stent restenosis and carotid atherosclerosis; however, it is unclear whether there is any correlation between plasma HC levels and the development of peripheral arterial disease (PAD). Methods: Plasma HC activity and the ankle brachial pressure index (ABI) were determined in 494 elderly subjects with cardiovascular risk factors. PAD was diagnosed by ABI below 0.9, and 62 subjects were diagnosed with PAD. The relationship between factors that affect cardiovascular events and the prevalence of PAD was statistically evaluated. Results: Mean HC activity in PAD subjects was significantly lower than in non-PAD subjects (87.5 ± 19.7% v.s. 94.6 ± 17.8%, p 0.009). Multivariate logistic regression analysis showed that age (odds ratio [OR]: 1.062, p 0.0016), current smoking (OR 3.028, p 0.002) and diabetes mellitus (OR 2.656, p 0.008) were independent and progressive determinants of PAD. In contrast, HC was an independent inhibitory factor of PAD (OR: 0.982, p 0.048). Conclusions: Plasma HC activity is inversely related to the prevalence of PAD. HC may function as the sole protective factor against PAD in elderly people with cardiovascular risk factors.

    DOI: 10.5551/jat.E695

    Web of Science

    Scopus

    PubMed

    CiNii Books

    researchmap

  • A successful transatrial repair in redo surgery of postinfarction inferoposterior ventricular septal rupture

    Takashi Tominaga, Hirotsugu Kurobe, Tamotsu Kanbara, Takeyuki Kanemura, Takashi Kitaichi, Tetsuya Kitagawa

    Journal of Medical Investigation   54 ( 1-2 )   184 - 186   2007.2

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:The University of Tokushima  

    A successful transatrial repair in redo surgery of postinfarction posterior ventricular septal rupture (VSR) was performed after an infarct exclusion technique through left ventriculotomy incision of the infarcted area. For the infarct lesion, this approach provides excellent results with sufficient closure of the VSR and prevention of the ventricular remodeling for five years. A right atrial approach for postinfarction posterior VSR is very useful for avoiding any further ventriculotomy in an already impaired ventricle, securing a stable suture, and preserving the left ventricular geometry and function.

    DOI: 10.2152/jmi.54.184

    Scopus

    PubMed

    CiNii Books

    researchmap

  • Significance of peritoneal fluid drainage in management after repair of complex heart defects in infancy - Cytokine dynamics in vivo Reviewed

    Hirotsugu Kurobe, Takashi Kitaichi, Yusuke Shimahara, Takeyuki Kanemura, Tamotsu Kanbara, Atsushi Kurushima, Masashi Kano, Takaki Hori, Homare Yoshida, Masahiro Urata, Tetsuya Kitagawa

    Circulation Journal   71 ( 6 )   941 - 947   2007

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:Japanese Circulation Society  

    Background: In vivo redundancy of pro-inflammatory cytokines results in a vicious cycle of systemic inflammatory response syndrome and low cardiac output syndrome (LOS). The purpose of this study was to elucidate the influence of peritoneal fluid (PF) drainage on cytokine dynamics in vivo and the significance of early induction for infants with LOS. Methods and Results: Seven infants, who underwent early PF drainage to manage LOS after repair of complex heart defects under cardiopulmonary bypass, were enrolled. The serum and PF levels of the pro- and antiinflammatory cytokines, interleukin (IL)-6, -8, -10 and tumor necrosis factor (TNF)-• ,•were measured during the perioperative period. Clinical outcomes were observed simultaneously. There were no cases of early or late death, or infectious complications. Drainage volume of PF peaked just after operation, and decreased completely. The amount of proinflammatory cytokines in the PF increased for 3 days after operation. Of the proinflammatory cytokines in the PF IL-6 increased the earliest and cleared the fastest. The amount of cleared IL-8 and TNF-• •peaked on the 3rd postoperative day and resembled the course of C-reactive protein (CRP). Serum levels of CRP and proinflammatory cytokines in patients with PF drainage decreased significantly more than those without PF drainage. Conclusions: Early initiation of PF drainage is useful in the postoperative critical care of infants with LOS by improving cytokine dynamics in vivo, although there are differences between the severity of patients undergoing PF drainage and those who do not.

    DOI: 10.1253/circj.71.941

    Web of Science

    Scopus

    PubMed

    CiNii Books

    J-GLOBAL

    researchmap

  • CCR7-dependent cortex-to-medulla migration of positively selected thymocytes is essential for establishing central tolerance Reviewed International journal

    Hirotsugu Kurobe, Cunlan Liu, Tomoo Ueno, Fumi Saito, Izumi Ohigashi, Natalie Seach, Rieko Arakaki, Yoshio Hayashi, Tetsuya Kitagawa, Martin Lipp, Richard L. Boyd, Yousuke Takahama

    Immunity   24 ( 2 )   165 - 177   2006.2

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:CELL PRESS  

    Immature CD4 CD8 thymocytes, which are generated in the thymic cortex, are induced upon positive selection to differentiate into mature T lymphocytes and relocate to the thymic medulla. It was recently shown that a chemokine signal via CCR7 is essential for the cortex-to-medulla migration of positively selected thymocytes in the thymus. However, the role of the cortex-to-medulla migration in T cell development and selection has remained unclear. The present study shows that the developmental kinetics and the thymic export of mature thymocytes were undisturbed in adult mice lacking CCR7 or its ligands (CCR7L). The inhibition of sphingosine-1-phosphate-mediated lymphocyte egress from the thymus led to the accumulation of mature thymocytes in the cortex of CCR7- or CCR7L-deficient mice, unlike the accumulation in the medulla of normal mice, thereby suggesting that mature thymocytes may be exported directly from the cortex in the absence of CCR7 signals. However, the thymocytes that were generated in the absence of CCR7 or CCR7L were potent in causing autoimmune dacryoadenitis and sialadenitis in mice and were thus incapable of establishing central tolerance to organ-specific antigens. These results indicate that CCR7-mediated cortex-to-medulla migration of thymocytes is essential for establishing central tolerance rather than for supporting the maturation or export of thymocytes. ©2006 Elsevier Inc. + +

    DOI: 10.1016/j.immuni.2005.12.011

    Web of Science

    Scopus

    PubMed

    researchmap

  • TNFα-dependent induction of cyclooxygenase-2 and its suppression by glucocorticoid: Transcriptional regulation

    Kei Yamamoto, Hirotsugu Kurobe, Shozo Yamamoto

    FASEB Journal   11 ( 9 )   1997

     More details

    Publishing type:Research paper (scientific journal)  

    Fatty acid cyclooxygenase-2 (COX-2) is induced by various hormones, cytokines, and prostaglandins (PGs) in a mouse osteoblastic cell line MC3T3-E1. The induction of the enzyme is suppressed by glucocorticoid. Recently we found a rapid and transient increase of COX activity by tumor necrosis factor a (TNFa) which was attributed to the induction of COX-2 rather than COX-1 on the basis of COX-2 specific inhibitor and Western and Northern blottings. Transcription factors presumably involved in the COX-2 induction were investigated. The 5'-flanking region of mouse COX-2 gene was cloned, and shown by luciferase analyses to include two positive regions with NFKB and NF-IL6 elements. Point mutations of these elements and gel shift assays suggested a potential role of both NFKB and NF-IL6 in the TNFa-dependent induction of COX-2 in MC3T3-E1 cells. When the cells were treated with dexamethasone (DEX), the TNFa-dependent COX activity was decreased in a dose-dependent manner. Induction of COX-2 protein and mRNA was suppressed by DEX. We are now investigating if other transcription factors in addition to NFKB and NF-IL6 are also involved in the COX-2 induction and how these transcription factors are related to the function of DEX.

    Scopus

    researchmap

▼display all

MISC

  • 張力固定型チタンケーブルを用いた胸骨固定による周術期経過の検討~患者術後QOL改善に寄与するか~

    檜垣知秀, 黒部裕嗣, 檜山七愛, 小関悠太郎, 梅津明子, 太田教隆, 坂上倫久, 西村隆, 泉谷裕則

    日本胸部外科学会定期学術集会(Web)   77th   2024

  • Modified Sternum-Closing Procedure with Titanium Cable and a Poly-Lactic Acid (PLA) Mesh Plate-For Improving QOL after Cardiac Surgery in Patient with Sternotomy

    檜垣知秀, 黒部裕嗣, 福西琢真, 坂上倫久, 西村隆, 泉谷裕則

    日本心臓血管外科学会雑誌   53 ( 2 )   2024

  • 自己心膜由来大動脈弁に対する生化学的および組織学的解析

    薦田宗則, 坂上倫久, 梅津明子, 檜垣知秀, 太田教隆, 黒部裕嗣, 西村隆, 泉谷裕則

    日本胸部外科学会定期学術集会(Web)   77th   2024

  • Frail/High age弓部大動脈瘤患者でのNAJUTA適応とその成績

    黒部裕嗣, 黒部裕嗣, 藤田博, 堀隆樹, 福西琢真, 檜垣知秀, 坂本裕司, 梅津明子, 太田教隆, 坂上倫久, 西村隆, 曽我部仁史, 泉谷裕則

    日本胸部外科学会定期学術集会(Web)   77th   2024

  • 大動脈弁石灰化におけるvalve interstitial cellsの役割

    坂上倫久, 坂上倫久, 菅野果穂, 浪口謙治, 黒部裕嗣, 福西琢真, 薦田宗則, 西村隆, 泉谷裕則

    日本心臓血管外科学会学術総会(Web)   53rd   2023

  • QOL向上を意図した開心術後閉胸方法の検討~早期日常生活復帰を促進するために~

    檜垣知秀, 黒部裕嗣, 福西琢真, 薦田宗則, 坂上倫久, 西村隆, 泉谷裕則

    日本胸部外科学会定期学術集会(Web)   76th   2023

  • Embolization Using Direct Puncture for Type II Endoleak after TEVAR: A Case Report

    福西琢真, 田中宏明, 本郷哲央, 八杉巧, 黒部裕嗣, 西村隆, 薦田宗則, 檜垣知秀, 坂上倫久, 泉谷裕則

    血管外科   42 ( 1 )   2023

  • Development of medical devices with biodegradable materials

    黒部裕嗣, 黒部裕嗣, 新岡俊治, 平田陽一郎, 福西琢真, 森谷友造, 倉田美恵, 坂上倫久, 檜垣高史, 泉谷裕則

    愛媛医学   42 ( 3 )   2023

  • 心膜癒着における血管新生の役割解明

    坂上倫久, 坂上倫久, 薦田宗則, 倉田美恵, 黒部裕嗣, 西村隆, 久保田義顕, 東山繁樹, 泉谷裕則

    日本血管生物医学会学術集会プログラム・抄録集   31st (CD-ROM)   2023

  • 大動脈弁石灰化を制御する遺伝子の網羅的探索研究

    薦田宗則, 坂上倫久, 坂上倫久, 濱口美香, 坂本裕司, 福西琢真, 倉田美恵, 倉田美恵, 青野潤, 黒部裕嗣, 西村隆, 山口修, 泉谷裕則

    日本胸部外科学会定期学術集会(Web)   76th   2023

  • 巨大冠動脈瘤に対する治療戦略

    檜垣知秀, 黒部裕嗣, 福西琢真, 薦田宗則, 坂上倫久, 西村隆, 泉谷裕則

    関西胸部外科学会学術集会プログラム・抄録集   66th   2023

  • 術後の胸骨固定性とQOL向上を目指して

    檜垣知秀, 黒部裕嗣, 福西琢真, 薦田宗則, 坂上倫久, 西村隆, 八杉巧, 泉谷裕則

    日本心臓血管外科学会学術総会(Web)   53rd   2023

  • 生体内分解性素材を用いた循環器治療用デバイス開発の現状

    黒部裕嗣, 黒部裕嗣, 新岡俊治, 平田陽一郎, 中村日菜美, 福西琢真, 坂上倫久, 泉谷裕則, 山内康治

    日本心臓血管外科学会学術総会(Web)   53rd   2023

  • 安全に小開胸心臓手術を遂行するために~下肢灌流を考慮したSize Down送血管使用時のパラメーターの検討~

    黒部裕嗣, 泉谷裕則, 檜垣知秀, 福西琢真, 管野司, 三木航太, 伴野誠幸, 杉村直紀, 平川太基, 塚本伶央奈, 品部雅俊, 坂上倫久, 山田文哉, 西村隆, 八杉巧

    日本胸部外科学会定期学術集会(Web)   75th   2022

  • 大動脈弁石灰化におけるプロスタグランジン代謝経路の役割

    坂上倫久, 濱口美香, 青野潤, 薦田宗則, 福西琢真, 黒部裕嗣, 西村隆, 泉谷裕則

    日本胸部外科学会定期学術集会(Web)   75th   2022

  • 循環器治療用デバイスへの生体吸収性素材の可能性

    黒部裕嗣, 新岡俊治, 中村日菜美, 花田幸太郎, 平田陽一郎, 福西琢真, 坂上倫久, 泉谷裕則, 山内康治

    人工臓器(日本人工臓器学会)   51 ( 2 )   2022

  • The Development of Biodegradable Medical devices

    黒部裕嗣, 黒部裕嗣, 中村日菜美, 平田陽一郎, 坂上倫久, 山内康治, 泉谷裕則, 新岡俊治

    繊維学会予稿集(CD-ROM)   77 ( 2 )   2022

  • IMPELLA使用による出血合併症の検討

    檜垣知秀, 西村隆, 薦田宗則, 福西琢真, 黒部裕嗣, 坂上倫久, 八杉巧, 泉谷裕則, 三好徹, 東晴彦, 山口修

    医工学治療   34 ( Supplement )   2022

  • 骨軟骨腫による圧迫が原因と思われる膝窩動脈瘤の1例

    薦田 宗則, 八杉 巧, 浪口 謙治, 黒部 裕嗣, 西村 隆, 泉谷 裕則

    血管外科   39 ( 1 )   82 - 87   2020.11

     More details

    Language:Japanese   Publisher:血管外科症例検討会  

    骨軟骨腫は頻度の高い良性骨腫瘍であるが時に悪性転化することもある。その骨腫頭による動脈破裂や形成された動脈瘤からの塞栓症、圧迫による深部静脈血栓症、神経障害を来す可能性があり、発見次第早期の手術が必要である。経験した症例は38歳男性。2ヵ月前からの左膝窩部から下腿後面の疼痛を主訴に来院した。CTにて骨軟骨腫および同部位の左膝窩動脈瘤と診断した。手術は、体位を腹臥位とし、後方アプローチを行った。まず軟骨腫を切除した後に膝窩動脈瘤を切除し、8mmリング付きePTFEグラフト(PROPATEN)を用い人工血管置換術を施行した。採取した動脈瘤は病理所見で真性動脈瘤であり骨軟骨腫の圧迫により形成されたと思われた。今回骨・血管同時手術を施行し、良好な結果が得られたので文献的考察を加えて報告する。(著者抄録)

    researchmap

  • 急性循環不全に対する最新の補助循環治療 当院における補助循環用ポンプカテーテル(IMPELLA)の臨床成績

    青野 潤, 稲葉 慎二, 東 晴彦, 上谷 晃由, 西村 和久, 池田 俊太郎, 井上 勝次, 薦田 宗則, 浪口 謙治, 黒部 裕嗣, 打田 俊司, 太田 教隆, 西村 隆, 泉谷 裕則, 山口 修

    人工臓器   49 ( 2 )   S - 85   2020.10

     More details

    Language:Japanese   Publisher:(一社)日本人工臓器学会  

    researchmap

  • 感染症対策を見据えたVAD治療の進歩と臨床展開 VAD治療における局所陰圧閉鎖療法の有効性と限界

    西村 隆, 坂本 裕司, 薦田 宗則, 浪口 謙治, 黒部 裕嗣, 太田 教隆, 打田 俊司, 泉谷 裕則

    人工臓器   49 ( 2 )   S - 52   2020.10

     More details

    Language:Japanese   Publisher:(一社)日本人工臓器学会  

    researchmap

  • ECMO管理中、遠心ポンプの異音発生前に揚程低下を呈した一例

    伴野 誠幸, 三木 航太, 杉村 直紀, 品部 雅俊, 山田 文哉, 坂本 裕司, 薦田 宗則, 浪口 謙治, 小嶋 愛, 杉浦 純也, 太田 教隆, 黒部 裕嗣, 西村 隆, 打田 俊司, 泉谷 裕則

    人工臓器   49 ( 2 )   S - 151   2020.10

     More details

    Language:Japanese   Publisher:(一社)日本人工臓器学会  

    researchmap

  • IMPELLA補助中に生じる出血性合併症の発生要因に関する検討

    薦田 宗則, 西村 隆, 坂本 裕司, 浪口 謙治, 太田 教隆, 黒部 裕嗣, 打田 俊司, 八杉 巧, 三好 徹, 稲葉 慎二, 東 晴彦, 上谷 晃由, 青野 潤, 西村 和久, 井上 勝次, 鈴木 純, 池田 俊太郎, 山口 修, 泉谷 裕則

    人工臓器   49 ( 2 )   S - 128   2020.10

     More details

    Language:Japanese   Publisher:(一社)日本人工臓器学会  

    researchmap

  • 心のう癒着防止剤の開発のためのモデルマウスの作成

    浪口 謙治, 坂上 倫久, 小嶋 愛, 薦田 宗則, 坂本 裕司, 杉浦 純也, 太田 教隆, 黒部 裕嗣, 西村 隆, 打田 俊司, 八杉 巧, 泉谷 裕則, 岡崎 幹生, 鹿田 文昭

    日本心臓血管外科学会学術総会抄録集   50回   O10 - 5   2020.3

     More details

    Language:Japanese   Publisher:(NPO)日本心臓血管外科学会  

    researchmap

  • 当院でのIMPELLAを用いた治療経験

    浪口 謙治, 西村 隆, 坂本 裕司, 薦田 宗則, 杉浦 純也, 太田 教隆, 黒部 裕嗣, 打田 俊司, 八杉 巧, 泉谷 裕則

    人工臓器   48 ( 2 )   S - 185   2019.10

     More details

    Language:Japanese   Publisher:(一社)日本人工臓器学会  

    researchmap

  • PAIVS、 Ebstein's anomalyに対するone and a half ventricle repair後の重度三尖弁逆流に対して自己心膜による弁尖延長を用いた三尖弁形成が奏功した一例

    菅野 幹雄, 本間 友佳子, 黒部 裕嗣, 藤本 鋭貴, 北市 隆, 早渕 康信, 北川 哲也

    日本小児循環器学会雑誌   35 ( Suppl.1 )   s1 - 419   2019.6

     More details

    Language:Japanese   Publisher:(NPO)日本小児循環器学会  

    researchmap

  • 有茎自己心膜を用いた右室流出路再建を行ったVSD/PA症例の遠隔期

    北市 隆, 菅野 幹雄, 黒部 裕嗣, 藤本 鋭貴, 本間 友佳子, 早渕 康信, 北川 哲也

    日本心臓血管外科学会学術総会抄録集   49回   [PP - 018]   2019.2

     More details

    Language:Japanese   Publisher:(NPO)日本心臓血管外科学会  

    researchmap

  • Scaffolds for Regenerative Medicine 生体分解性素材を用いた医療デバイス開発とその現状

    黒部 裕嗣, 奥村 早紀, 中山 英隆, 坂元 悠紀, 佐藤 秀樹, 山内 康治, 松崎 雄一, 宮本 真嘉, 宮地 秀樹, 鈴木 昌和, 森田 真一郎, 新岡 俊治

    日本バイオマテリアル学会大会予稿集   40回   78 - 78   2018.11

     More details

    Language:Japanese   Publisher:日本バイオマテリアル学会  

    researchmap

  • 次世代育成プロジェクト2 日本での次世代育成プラン 地方病院の現状から見た小児心臓血管外科診療の将来的展望

    菅野 幹雄, 荒瀬 裕己, 川谷 洋平, 黒部 裕嗣, 藤本 鋭貴, 北市 隆, 北川 哲也

    日本小児循環器学会雑誌   34 ( Suppl.1 )   s1 - 129   2018.7

     More details

    Language:Japanese   Publisher:(NPO)日本小児循環器学会  

    researchmap

  • NCCPによるmoderate ARを伴うVSD閉鎖の術中に緊急大動脈弁形成を要した一例

    菅野 幹雄, 荒瀬 裕己, 川谷 洋平, 小野 朱美, 黒部 裕嗣, 藤本 鋭貴, 北市 隆, 早渕 康信, 北川 哲也

    日本小児循環器学会雑誌   34 ( Suppl.1 )   s1 - 374   2018.7

     More details

    Language:Japanese   Publisher:(NPO)日本小児循環器学会  

    researchmap

  • Aorfixによる腹部ステントグラフト内挿術の中期成績 Aorfixの動脈瘤径縮小効果

    川谷 洋平, 藤本 鋭貴, 割石 精一郎, 加納 正志, 筑後 文雄, 荒瀬 裕己, 菅野 幹雄, 黒部 裕嗣, 北市 隆, 北川 哲也

    日本血管外科学会雑誌   27 ( Suppl. )   P9 - 8   2018.6

     More details

    Language:Japanese   Publisher:(NPO)日本血管外科学会  

    researchmap

  • IFU外の腹部大動脈瘤に対するEVAR-高難易度症例の遠隔成績はどう変化したか? 当科におけるIFU外症例に対するEndurantの短中期成績

    藤本 鋭貴, 筑後 文雄, 川谷 洋平, 荒瀬 裕己, 菅野 幹雄, 黒部 裕嗣, 割石 精一郎, 加納 正志, 北市 隆, 北川 哲也

    日本血管外科学会雑誌   27 ( Suppl. )   PD1 - 6   2018.6

     More details

    Language:Japanese   Publisher:(NPO)日本血管外科学会  

    researchmap

  • 末梢動脈バイパス術後のグラフト閉塞に対して、グラフト内へのステントグラフト内挿を行った2例治験例

    川谷 洋平, 藤本 鋭貴, 荒瀬 裕己, 菅野 幹雄, 黒部 裕嗣, 北市 隆, 北川 哲也

    日本血管外科学会雑誌   27 ( Suppl. )   P32 - 2   2018.6

     More details

    Language:Japanese   Publisher:(NPO)日本血管外科学会  

    researchmap

  • 下肢静脈瘤の炎症性サイトカインついての検討

    荒瀬 裕己, 菅澤 典子, 川谷 洋平, 菅野 幹雄, 黒部 裕嗣, 藤本 鋭貴, 北市 隆, 北川 哲也

    静脈学   29 ( 2 )   175 - 175   2018.5

     More details

    Language:Japanese   Publisher:日本静脈学会  

    researchmap

  • 外科学の新知見(3)再生医療の最前線 鋳型として生体吸収性素材を用いた再生医療の現状と課題 Tissue engineered vascular graftの臨床とその技術を応用した開発研究

    黒部 裕嗣, 太良 修平, 宮地 秀樹, 宮本 真嘉, 杉浦 唯久, 坂元 悠紀, 中山 英隆, 佐藤 秀樹, 奥村 早紀, 平田 陽一郎, 鈴木 昌和, Breuer Christopher K., 新岡 俊治

    日本外科学会定期学術集会抄録集   118回   294 - 294   2018.4

     More details

    Language:Japanese   Publisher:(一社)日本外科学会  

    researchmap

  • Calcified Amorphous Tumorに対し腫瘍摘出術を行った一例

    清水 郁子, 瀬野 弘光, 山口 浩司, 楠瀬 賢也, 山田 博胤, 若槻 哲三, 添木 武, 佐田 政隆, 岩瀬 俊, 黒部 裕嗣, 北川 哲也

    四国医学雑誌   74 ( 1-2 )   84 - 84   2018.4

     More details

    Language:Japanese   Publisher:徳島医学会  

    researchmap

  • 小児心臓血管外科手術後のSSI防止対策の取組み

    北市 隆, 菅野 幹雄, 荒瀬 裕己, 川谷 洋平, 黒部 裕嗣, 藤本 鋭貴, 藤原 範子, 林 順子, 東 桃代, 池添 照代, 佐藤 浩美, 北川 哲也

    日本心臓血管外科学会学術総会抄録集   48回   593 - 593   2018.2

     More details

    Language:Japanese   Publisher:(NPO)日本心臓血管外科学会  

    researchmap

  • 急性大動脈解離Stanford B型に対する保存的加療における筋肉量の変化

    川谷 洋平, 黒部 裕嗣, 中村 喜次, 北川 哲也, 堀 隆樹

    日本心臓血管外科学会学術総会抄録集   48回   136 - 136   2018.2

     More details

    Language:Japanese   Publisher:(NPO)日本心臓血管外科学会  

    researchmap

  • ICUにおけるせん妄発症が2年間生存に与える影響 生命予後予測因子としてのせん妄

    川谷 洋平, 黒田 美穂, 黒部 裕嗣, 中村 喜次, 堀 隆樹

    日本集中治療医学会雑誌   25 ( Suppl. )   [O91 - 3]   2018.2

     More details

    Language:Japanese   Publisher:(一社)日本集中治療医学会  

    researchmap

  • A case of ureteroarterial fistula after urinary diversion

    80 ( 2 )   196 - 198   2018.2

     More details

  • 開心手術後早期離床介入が術後在院日数に与える影響

    黒部 裕嗣, 西川 幸治, 石井 亜由美, 河原 良美, 中田 恵理, 土肥 智史, 福岡 千佳, 梶本 美佳, 杉村 美穂, 野村 慶子, 吉坂 真奈, 川谷 洋平, 荒瀬 裕己, 伊勢 孝之, 相原 奈緒美, 原田 千春, 東根 美智子, 中山 志津, 中野 あけみ, 加藤 真介, 北川 哲也

    日本心臓血管外科学会学術総会抄録集   48回   978 - 978   2018.2

     More details

    Language:Japanese   Publisher:(NPO)日本心臓血管外科学会  

    researchmap

  • 下肢静脈瘤と炎症性サイトカインについての検討

    荒瀬 裕己, 川谷 洋平, 菅野 幹雄, 黒部 裕嗣, 藤本 鋭貴, 北市 隆, 北川 哲也

    脈管学   57 ( Suppl. )   S152 - S152   2017.10

     More details

    Language:Japanese   Publisher:(一社)日本脈管学会  

    researchmap

  • ステントグラフト内挿術後造影剤腎症発症の予測因子 造影剤使用量/術前eGFR比の有用性

    川谷 洋平, 黒部 裕嗣, 中村 喜次, 北川 哲也, 堀 隆樹

    脈管学   57 ( Suppl. )   S128 - S128   2017.10

     More details

    Language:Japanese   Publisher:(一社)日本脈管学会  

    researchmap

  • 急性大動脈解離Stanford B型急性期治療におけるPeripherally inserted central catheterによる静脈炎予防効果

    川谷 洋平, 黒部 裕嗣, 中村 喜次, 北川 哲也, 堀 隆樹

    日本救急医学会雑誌   28 ( 9 )   498 - 498   2017.9

     More details

    Language:Japanese   Publisher:(一社)日本救急医学会  

    researchmap

  • FDG-PET/CTが発見の契機となり診断できた心臓腫瘤性病変の4症例

    荒瀬 真紀, 音見 暢一, 寺澤 かおり, 久保 典子, 宇山 直人, 大塚 秀樹, 原田 雅史, 荒瀬 裕己, 黒部 裕嗣, 北川 哲也

    日本医学放射線学会秋季臨床大会抄録集   53回   S481 - S481   2017.8

     More details

    Language:Japanese   Publisher:(公社)日本医学放射線学会  

    researchmap

  • 新生児期・乳児期BTシャント術と肺動脈発達との関係

    荒瀬 裕己, 川谷 洋平, 菅野 幹雄, 黒部 裕嗣, 藤本 鋭貴, 北市 隆, 北川 哲也, 小野 朱美, 早渕 康信

    日本小児循環器学会雑誌   33 ( Suppl.1 )   s1 - 176   2017.7

     More details

    Language:Japanese   Publisher:(NPO)日本小児循環器学会  

    researchmap

  • 出生後早期に手術介入を要した胎児期発症の左室内心臓腫瘍の一例

    菅野 幹雄, 亀田 香奈子, 荒瀬 裕己, 川谷 洋平, 小野 朱美, 黒部 裕嗣, 藤本 鋭貴, 北市 隆, 早渕 康信, 北川 哲也

    日本小児循環器学会雑誌   33 ( Suppl.1 )   s1 - 410   2017.7

     More details

    Language:Japanese   Publisher:(NPO)日本小児循環器学会  

    researchmap

  • 動脈閉塞性疾患に対し低侵襲を目的としたハイブリッド治療の経験

    藤本 鋭貴, 亀田 加奈子, 川谷 洋平, 荒瀬 裕己, 菅野 幹雄, 黒部 裕嗣, 北市 隆, 北川 哲也

    日本血管外科学会雑誌   26 ( Suppl. )   P27 - 7   2017.6

     More details

    Language:Japanese   Publisher:(NPO)日本血管外科学会  

    researchmap

  • 腹部大動脈瘤破裂に対する緊急手術と術後腎機能予後についての検討 Open v.s EVAR

    川谷 洋平, 黒部 裕嗣, 中村 喜次, 北川 哲也, 堀 隆樹

    日本血管外科学会雑誌   26 ( Suppl. )   O4 - 6   2017.6

     More details

    Language:Japanese   Publisher:(NPO)日本血管外科学会  

    researchmap

  • 弓部大動脈瘤に対する2 debranch TEVARの治療成績の検討

    藤本 鋭貴, 筑後 文雄, 亀田 加奈子, 川谷 洋平, 荒瀬 裕己, 菅野 幹雄, 黒部 裕嗣, 割石 精一郎, 加納 正志, 北市 隆, 北川 哲也

    日本血管外科学会雑誌   26 ( Suppl. )   O8 - 5   2017.6

     More details

    Language:Japanese   Publisher:(NPO)日本血管外科学会  

    researchmap

  • The Contrast Medium Volume to Estimated Glomerular Filtration Rate Ratio as a Predictor of Contrast-induced Nephropathy After Endovascular Aortic Repair Reviewed

    Yohei Kawatani, Hirotsugu Kurobe, Yoshitsugu Nakamura, Tetsuya Kitagawa, Takaki Hori

    JOURNAL OF VASCULAR SURGERY   65 ( 6 )   36S - 36S   2017.6

     More details

    Language:English   Publishing type:Research paper, summary (international conference)   Publisher:MOSBY-ELSEVIER  

    DOI: 10.1016/j.jvs.2017.03.072

    Web of Science

    researchmap

  • うっ滞性皮膚炎を伴う下肢静脈瘤の自験例

    荒瀬 裕己, 亀田 香奈子, 川谷 洋平, 菅野 幹雄, 黒部 裕嗣, 藤本 鋭貴, 北市 隆, 北川 哲也

    日本血管外科学会雑誌   26 ( Suppl. )   P38 - 10   2017.6

     More details

    Language:Japanese   Publisher:(NPO)日本血管外科学会  

    researchmap

  • 下腿バイパスにて救肢できた難治性潰瘍を伴った重症下肢虚血肢の1例

    荒瀬 裕己, 藤本 鋭貴, 亀田 香奈子, 川谷 洋平, 菅野 幹雄, 黒部 裕嗣, 北市 隆, 北川 哲也

    日本血管外科学会雑誌   26 ( Suppl. )   P30 - 1   2017.6

     More details

    Language:Japanese   Publisher:(NPO)日本血管外科学会  

    researchmap

  • 上大静脈症候群に起因する下大静脈のうっ滞により重症皮膚潰瘍を伴う二次性下肢静脈瘤を発症した一例

    亀田 香奈子, 荒瀬 裕己, 川谷 洋平, 菅野 幹雄, 黒部 裕嗣, 藤本 鋭貴, 北市 隆, 北川 哲也

    静脈学   28 ( 2 )   282 - 282   2017.5

     More details

    Language:Japanese   Publisher:日本静脈学会  

    researchmap

  • 深部静脈血栓症モデルマウスの確立と抗血栓薬の血栓消退効果の検討

    佐藤 勝哉, 菅澤 典子, 荒瀬 裕己, 川谷 洋平, 黒部 裕嗣, 北市 隆, 北川 哲也

    静脈学   28 ( 2 )   270 - 270   2017.5

     More details

    Language:Japanese   Publisher:日本静脈学会  

    researchmap

  • 下肢静脈瘤レーザー焼灼術後の圧迫方法の検討

    中西 唯, 池添 照代, 秋山 幸子, 荒瀬 裕己, 川谷 洋平, 亀田 香奈子, 菅野 幹雄, 黒部 裕嗣, 藤本 鋭貴, 北市 隆, 佐藤 浩美, 北川 哲也

    静脈学   28 ( 2 )   245 - 245   2017.5

     More details

    Language:Japanese   Publisher:日本静脈学会  

    researchmap

  • 下肢静脈瘤における炎症性サイトカインの検討

    荒瀬 裕己, 川谷 洋平, 菅澤 典子, 菅野 幹雄, 黒部 裕嗣, 藤本 鋭貴, 北市 隆, 北川 哲也

    静脈学   28 ( 2 )   240 - 240   2017.5

     More details

    Language:Japanese   Publisher:日本静脈学会  

    researchmap

  • 下大静脈内腫瘍栓に対する外科的治療の検討

    藤本 鋭貴, 亀田 香奈子, 川谷 洋平, 荒瀬 裕己, 菅野 幹雄, 黒部 裕嗣, 北市 隆, 北川 哲也

    静脈学   28 ( 2 )   179 - 179   2017.5

     More details

    Language:Japanese   Publisher:日本静脈学会  

    researchmap

  • 若年女性に発症した一次性伏在型下肢静脈瘤の一例

    美馬 惇, 荒瀬 裕己, 亀田 香奈子, 黒部 裕嗣, 北市 隆, 北川 哲也

    静脈学   28 ( 2 )   281 - 281   2017.5

     More details

    Language:Japanese   Publisher:日本静脈学会  

    researchmap

  • 下肢静脈瘤手術における麻酔方法 TLA針によるTLA麻酔の方法と、その有用性

    川谷 洋平, 荒瀬 裕己, 亀田 香奈子, 菅野 幹雄, 黒部 裕嗣, 藤本 鋭貴, 北市 隆, 北川 哲也

    静脈学   28 ( 2 )   284 - 284   2017.5

     More details

    Language:Japanese   Publisher:日本静脈学会  

    researchmap

  • 剖検により診断されたAcromegalic cardiomyopathyの1例

    西條 良仁, 山田 博胤, 楠瀬 賢也, 瀬野 弘光, 天野 里江, 山尾 雅美, 西尾 進, 黒部 裕嗣, 渡邉 俊介, 佐田 政隆

    超音波医学   44 ( Suppl. )   S476 - S476   2017.4

     More details

    Language:Japanese   Publisher:(公社)日本超音波医学会  

    researchmap

  • トルバプタンが術後腎機能(亜急性期)に与える影響の検討

    黒部 裕嗣, 片木 絢子, 西雄 千佳, 亀田 香奈子, 荒瀬 裕己, 川谷 洋平, 菅澤 典子, 北川 哲也

    日本外科学会定期学術集会抄録集   117回   PS - 7   2017.4

     More details

    Language:Japanese   Publisher:(一社)日本外科学会  

    researchmap

  • ステントグラフト内挿術後の造影剤腎症発症と遠隔期腎機能との関連

    川谷 洋平, 黒部 裕嗣, 中村 喜次, 北川 哲也, 堀 隆樹

    日本外科学会定期学術集会抄録集   117回   PS - 8   2017.4

     More details

    Language:Japanese   Publisher:(一社)日本外科学会  

    researchmap

  • 大伏在静脈-大腿静脈接合部の破格に対し、MRI検査による形態把握が有用であった一例

    亀田 香奈子, 川谷 洋平, 荒瀬 裕己, 菅野 幹雄, 黒部 裕嗣, 藤本 鋭貴, 北市 隆, 北川 哲也

    四国医学雑誌   73 ( 1-2 )   135 - 135   2017.4

     More details

    Language:Japanese   Publisher:徳島医学会  

    researchmap

  • 動脈閉塞性病変に対する当科での治療経験

    荒瀬 裕己, 藤本 鋭貴, 亀田 香奈子, 川谷 洋平, 菅野 幹雄, 黒部 裕嗣, 北市 隆, 北川 哲也

    四国医学雑誌   73 ( 1-2 )   133 - 133   2017.4

     More details

    Language:Japanese   Publisher:徳島医学会  

    researchmap

  • 当科におけるdebranch TEVERの検討

    藤本 鋭貴, 筑後 文雄, 亀田 加奈子, 川谷 洋平, 荒瀬 裕己, 菅野 幹雄, 黒部 裕嗣, 割石 精一郎, 加納 正志, 北市 隆, 北川 哲也

    日本心臓血管外科学会学術総会抄録集   47回   254 - 254   2017.2

     More details

    Language:Japanese   Publisher:(NPO)日本心臓血管外科学会  

    researchmap

  • 二心室修復における左房直接還流型左上大静脈のreroutingについて

    荒瀬裕己, 北市隆, 亀田香奈子, 川谷洋平, 黒部裕嗣, 藤本鋭貴, 北川哲也, 小野朱美, 早渕康信

    日本心臓血管外科学会学術総会(Web)   47回   358 - 358   2017.2

     More details

    Language:Japanese   Publisher:(NPO)日本心臓血管外科学会  

    J-GLOBAL

    researchmap

  • 生体分解性素材を用いた心房中隔欠損症閉鎖デバイスが可能か

    黒部 裕嗣, 杉浦 唯久, 宮地 秀樹, 佐藤 秀樹, 坂元 悠紀, 平田 陽一郎, 太良 修平, 木下 肇, 北川 哲也, 鈴木 昌和, 新岡 俊治

    日本心臓血管外科学会学術総会抄録集   47回   351 - 351   2017.2

     More details

    Language:Japanese   Publisher:(NPO)日本心臓血管外科学会  

    researchmap

  • 肺癌術前にバルーン大動脈弁形成術を施行し良好な開大が得られた重症大動脈弁狭窄症の一例

    川端豊, 伊勢孝之, 山口浩司, 若槻哲三, 松浦朋美, 楠瀬賢也, 八木秀介, 飛梅威, 山田博胤, 添木武, 川谷洋平, 荒瀬裕己, 黒部裕嗣, 藤本鋭貴, 北川哲也, 佐田政隆

    日本循環器学会中国地方会(Web)   110th   2017

  • Ischemic Heart Disease -from Clinical Side-

    Kurobe Hirotsugu, Sata Masataka

    Nihon Ika Daigaku Igakkai Zasshi   13 ( 4 )   210 - 213   2017

     More details

    Language:Japanese   Publisher:The Medical Association of Nippon Medical School  

    <p>Over 190,000 patients die each year in japan due to ischemic heart disease. For these patients, percutaneous coronary intervention (PCI) or coronary artery bypass graft (CABG) are done to improve the blood flow of coronary artery with stenosis. It would be better to prevent or mitigate the progress of atherosclerosis in these patients before requiring surgery. Recently, it has been reported that epicardial adipose tissue plays an important role in the progression of atherosclerosis and ischemic heart disease.</p><p>This review shows the recent trends about ischemic heart disease from the clinical perspective, including its' treatment, pathology and preventive measure. </p>

    DOI: 10.1272/manms.13.210

    CiNii Books

    researchmap

    Other Link: http://search.jamas.or.jp/link/ui/2018120102

  • Management of Huge Arteriovenous Malformations of the Neck and Trunk

    Kitaichi Takashi, Arase Hiroki, Kawatani Yohei, Kameta Kanako, Sugano Mikio, Kurobe Hirotsugu, Fujimoto Eiki, Sogabe Hitoshi, Kitagawa Tetsuya

    The Japanese Journal of Phlebology   28 ( 2 )   91 - 97   2017

     More details

    Language:Japanese   Publisher:Japanese Society of Phlebology  

    <p>Therapeutic management of huge arteriovenous malformation (AVM) of the neck and trunk was described according to our experiences. Four patients with AVM were evaluated in this study. Case 1 was of a 24-year-old woman with a huge AVM of the neck who had cardiac failure and syncope. She underwent total resection of the AVM along with the right internal jugular vein, right subclavian artery and vein, right clavicle, right first rib and right hemi-manubrium of the sternum after embolization of the arteries. No recurrence was observed during 7 years after surgery. Case 2 was of a 32-year-old woman with a huge AVM of the neck and back with local pain, bleeding and heat sensation. She underwent sclerotherapy with ethanol. The AVM grew gradually in spite of temporary relief of the symptoms. The remaining two patients were 61 and 55-year-old men with pelvic AVM. They were observed without any treatments for AVM because no symptoms were found except for temporary hematuria. Our results suggested that a complete resection was preferable for symptomatic AVM after appropriate embolization to avoid the progressive deterioration of quality of life. The strategy to manage AVM should be planned by considering pathologies, especially those involving the structures of AVMs, symptoms and patient characteristics.</p>

    DOI: 10.7134/phlebol.17-06

    researchmap

  • CAVI (cardio-ankle vascular index)を用いた、小児先天性心疾患術後患者の血管機能評価

    平田 陽一郎, 田中 優, 黒部 裕嗣, 佐田 政隆, 岡 明

    福田記念医療技術振興財団情報   ( 29 )   53 - 56   2016.12

     More details

    Language:Japanese   Publisher:福田記念医療技術振興財団  

    東大病院で2007〜2014年にCAVI検査が行われた18歳未満の患者130例を対象とし、心構造が正常な群、左右短絡疾患群、左心系閉塞性疾患群、右心系閉塞性疾患群、大血管転換群、単心室循環群に分け、CAVI値を群間比較した。結果、心構造が正常な群に比べて右心系閉塞性疾患群は有意な低値を示し、大血管転換群と単心室循環群は低値の傾向を示した。心構造が正常な群のみを対象とし、年齢とCAVI値との関連性について検討した結果、正相関が認められた。

    CiNii Books

    researchmap

    Other Link: http://search.jamas.or.jp/link/ui/2018145512

  • 腹部大動脈瘤破裂に対するステントグラフト内挿術施行症例における周術期凝固能、輸血、輸液と術後生存の関連

    川谷 洋平, 黒部 裕嗣, 中村 喜次, 北川 哲也, 堀 隆樹

    日本救急医学会雑誌   27 ( 9 )   531 - 531   2016.9

     More details

    Language:Japanese   Publisher:(一社)日本救急医学会  

    researchmap

  • 細径プローブを用いたTransesophageal echocardiographyにより小児心臓手術周術期の気道合併症は予防できる

    北市 隆, 荒瀬 裕己, 木下 肇, 黒部 裕嗣, 藤本 鋭貴, 浦田 雅弘, 川人 伸次, 小野 朱美, 早渕 康信, 北川 哲也

    日本小児循環器学会雑誌   32 ( Suppl.1 )   s1 - 303   2016.7

     More details

    Language:Japanese   Publisher:(NPO)日本小児循環器学会  

    researchmap

  • 新生児期・乳児期modified Blalock-Taussig shunt術のブラッシュアップ

    荒瀬 裕己, 北川 哲也, 北市 隆, 藤本 鋭貴, 黒部 裕嗣, 木下 肇, 早渕 康信, 小野 朱美

    日本小児循環器学会雑誌   32 ( Suppl.1 )   s1 - 384   2016.7

     More details

    Language:Japanese   Publisher:(NPO)日本小児循環器学会  

    researchmap

  • 破裂性腹部大動脈瘤に対するステントグラフト治療の検討

    藤本 鋭貴, 筑後 文雄, 荒瀬 裕己, 木下 肇, 浦田 雅弘, 黒部 裕嗣, 割石 精一郎, 加納 正志, 北市 隆, 北川 哲也

    日本血管外科学会雑誌   25 ( Suppl. )   315 - 315   2016.6

     More details

    Language:Japanese   Publisher:(NPO)日本血管外科学会  

    researchmap

  • 弓部大動脈瘤の手術適応 1 Debranching TEVARが施行困難な弓部大動脈瘤における術式決定と治療成績の検討

    川谷 洋平, 中村 喜次, 林 裕次郎, 種市 哲吉, 伊藤 雄次郎, 黒部 裕嗣, 須田 優司, 堀 隆樹

    日本血管外科学会雑誌   25 ( Suppl. )   297 - 297   2016.6

     More details

    Language:Japanese   Publisher:(NPO)日本血管外科学会  

    researchmap

  • ステントグラフト術後にtype II endoleakが残存し、瘤径拡大をきたしたが開腹、腰動脈結紮にて治療し得た一治験例

    川谷 洋平, 中村 喜次, 林 裕次郎, 種市 哲吉, 伊藤 雄次郎, 黒部 裕嗣, 須田 優司, 堀 隆樹

    日本血管外科学会雑誌   25 ( Suppl. )   222 - 222   2016.6

     More details

    Language:Japanese   Publisher:(NPO)日本血管外科学会  

    researchmap

  • 組織再生型心臓弁を指向したシルクフィブロイン複合化材料の開発

    田中 咲里, 岩本 脩成, 田中 綾, 島田 香寿美, 黒部 裕嗣, 中澤 靖元

    人工臓器   45 ( 1 )   42 - 42   2016.6

     More details

    Language:Japanese   Publisher:(一社)日本人工臓器学会  

    researchmap

  • 洞機能不全を機に上行置換術施行したStanford A型大動脈解離の1例

    荒瀬 裕己, 黒部 裕嗣, 木下 肇, 浦田 雅弘, 藤本 鋭貴, 北市 隆, 北川 哲也, 今田 久美子, 高島 啓, 尾形 竜郎

    日本血管外科学会雑誌   25 ( Suppl. )   386 - 386   2016.6

     More details

    Language:Japanese   Publisher:(NPO)日本血管外科学会  

    researchmap

  • 破裂性腹部大動脈瘤に対する治療選択 術後臓器障害の観点からの比較検討

    川谷 洋平, 中村 喜次, 林 裕次郎, 種市 哲吉, 伊藤 雄次郎, 黒部 裕嗣, 須田 優司, 堀 隆樹

    日本血管外科学会雑誌   25 ( Suppl. )   353 - 353   2016.6

     More details

    Language:Japanese   Publisher:(NPO)日本血管外科学会  

    researchmap

  • 新しい深部静脈血栓症モデルの作製と薬剤効果の検討

    原 まどか, 菅澤 典子, 西雄 千佳, 荒瀬 裕己, 浦田 雅弘, 川谷 洋平, 黒部 裕嗣, 北川 哲也

    静脈学   27 ( 2 )   156 - 156   2016.5

     More details

    Language:Japanese   Publisher:日本静脈学会  

    researchmap

  • 血栓リスクを有する下肢静脈瘤に対する血管内レーザー治療の経験

    荒瀬 裕己, 木下 肇, 浦田 雅弘, 黒部 裕嗣, 藤本 鋭貴, 北市 隆, 北川 哲也

    静脈学   27 ( 2 )   139 - 139   2016.5

     More details

    Language:Japanese   Publisher:日本静脈学会  

    researchmap

  • プレートによる胸骨固定法の有用性 Off pump冠動脈バイパス術におけるワイヤーによる固定とプレート固定の比較検討

    川谷 洋平, 林 裕次郎, 種市 哲吉, 伊藤 雄次郎, 黒部 裕嗣, 中村 喜次, 須田 優司, 堀 隆樹

    日本外科学会定期学術集会抄録集   116回   PS - 8   2016.4

     More details

    Language:Japanese   Publisher:(一社)日本外科学会  

    researchmap

  • 小児期にVSD閉鎖を伴う心内修復を行った成人先天性心疾患におけるVSD閉鎖に関わる問題点の検討

    北市隆, 荒瀬裕己, 木下肇, 黒部裕嗣, 藤本鋭貴, 浦田雅弘, 早渕康信, 小野朱美, 北川哲也

    日本外科学会定期学術集会(Web)   116回   PS - 2   2016.4

     More details

    Language:Japanese   Publisher:(一社)日本外科学会  

    J-GLOBAL

    researchmap

  • ステントグラフト内挿術後の造影剤腎症 有病率、リスクファクターについての検討

    川谷 洋平, 黒部 裕嗣, 林 裕次郎, 種市 哲吉, 伊藤 雄次郎, 中村 喜次, 須田 優司, 堀 隆樹

    日本心臓血管外科学会学術総会抄録集   46回   PP - 279   2016.2

     More details

    Language:Japanese   Publisher:(NPO)日本心臓血管外科学会  

    researchmap

  • 破裂性腹部大動脈瘤に対するEVARの有用性 羽裂性腹部大動脈瘤に対するEVARの検討

    藤本 鋭貴, 筑後 文雄, 荒瀬 裕己, きのした 肇, 黒部 裕嗣, 割石 精一郎, 加納 正志, 北市 隆, 北川 哲也

    日本心臓血管外科学会学術総会抄録集   46回   PR21 - 3   2016.2

     More details

    Language:Japanese   Publisher:(NPO)日本心臓血管外科学会  

    researchmap

  • 生体分解性素材を用いたデバイスの開発の可能性

    黒部 裕嗣, 杉浦 唯久, 宮地 秀樹, 坂元 悠紀, 佐藤 秀樹, 木下 肇, 西雄 千佳, 島本 偉志, 北川 哲也, 鈴木 昌和, 新岡 俊治

    日本心臓血管外科学会学術総会抄録集   46回   OP10 - 3   2016.2

     More details

    Language:Japanese   Publisher:(NPO)日本心臓血管外科学会  

    researchmap

  • Off pump CABGにおける胸骨プレート(Sternalock plating system)の有用性

    川谷 洋平, 中村 喜次, 林 裕次郎, 種市 哲吉, 伊藤 雄次郎, 黒部 裕嗣, 須田 優司, 堀 隆樹

    日本心臓血管外科学会学術総会抄録集   46回   PP - 273   2016.2

     More details

    Language:Japanese   Publisher:(NPO)日本心臓血管外科学会  

    researchmap

  • 生体分解性素材を用いた血管再生医療現況 心臓・血管外科領域を中心に

    黒部 裕嗣, 太良 修平, 杉浦 唯久, 新岡 俊治

    血管   38 ( 4 )   135 - 144   2015.12

     More details

    Language:Japanese   Publisher:日本心脈管作動物質学会  

    組織工学(TE)を用いた生体分解性人工血管(TEVG)の利点には、再生後に血管としての生理学的特性が期待できる、小児患児では身体的な成長に伴い生物学的成長が期待できる、傷害時の自己修復機転が期待できるなどがある。心臓・血管外科領域における生体分解性素材を用いた血管再生医療の現況について、以下の項目に分けて述べた。1)TEを用いた血管再生医療の構成、2)TEVGの臨床応用、3)再生血管における組織形成のメカニズム、4)小口径動脈でのTEVG、とした。

    researchmap

  • 急激な弁破壊を認めたメチシリン感受性表皮ブドウ球菌による感染性心内膜炎の一例

    瀬野 弘光, 山崎 宙, 八木 秀介, 楠瀬 賢也, 伊勢 孝之, 山口 浩二, 山田 博嗣, 添木 武, 若槻 哲三, 佐田 政隆, 黒部 裕嗣, 高森 信行

    四国医学雑誌   71 ( 5-6 )   170 - 170   2015.12

     More details

    Language:Japanese   Publisher:徳島医学会  

    researchmap

  • ステントグラフト合併症に対する治療 ステントグラフト合併症に対する治療と対策

    藤本 鋭貴, 筑後 文雄, 荒瀬 裕己, 木下 肇, 黒部 裕嗣, 割石 精一郎, 加納 正志, 北市 隆, 北川 哲也

    人工臓器   44 ( 2 )   S - 62   2015.10

     More details

    Language:Japanese   Publisher:(一社)日本人工臓器学会  

    researchmap

  • 組織再生型心臓弁を指向したシルクフィブロイン複合化材料の開発

    田中 咲里, 岩本 脩成, 田中 綾, 島田 香寿美, 黒部 裕嗣, 中澤 靖元

    人工臓器   44 ( 2 )   S - 177   2015.10

     More details

    Language:Japanese   Publisher:(一社)日本人工臓器学会  

    researchmap

  • 小児開心術後反回神経麻痺における発生因子の検討

    北市隆, 木下肇, 黒部裕嗣, 神原保, 藤本鋭貴, 川人伸次, 阪田美穂, 早渕康信, 北川哲也

    日本小児循環器学会雑誌   31 ( Suppl.1 )   s1 - 195   2015.7

     More details

    Language:Japanese   Publisher:(NPO)日本小児循環器学会  

    J-GLOBAL

    researchmap

  • 大動脈が高度に屈曲した症例に対し、Stiff wireを追加することでTEVARを施行した症例

    川谷 洋平, 林 祐次郎, 伊藤 雄二郎, 黒部 裕嗣, 中村 喜次, 須田 優司, 堀 隆樹

    日本胸部外科学会関東甲信越地方会要旨集   ( 168回 )   21 - 21   2015.6

     More details

    Language:Japanese   Publisher:日本胸部外科学会-関東甲信越地方会  

    researchmap

  • 当科における一次性下肢静脈瘤に対する下肢静脈瘤血管内レーザー治療の経験

    木下 肇, 黒部 裕嗣, 神原 保, 藤本 鋭貴, 北市 隆, 北川 哲也

    静脈学   26 ( 2 )   203 - 203   2015.6

     More details

    Language:Japanese   Publisher:日本静脈学会  

    researchmap

  • EVAR術後の中枢側ネック径の変化は瘤縮小の規定因子であるか?

    藤本 鋭貴, 木下 馨, 菅野 幹雄, 黒部 裕嗣, 神原 保, 割石 精一郎, 加納 正志, 北市 隆, 筑後 文雄, 北川 哲也

    日本血管外科学会雑誌   24 ( 3 )   581 - 581   2015.5

     More details

    Language:Japanese   Publisher:(NPO)日本血管外科学会  

    researchmap

  • 慢性期B型大動脈解離に対するステントグラフト内挿術の短期成績

    川谷 洋平, 林 祐次郎, 伊藤 雄二郎, 黒部 裕嗣, 中村 喜次, 須田 優司, 堀 隆樹

    日本血管外科学会雑誌   24 ( 3 )   497 - 497   2015.5

     More details

    Language:Japanese   Publisher:(NPO)日本血管外科学会  

    researchmap

  • 破裂性腹部大動脈瘤に対する緊急ステントグラフト内挿術の検討

    木下 肇, 藤本 鋭貴, 菅野 幹雄, 黒部 裕嗣, 神原 保, 割石 精一郎, 加納 正志, 筑後 文雄, 北市 隆, 北川 哲也

    日本血管外科学会雑誌   24 ( 3 )   551 - 551   2015.5

     More details

    Language:Japanese   Publisher:(NPO)日本血管外科学会  

    researchmap

  • Stanford B型大動脈解離に対するステントグラフト内挿術の有効性

    木下 肇, 藤本 鋭貴, 菅野 幹雄, 黒部 裕嗣, 神原 保, 割石 精一郎, 加納 正志, 筑後 文雄, 北市 隆, 北川 哲也

    日本血管外科学会雑誌   24 ( 3 )   637 - 637   2015.5

     More details

    Language:Japanese   Publisher:(NPO)日本血管外科学会  

    researchmap

  • 心臓血管 腹部大動脈瘤破裂に対する緊急手術と周術期腎機能についての検討 開腹手術かステントグラフトか

    川谷 洋平, 林 祐次郎, 伊藤 雄二郎, 黒部 裕嗣, 中村 喜次, 須田 優司, 堀 隆樹

    日本外科学会定期学術集会抄録集   115回   OP - 5   2015.4

     More details

    Language:Japanese   Publisher:(一社)日本外科学会  

    researchmap

  • 胸部大動脈破裂に対し、Debranchを伴うステントグラフト内挿術を施行し、救命し得た1例

    川谷 洋平, 林 裕二郎, 伊藤 雄二郎, 中村 喜次, 村上 貴志, 堀 隆樹, 黒部 裕嗣, 北川 哲也

    日本血管外科学会雑誌   24 ( 1 )   71 - 71   2015.2

     More details

    Language:Japanese   Publisher:(NPO)日本血管外科学会  

    researchmap

  • 大動脈内バルーンパンピング抜去後に生じた大腿動脈巨大仮性動脈瘤に対し、手術を施行した1例

    川谷 洋平, 林 裕二郎, 伊藤 雄二郎, 中村 喜次, 村上 貴志, 堀 隆樹, 黒部 裕嗣, 北川 哲也

    日本血管外科学会雑誌   24 ( 1 )   74 - 74   2015.2

     More details

    Language:Japanese   Publisher:(NPO)日本血管外科学会  

    researchmap

  • 当科における破裂性腹部大動脈瘤に対する緊急ステントグラフト内挿術の検討

    木下 肇, 藤本 鋭貴, 菅野 幹雄, 黒部 裕嗣, 神原 保, 割石 精一郎, 加納 正志, 筑後 文雄, 北市 隆, 北川 哲也

    日本心臓血管外科学会雑誌   44 ( Suppl. )   526 - 526   2015.1

     More details

    Language:Japanese   Publisher:(NPO)日本心臓血管外科学会  

    researchmap

  • 心血管領域における再生医療の最前線 生体吸収性素材を鋳型とした再生血管移植の研究と臨床の現状

    黒部 裕嗣, 日比野 成俊, 太良 修平, 杉浦 唯久, Breuer Christpher K., 新岡 俊治

    日本心臓血管外科学会雑誌   44 ( Suppl. )   155 - 155   2015.1

     More details

    Language:Japanese   Publisher:(NPO)日本心臓血管外科学会  

    researchmap

  • 大動脈解離に対するステントグラフト治療 B型大動脈解離に対するステントグラフト治療の検討

    藤本 鋭貴, 筑後 文雄, 木下 肇, 黒部 裕嗣, 神原 保, 割石 精一郎, 加納 正志, 北市 隆, 北川 哲也

    脈管学   54 ( Suppl. )   S128 - S128   2014.10

     More details

    Language:Japanese   Publisher:(一社)日本脈管学会  

    researchmap

  • 当科における破裂性腹部大動脈瘤に対する緊急ステントグラフト内挿術の検討

    木下 肇, 菅野 幹雄, 黒部 裕嗣, 神原 保, 藤本 鋭貴, 加納 正志, 北市 隆, 筑後 文雄, 北川 哲也

    脈管学   54 ( Suppl. )   S252 - S253   2014.10

     More details

    Language:Japanese   Publisher:(一社)日本脈管学会  

    researchmap

  • EFFECTS OF EZETIMIBE ON OXIDIZED CHOLESTEROL COMPONENTS IN EPICARDIAL FAT AND MYOCARDIUM: A GAS CHROMATOGRAPHY-MASS SPECTROMETRY ANALYSIS

    M. Shimabukuro, C. Okawa, X. F. Lei, J. R. Kim-Kaneyama, H. Yamada, H. Kurobe, D. Fukuda, M. Sato, T. Kitagawa, M. Sata

    ATHEROSCLEROSIS   235 ( 2 )   E113 - E113   2014.8

     More details

    Language:English   Publishing type:Research paper, summary (international conference)   Publisher:ELSEVIER IRELAND LTD  

    Web of Science

    researchmap

  • 小児心臓手術時における経食道心エコーの合併症の検討

    北市隆, 菅野幹雄, 木下肇, 中山泰介, 黒部裕嗣, 神原保, 藤本鋭貴, 川人伸次, 阪田美穂, 早渕康信, 北川哲也

    日本小児循環器学会雑誌   30 ( Suppl. )   s294 - s294   2014.6

     More details

    Language:Japanese   Publisher:(NPO)日本小児循環器学会  

    J-GLOBAL

    researchmap

  • 二尖性大動脈弁に対する大動脈弁置換術時の上行大動脈壁の問題点

    木下 肇, 中山 泰介, 菅野 幹雄, 黒部 裕嗣, 神原 保, 藤本 鋭貴, 北市 隆, 北川 哲也

    日本血管外科学会雑誌   23 ( 2 )   450 - 450   2014.4

     More details

    Language:Japanese   Publisher:(NPO)日本血管外科学会  

    researchmap

  • 傍腎動脈腹部大動脈瘤の治療 open surgery vs EVAR 傍腎動脈腹部大動脈瘤に対するEVARの検討

    藤本 鋭貴, 筑後 文雄, 中山 泰介, 木下 肇, 菅野 幹雄, 黒部 裕嗣, 神原 保, 割石 精一郎, 加納 正志, 北市 隆, 北川 哲也

    日本血管外科学会雑誌   23 ( 2 )   255 - 255   2014.4

     More details

    Language:Japanese   Publisher:(NPO)日本血管外科学会  

    researchmap

  • 【左心低形成症候群に対する治療戦略】Norwood手術におけるBlalock-Taussigシャント 実験から臨床への展開

    北市 隆, 菅野 幹雄, 木下 肇, 中山 泰介, 黒部 裕嗣, 神原 保, 藤本 鋭貴, 北川 哲也

    胸部外科   67 ( 4 )   274 - 277   2014.4

  • ヘスペリジンと健康 メタボリックシンドロームの総合対策素材としての可能性 ヘスペリジンと血管機能 ヘスペリジンは動脈硬化進行を予防するか

    黒部 裕嗣, 菅澤 典子, 中山 泰介, 宅見 央子, 東口 文治, 松本 幸子, 粟飯原 賢一, 島袋 充生, 佐田 政隆, 北川 哲也

    日本栄養・食糧学会大会講演要旨集   68回   117 - 117   2014.4

     More details

    Language:Japanese   Publisher:(公社)日本栄養・食糧学会  

    researchmap

  • 感染性腹部大動脈瘤に対して上腸間膜動脈にsnorkeling EVARを施行した1例

    木下 肇, 中山 泰介, 菅野 幹雄, 黒部 裕嗣, 神原 保, 藤本 鋭貴, 北市 隆, 北川 哲也

    日本血管外科学会雑誌   23 ( 2 )   521 - 521   2014.4

     More details

    Language:Japanese   Publisher:(NPO)日本血管外科学会  

    researchmap

  • エゼチミブ投与が動脈リモデリング・機能へ与える影響の検討

    黒部 裕嗣, 菅澤 典子, 平田 陽一郎, 島袋 充生, 中山 泰介, 吉田 恭史, 松岡 祐貴, 木下 肇, 佐田 政隆, 北川 哲也

    日本血管外科学会雑誌   23 ( 2 )   492 - 492   2014.4

     More details

    Language:Japanese   Publisher:(NPO)日本血管外科学会  

    researchmap

  • PS-096-2 胸部大動脈破裂に対する緊急TEVARの検討(PS-096 大血管 ステントグラフト2,ポスターセッション,第114回日本外科学会定期学術集会)

    藤本 鋭貴, 筑後 文雄, 中山 泰介, 木下 肇, 菅野 幹雄, 黒部 裕嗣, 神原 保, 割石 精一郎, 加納 正志, 北市 隆, 北川 哲也

    日本外科学会雑誌   115 ( 2 )   766 - 766   2014.3

     More details

    Language:Japanese   Publisher:一般社団法人日本外科学会  

    CiNii Books

    researchmap

  • PS-177-2 肺高血圧モデルを用いたヒト臍帯血細胞移植による肺リモデリングの検討(PS-177 基礎 再生医療,ポスターセッション,第114回日本外科学会定期学術集会)

    菅野 幹雄, 菅澤 典子, 黒部 裕嗣, 中山 泰介, 吉田 誉, 北市 隆, 木下 肇, 神原 保, 藤本 鋭貴, 苛原 稔, 北川 哲也

    日本外科学会雑誌   115 ( 2 )   928 - 928   2014.3

     More details

    Language:Japanese   Publisher:一般社団法人日本外科学会  

    CiNii Books

    researchmap

  • 胸部大動脈破裂に対する緊急TEVARの検討

    藤本 鋭貴, 筑後 文雄, 中山 泰介, 木下 肇, 菅野 幹雄, 黒部 裕嗣, 神原 保, 割石 精一郎, 加納 正志, 北市 隆, 北川 哲也

    日本外科学会雑誌   115 ( 臨増2 )   766 - 766   2014.3

     More details

    Language:Japanese   Publisher:(一社)日本外科学会  

    researchmap

  • うっ滞性皮膚潰瘍を合併した下肢静脈瘤に対して血管内レーザー焼灼術の有効性

    木下 肇, 中山 泰介, 菅野 幹雄, 黒部 裕嗣, 神原 保, 藤本 鋭貴, 北市 隆, 北川 哲也

    静脈学   25 ( 2 )   260 - 260   2014.3

     More details

    Language:Japanese   Publisher:日本静脈学会  

    researchmap

  • 肺高血圧モデルを用いたヒト臍帯血細胞移植による肺リモデリングの検討

    菅野 幹雄, 菅澤 典子, 黒部 裕嗣, 中山 泰介, 吉田 誉, 北市 隆, 木下 肇, 神原 保, 藤本 鋭貴, 苛原 稔, 北川 哲也

    日本外科学会雑誌   115 ( 臨増2 )   928 - 928   2014.3

     More details

    Language:Japanese   Publisher:(一社)日本外科学会  

    researchmap

  • 特異な臨床経過を認めた静脈血栓塞栓症の2例

    北市 隆, 木下 肇, 中山 泰介, 菅野 幹雄, 黒部 裕嗣, 神原 保, 藤本 鋭貴, 北川 哲也

    静脈学   25 ( 2 )   176 - 176   2014.3

     More details

    Language:Japanese   Publisher:日本静脈学会  

    researchmap

  • 臍帯血細胞移植は肺高血圧を改善させるか

    菅野 幹雄, 菅澤 典子, 黒部 裕嗣, 中山 泰介, 吉田 誉, 北市 隆, 神原 保, 藤本 鋭貴, 苛原 稔, 北川 哲也

    日本心臓血管外科学会雑誌   43 ( Suppl. )   327 - 327   2014.1

     More details

    Language:Japanese   Publisher:(NPO)日本心臓血管外科学会  

    researchmap

  • 胸部大動脈破裂に対する緊急TEVARの検討

    藤本 鋭貴, 筑後 文雄, 木下 肇, 中山 泰介, 菅野 幹雄, 黒部 裕嗣, 神原 保, 割石 精一郎, 加納 正志, 北市 隆, 北川 哲也

    日本心臓血管外科学会雑誌   43 ( Suppl. )   339 - 339   2014.1

     More details

    Language:Japanese   Publisher:(NPO)日本心臓血管外科学会  

    researchmap

  • 大動脈瘤患者におけるPPAR-γ agonist投与による抗動脈硬化作用の検討

    黒部 裕嗣, 元木 達夫, 平田 陽一郎, 中山 泰介, 木下 肇, 菅野 幹雄, 神原 保, 藤本 鋭貴, 北市 隆, 菅澤 典子, 筑後 文雄, 堀 隆樹, 佐田 政隆, 北川 哲也

    日本心臓血管外科学会雑誌   43 ( Suppl. )   383 - 383   2014.1

     More details

    Language:Japanese   Publisher:(NPO)日本心臓血管外科学会  

    researchmap

  • 心臓大血管手術におけるブタ由来ヘパリンの問題点について

    中山 泰介, 木下 肇, 菅野 幹雄, 黒部 裕嗣, 神原 保, 藤本 鋭貴, 北市 隆, 北川 哲也

    日本心臓血管外科学会雑誌   43 ( Suppl. )   504 - 504   2014.1

     More details

    Language:Japanese   Publisher:(NPO)日本心臓血管外科学会  

    researchmap

  • 動脈硬化病巣進展に対する糖転移ヘスペリジンの抑制効果についての検討

    菅澤 典子, 中山 泰介, 黒部 裕嗣, 宅見 央子, 東口 文治, 木下 肇, 菅野 幹雄, 神原 保, 藤本 鋭貴, 粟飯原 賢一, 北市 隆, 松本 俊夫, 北川 哲也

    日本心臓血管外科学会雑誌   43 ( Suppl. )   384 - 384   2014.1

     More details

    Language:Japanese   Publisher:(NPO)日本心臓血管外科学会  

    researchmap

  • A successful operation for severe tricuspid valve insufficiency caused by penetration of the anterior leaflet by permanent pacemaker lead

    Nakayama Taisuke, Fujita Hiroshi, Sogabe Hitoshi, Kitagawa Tetsuya, Kinoshita Hajime, Sugano Mikio, Kurobe Hirotsugu, Kanbara Tamotsu, Fujimoto Eiki, Kitaichi Takashi, Yamada Hirotsugu, Sata Masataka

    Shinzo   46 ( 3 )   378 - 383   2014

     More details

    Language:Japanese   Publisher:Japan Heart Foundation  

    経静脈ペースメーカリードの前尖穿通により, 遠隔期に三尖弁の動きが障害され, 重症三尖弁逆流 (tricuspid regurgitation ; TR) をきたして手術した1例を経験したので報告する. 症例は, 83歳, 女性. 10年前に洞不全症候群にて経静脈的ペースメーカ植え込み術が施行された. 1年前より顔面浮腫と労作時呼吸困難が出現した. 経食道3D心エコー検査で, 三尖弁前尖を穿通する経静脈リードが弁尖の可動性を著明に制限しているために重症TRを生じていると診断した. 手術所見では, リードが前尖中央の弁腹を貫通し, 前乳頭筋と一体となって棍棒状に肥厚した線維束となり, 前尖中央に直接癒着し著明に弁機能を障害していた. 穿通したリードと傷んだ弁尖組織を可及的に切除し, 前尖を自己心膜で補填, 拡大し, DeVega法による弁輪縫縮術を施行し, ペースメーカを心筋リードに切り替えた. 術後しばらくは自覚症状の改善を認めたが, 1年後に再度TRの増悪をきたし三尖弁の生体弁置換術を施行した. 本例のように前尖を穿通する症例は極めて稀だが, ペースメーカ植え込み術時あるいは留置後早期に3D心エコーで経静脈リードの走行と三尖弁の形態と機能についてルーチンに精査しておくことが望ましい.

    DOI: 10.11281/shinzo.46.378

    researchmap

  • The role of smooth muscle cells specific HIF-1 alpha in pulmonary hypertension in mice Reviewed

    Michiyo Iguchi, Noriko Tomita, Masaki Imanishi, Hirotsugu Kurobe, Noriko Sugasawa, Itaru Satoh, Shinji Matsunaga, Toshiaki Tamaki, Shuhei Tomita

    JOURNAL OF PHARMACOLOGICAL SCIENCES   124   161P - 161P   2014

     More details

    Language:English   Publishing type:Research paper, summary (international conference)   Publisher:JAPANESE PHARMACOLOGICAL SOC  

    Web of Science

    researchmap

  • 大動脈弓部全置換術後遠隔期の縦隔炎に対して持続洗浄、閉鎖陰圧療法及び大胸筋充填治療を行った1例

    神原 保, 木下 肇, 中山 泰介, 菅野 幹雄, 黒部 裕嗣, 藤本 鋭貴, 北市 隆, 藤田 博, 曽我部 仁史, 北川 哲也

    血管外科   32 ( 1 )   110 - 115   2013.11

     More details

    Language:Japanese   Publisher:血管外科症例検討会  

    症例は69歳、男性。遠位弓部大動脈瘤に対する弓部全置換術を施行し順調に経過していたが、5年後に近傍の肺炎を契機に縦隔炎を発症した。縦隔洗浄とdebridementを施行後、約2ヵ月にわたり人工呼吸管理下に胸骨解放下の持続洗浄と頻回の縦隔洗浄、debridementをベッドサイドにて施行した。炎症反応の改善後に人工血管露出部の被覆目的に陰圧閉鎖療法を行い、周囲肉芽増生後の第68病日に縦隔debridementと大胸筋充填を施行し軽快した。(著者抄録)

    researchmap

  • Small Diameter Tissue Engineered Vascular Grafts for Arterial Bypass Applications Reviewed

    Hirotsugu Kurobe, Mark W. Maxfield, Shuhei Tara, Paul S. Bagi, Hidetaka Nakayama, Yuki Sakamoto, Kensuke Taki, Tai Yi, Kevin A. Rocco, Zhen W. Zhuang, Yasuko Iwakiri, Christopher K. Breuer, Toshiharu Shinoka

    CIRCULATION   128 ( 22 )   2013.11

     More details

    Language:English   Publishing type:Research paper, summary (international conference)   Publisher:LIPPINCOTT WILLIAMS & WILKINS  

    Web of Science

    researchmap

  • 【循環器再生医療の現状と展望】組織工学を用いた血管再生医療

    黒部 裕嗣, 太良 修平, 日比野 成俊, 新岡 俊治

    Circulation   3 ( 9 )   29 - 38   2013.9

     More details

    Language:Japanese   Publisher:(株)医学出版  

    researchmap

  • ワイヤー障害後の血管リモデリングにおけるToll like receptor 9の果たす役割

    平田 陽一郎, 黒部 裕嗣, 北川 哲也, 佐田 政隆, 岡 明

    日本小児循環器学会雑誌   29 ( Suppl. )   s273 - s273   2013.6

     More details

    Language:Japanese   Publisher:(NPO)日本小児循環器学会  

    researchmap

  • 乳児期特発性腱索断裂による急性僧帽弁閉鎖不全症の2例

    木下肇, 中山泰介, 菅野幹雄, 黒部裕嗣, 神原保, 藤本鋭貴, 北市隆, 阪田美穂, 早渕康信, 北川哲也

    日本小児循環器学会雑誌   29 ( Suppl. )   s316 - s316   2013.6

     More details

    Language:Japanese   Publisher:(NPO)日本小児循環器学会  

    J-GLOBAL

    researchmap

  • 大動脈弓部全置換術後の縦隔炎に対する持続洗浄・VAC療法・大胸筋充填治療の有用性

    神原 保, 藤本 鋭貴, 木下 肇, 中山 泰介, 菅野 幹雄, 黒部 裕嗣, 北市 隆, 高久 暢, 松尾 伸二, 中西 秀樹, 北川 哲也

    日本血管外科学会雑誌   22 ( 2 )   500 - 500   2013.4

     More details

    Language:Japanese   Publisher:(NPO)日本血管外科学会  

    researchmap

  • Stanford B型大動脈解離に対するステントグラフト内挿術の有効性

    木下 肇, 中山 泰介, 菅野 幹雄, 黒部 裕嗣, 神原 保, 藤本 鋭貴, 北市 隆, 北川 哲也

    日本血管外科学会雑誌   22 ( 2 )   358 - 358   2013.4

     More details

    Language:Japanese   Publisher:(NPO)日本血管外科学会  

    researchmap

  • 小口径グラフト開存を目的とするマクロファージHIFと極性の動脈リモデリング基礎研究

    中山 泰介, 冨田 修平, 黒部 裕嗣, 菅澤 典子, 木下 肇, 菅野 幹雄, 神原 保, 藤本 鋭貴, 北市 隆, 玉置 俊晃, 佐田 政隆, 北川 哲也

    日本心臓血管外科学会雑誌   42 ( Suppl. )   355 - 355   2013.2

     More details

    Language:Japanese   Publisher:(NPO)日本心臓血管外科学会  

    researchmap

  • 弓部全置換術後の縦隔炎/敗血症に対するグラフト温存治療について

    神原 保, 黒部 裕嗣, 木下 肇, 中山 泰介, 菅野 幹雄, 藤本 鋭貴, 北市 隆, 北川 哲也

    日本心臓血管外科学会雑誌   42 ( Suppl. )   330 - 330   2013.2

     More details

    Language:Japanese   Publisher:(NPO)日本心臓血管外科学会  

    researchmap

  • HMGB1の血管リモデリングにおける炎症性メディエーターとしての役割

    平田 陽一郎, 黒部 裕嗣, 中屋 豊, 北川 哲也, 五十嵐 隆, 佐田 政隆

    日本小児科学会雑誌   117 ( 2 )   554 - 554   2013.2

     More details

    Language:Japanese   Publisher:(公社)日本小児科学会  

    researchmap

  • 新規プロスタサイクリンアゴニストの心筋炎後拡張型心筋症モデルにおける有用性

    平田 陽一郎, 黒部 裕嗣, 酒井 芳紀, 北川 哲也, 五十嵐 隆, 佐田 政隆

    日本小児科学会雑誌   117 ( 2 )   553 - 553   2013.2

     More details

    Language:Japanese   Publisher:(公社)日本小児科学会  

    researchmap

  • 徳島県に企業性大動脈瘤ステントグラフトを導入して4年の経過報告

    藤本鋭貴, 筑後文雄, 木下肇, 中山泰介, 菅野幹雄, 黒部裕嗣, 神原保, 加納正志, 北市隆, 北川哲也

    四国医学雑誌   68 ( 5-6 )   278 - 278   2012.12

     More details

    Language:Japanese  

    J-GLOBAL

    researchmap

  • 不幸な転機をとった大腿部の巨大脂肪肉腫の1例

    森本篤志, 橋本一郎, 安倍吉郎, 柏木圭介, 中西秀樹, 黒部裕嗣, 元木達夫, 北川哲也, 鳥羽博明, 先山正二, 武知浩和, 森本雅美, 丹黒章

    日本形成外科学会会誌   32 ( 10 )   787 - 787   2012.10

     More details

    Language:Japanese  

    J-GLOBAL

    researchmap

  • 小口径グラフト開存性改善を目的とする血管リモデリングにおけるマクロファージの基礎研究

    中山泰介, 冨田修平, 黒部裕嗣, 菅澤典子, 木下肇, 管野幹雄, 神原保, 藤本鋭貴, 北市隆, 玉木俊晃, 佐田政隆, 高浜洋介, 北川哲也

    Gen Thorac Cardiovasc Surg   60 ( Supplement )   579   2012.9

     More details

    Language:Japanese  

    J-GLOBAL

    researchmap

  • Stanford B型大動脈解離に対するステントグラフト内挿術の手術時期の検討

    木下肇, 中山泰介, 菅野幹雄, 黒部裕嗣, 神原保, 藤本鋭貴, 北市隆, 北川哲也

    Gen Thorac Cardiovasc Surg   60 ( Supplement )   622   2012.9

     More details

    Language:Japanese  

    J-GLOBAL

    researchmap

  • ヒト脂肪組織における炎症性シグナルとNLRP3インフラマソームの関与

    佐藤 寛美, 平田 陽一郎, 島袋 充生, 福田 大受, 田端 実, 黒部 裕嗣, 高梨 秀一郎, 北川 哲也, 中屋 豊, 佐田 政隆

    肥満研究   18 ( Suppl. )   178 - 178   2012.9

     More details

    Language:Japanese   Publisher:(一社)日本肥満学会  

    researchmap

  • Region-specific regulation of the innate immune system, NLRP3 inflammasome, in human abdominal adipose tissue

    H. Sato, M. Shimabukuro, Y. Hirata, H. Izaki, M. Higashida, H. Kurobe, H. Kanayama, H. Sakaue, Y. Nakaya, M. Sata

    EUROPEAN HEART JOURNAL   33   424 - 424   2012.8

     More details

    Language:English   Publishing type:Research paper, summary (international conference)   Publisher:OXFORD UNIV PRESS  

    Web of Science

    researchmap

  • エゼチミブ投与によるブタ心臓周囲脂肪ならびに心筋組織の酸化コレステロール,脂肪酸分画の変動:GC/MS法による検討

    島袋充生, 大川知奈美, 東田真由子, 黒部裕嗣, 佐藤寛美, 高尾正一郎, 平田陽一郎, 雷小峰, 金山朱里, 中山泰介, 福田大受, 山田博胤, 佐藤匡央, 北川哲也, 佐田政隆

    日本心臓病学会誌   7 ( Suppl.I )   530 - 530   2012.8

     More details

    Language:Japanese  

    J-GLOBAL

    researchmap

  • 心臓周囲脂肪NLRP3インフラマゾームのヒト冠動脈硬化症における役割

    佐藤寛美, 島袋充生, 平田陽一郎, 田端実, MUNKHBAATAR Dagvasumberel, 坂東佐知子, 黒部裕嗣, 福田大受, 添木武, 高梨秀一郎, 北川哲也, 中屋豊, 佐田政隆

    日本心臓病学会誌   7 ( Suppl.I )   323 - 323   2012.8

     More details

    Language:Japanese  

    J-GLOBAL

    researchmap

  • The innate immune system, NLRP3 inflammasome, in epicardial adipose tissue intensifies human coronary atherosclerosis

    H. Sato, Y. Hirata, M. Shimabukuro, M. Tabata, H. Kurobe, M. Higashida, S. Takanashi, Y. Nakaya, T. Kitagawa, M. Sata

    EUROPEAN HEART JOURNAL   33   424 - 424   2012.8

     More details

    Language:English   Publishing type:Research paper, summary (international conference)   Publisher:OXFORD UNIV PRESS  

    Web of Science

    researchmap

  • HMGB1の血管リモデリングにおける炎症性メディエーターとしての役割

    平田陽一郎, 平田陽一郎, 黒部裕嗣, 中屋豊, 北川哲也, 五十嵐隆, 佐田政隆

    日本小児循環器学会雑誌   28 ( Suppl. )   s336 - s336   2012.6

     More details

    Language:Japanese  

    J-GLOBAL

    researchmap

  • 新規プロスタサイクリンアゴニスト(ONO‐1301)の心筋炎後拡張型心筋症モデルにおける有用性

    平田陽一郎, 平田陽一郎, 黒部裕嗣, 酒井芳樹, 北川哲也, 五十嵐隆, 佐田政隆

    日本小児循環器学会雑誌   28 ( Suppl. )   s271 - s271   2012.6

     More details

    Language:Japanese  

    J-GLOBAL

    researchmap

  • 成人期先天性心疾患患者の大動脈手術の経験

    菅野幹雄, 中山泰介, 木下肇, 黒部裕嗣, 神原保, 藤本鋭貴, 北市隆, 大西達也, 阪田美穂, 早渕康信, 北川哲也

    日本血管外科学会雑誌   21 ( 3 )   337 - 337   2012.5

     More details

    Language:Japanese  

    J-GLOBAL

    researchmap

  • 両側腸骨動脈アクセス不良症例に対しY型ステントグラフトを留置した腹部大動脈瘤の1例

    木下 肇, 中山 泰介, 菅野 幹雄, 黒部 裕嗣, 神原 保, 藤本 鋭貴, 北市 隆, 北川 哲也

    日本血管外科学会雑誌   21 ( 3 )   467 - 468   2012.5

     More details

    Language:Japanese   Publisher:(NPO)日本血管外科学会  

    researchmap

  • 野生型マウス大動脈瘤モデルの確立とsmall aortic aneurysm拡大予防について

    松岡 祐貴, 黒部 裕嗣, 中山 泰介, 北川 哲也

    日本血管外科学会雑誌   21 ( 3 )   334 - 335   2012.5

     More details

    Language:Japanese   Publisher:(NPO)日本血管外科学会  

    researchmap

  • Budd-Chiari症候群術後34年の下肢静脈瘤の1例

    木下 肇, 高柳 友貴, 中山 泰介, 菅野 幹雄, 黒部 裕嗣, 神原 保, 藤本 鋭貴, 北市 隆, 北川 哲也

    静脈学   23 ( 2 )   193 - 193   2012.4

     More details

    Language:Japanese   Publisher:日本静脈学会  

    researchmap

  • 心臓周囲脂肪NLRP3インフラマゾームのヒト冠動脈硬化症における役割

    佐藤 寛美, 平田 陽一郎, 島袋 充生, 田端 実, 黒部 裕嗣, 東田 真由子, 塩田 あすか, 伊崎 博文, 金山 博臣, 高梨 秀一郎, 北川 哲也, 中屋 豊, 佐田 政隆

    糖尿病   55 ( Suppl.1 )   S - 89   2012.4

     More details

    Language:Japanese   Publisher:(一社)日本糖尿病学会  

    researchmap

  • PS-108-4 活動期感染症心内膜炎に対する術前抗菌薬治療の検討(PS-108 心臓 その他,ポスターセッション,第112回日本外科学会定期学術集会)

    木下 肇, 中山 泰介, 菅野 幹雄, 黒部 裕嗣, 神原 保, 藤本 鋭貴, 北市 隆, 北川 哲也

    日本外科学会雑誌   113 ( 2 )   707 - 707   2012.3

     More details

    Language:Japanese   Publisher:一般社団法人日本外科学会  

    CiNii Books

    researchmap

  • 超高齢者弓部大動脈瘤に対するdebranching TEVARの検討

    藤本 鋭貴, 筑後 文雄, 木下 肇, 中山 泰介, 菅野 幹雄, 黒部 裕嗣, 神原 保, 加納 正志, 北市 隆, 北川 哲也

    日本心臓血管外科学会雑誌   41 ( Suppl. )   524 - 524   2012.3

     More details

    Language:Japanese   Publisher:(NPO)日本心臓血管外科学会  

    researchmap

  • 野生型マウス大動脈瘤モデルの確立とsmall aortic aneurysum拡大予防について

    松岡 祐貴, 黒部 裕嗣, 平田 陽一郎, 菅澤 典子, 東田 真由子, 中山 泰介, 神原 保, 佐田 政隆, 北川 哲也

    日本心臓血管外科学会雑誌   41 ( Suppl. )   490 - 490   2012.3

     More details

    Language:Japanese   Publisher:(NPO)日本心臓血管外科学会  

    researchmap

  • 小口径グラフト開存性改善を目的とするマクロファージHIF制御に関しての基礎研究

    中山 泰介, 黒部 裕嗣, 菅澤 典子, 東田 真由子, 吉田 恭史, 佐田 政隆, 玉置 俊晃, 北川 哲也, 冨田 修平

    日本心臓血管外科学会雑誌   41 ( Suppl. )   490 - 490   2012.3

     More details

    Language:Japanese   Publisher:(NPO)日本心臓血管外科学会  

    researchmap

  • B型大動脈解離に対するステントグラフト内挿術の検討

    藤本 鋭貴, 筑後 文雄, 中山 泰介, 木下 肇, 菅野 幹雄, 黒部 裕嗣, 神原 保, 加納 正志, 北市 隆, 北川 哲也

    日本心臓血管外科学会雑誌   41 ( Suppl. )   504 - 504   2012.3

     More details

    Language:Japanese   Publisher:(NPO)日本心臓血管外科学会  

    researchmap

  • Mitral Valve Replacement for Recurrent and Multiple Cerebral Embolisms Caused by Mitral Annular Calcification

    Sugano Mikio, Kitagawa Tetsuya, Motoki Tatsuo, Kurobe Hirotsugu, Yoshida Homare, Nakayama Taisuke, Kinoshita Hajime, Kanbara Tamotsu, Fujimoto Eiki, Kitaichi Takashi

    Japanese Journal of Cardiovascular Surgery   41 ( 6 )   299 - 303   2012

     More details

    Language:Japanese   Publisher:The Japanese Society for Cardiovascular Surgery  

    A 69-year-old woman had syncope and aphasia. Magnetic resonance imaging showed multiple cerebral infarctions in both hemispheres. Cardiogenic embolisms were suspected, but no arrhythmic causes were shown. Transesophageal echocardiography revealed a highly calcified mitral annulus (MAC) with a rough intraluminal surface and mild mitral regurgitation, but no thrombus or tumor in the left heart system. However, recurrent multiple cerebral embolisms occurred in spite of strict anticoagulation therapy. We speculated that spontaneous rupture of the MAC was the cause of the scattered cerebral embolisms, and we therefore planned to remove the MAC as safely as possible and to endothelialize the deficit of MAC with autologous pericardium. Operative findings revealed that the MAC in P2-P3 had ruptured longitudinally and the ostium of the left atrium was connected to the ostium of the left ventricle as an inter-atrioventricular tunnel beneath the posterior mitral annulus with a fragile calcified wall. The finding suggested that calcified particles that had peeled away from the MAC by normal heart beating resulted in the cerebral infarctions. Therefore, she underwent resection of the MAC and mitral valve replacement with reinforcement of the decalcified posterior mitral annulus between the posterior left ventricular wall and the left atrial wall using autologous pericardium, which enabled both appropriate insertion of a mechanical prosthetic valve and endothelial continuity covering the surface of the residual MAC. No systemic embolism has occurred for two and a half years after surgery. This is the first case report of cerebral embolism caused by a spontaneously ruptured MAC.

    DOI: 10.4326/jjcvs.41.299

    researchmap

  • アンジオテンシンII受容体拮抗薬カンデサルタンベースの降圧療法からカンデサルタン/アムロジピン配合錠に切り替えた際の降圧効果に関する検討

    伊藤 祐司, 井上 洋行, 井原 義雄, 折野 俊介, 亀山 和人, 河野 和弘, 黒部 裕嗣, 河野 光宏, 斎藤 彰浩, 多田 嘉明, 陳 博敏, 長瀬 教夫, 原田 浩臣, 日浅 芳一, 藤永 裕之, 古本 渉, 南 定, 村上 昌, 矢田 健一郎, 山口 浩司, 幸田 トモ子, UNICORN研究グループ

    Progress in Medicine   31 ( 12 )   2861 - 2869   2011.12

     More details

    Language:Japanese   Publisher:(株)ライフ・サイエンス  

    徳島県内の医療機関20施設から外来通院中の高血圧患者117例を多施設共同研究であるUNICORN研究(UNisia Improving conCORdance and Normotension study)に登録した。117例中92例(78.6%)はカンデサルタンまたは他のアンジオテンシンII受容体拮抗薬(ARB)をベースにした降圧療法が施行され、94例(80.3%)にカルシウム拮抗薬が併用されていた。服用中の降圧薬の数は平均1.70±0.61剤であった。これら117例を対象とし、従来療法からカンデサルタン8mgとアムロジピン2.5mg/5mgを含有する配合錠ユニシアLD/HDに切り替えた際の実地診療下における降圧効果を最大12週間にわたり検討した。収縮期血圧、拡張期血圧の推移は、それぞれ145.1mmHgから134.8mmHgへ、79.1mmHgから74.1mmHgへと有意な低下を認めた。降圧目標達成率は、若年者・中年者(<130/85mmHg)で24.2%から48.5%へ、高齢者(<140/90mmHg)で33.1%から55.6%へ、それぞれ有意な改善を認めた。さらに、カンデサルタン8mgとアムロジピン5mgの併用例を対象とし、同一用量が配合されているユニシアHDに切り替えたところ、収縮期血圧は136.7mmHgから131.3mmHgへと有意な低下を示した。2剤が1剤になり、服薬コンコーダンスが改善した結果と推察された。配合錠へ切り替えることによって、降圧薬を2剤以上服用する患者の割合は65.0%から10.3%へ、服用薬剤数は1.70±0.61剤から1.12±0.40剤へ、それぞれ有意な減少を認めた。また、配合錠に関して患者に実施したアンケート調査によると、75%の患者が飲み忘れが減ったと回答し、58%の患者が負担額が減りメリットを感じたと回答した。以上より、降圧薬2剤を配合錠1剤に変更するだけで、血圧コントロールのみならず、費用面に関してもより大きなメリットを生じることが示唆された。(著者抄録)

    researchmap

  • 肝機能低下症例における拍動流体外循環の有用性

    樋口 精一, 藤井 有美子, 林 昌晃, 山下 陽子, 麻植塚 浩康, 近田 優介, 久原 幸典, 野田 康裕, 竹内 理沙, 大西 芳明, 上田 雅彦, 黒部 裕嗣, 北川 哲也

    体外循環技術   38 ( 4 )   582 - 582   2011.12

     More details

    Language:Japanese   Publisher:(一社)日本体外循環技術医学会編集委員会  

    researchmap

  • 血管リモデリングにおけるHMGB1の果たす役割

    東田 真由子, 西雄 千佳, 松岡 祐貴, 平田 陽一郎, 黒部 裕嗣, 中屋 豊, 北川 哲也, 佐田 政隆

    Anti-aging Science   3 ( Suppl.1 )   324 - 324   2011.11

     More details

    Language:Japanese   Publisher:(株)メディカルレビュー社  

    researchmap

  • 胸腹部大動脈人工血管置換術後に残存する遠位弓部大動脈瘤のステントグラフト治療適応について

    木下 肇, 中山 泰介, 菅野 幹雄, 黒部 裕嗣, 神原 保, 藤本 鋭貴, 北市 隆, 北川 哲也

    日本血管外科学会雑誌   20 ( 6 )   898 - 898   2011.10

     More details

    Language:Japanese   Publisher:(NPO)日本血管外科学会  

    researchmap

  • B型解離に対するステントグラフト内挿術の検討

    藤本 鋭貴, 筑後 文雄, 木下 肇, 中山 泰介, 菅野 幹雄, 黒部 裕嗣, 神原 保, 加納 正志, 北市 隆, 北川 哲也

    日本血管外科学会雑誌   20 ( 6 )   899 - 899   2011.10

     More details

    Language:Japanese   Publisher:(NPO)日本血管外科学会  

    researchmap

  • 心臓周囲脂肪におけるインフラマゾームの病態的意義

    佐藤 寛美, 平田 陽一郎, 島袋 充生, 塩田 あすか, 田端 実, 黒部 裕嗣, 東田 真由子, 井崎 博文, 金山 博臣, 高梨 秀一郎, 中屋 豊, 北川 哲也, 佐田 政隆

    肥満研究   17 ( Suppl. )   167 - 167   2011.9

     More details

    Language:Japanese   Publisher:(一社)日本肥満学会  

    researchmap

  • 大動脈解離の最前線 Stanford B型大動脈解離に対するステントグラフト内挿術の検討

    藤本 鋭貴, 筑後 文雄, 中山 泰介, 木下 肇, 菅野 幹雄, 黒部 裕嗣, 神原 保, 加納 正志, 北市 隆, 北川 哲也

    脈管学   51 ( Suppl. )   S79 - S79   2011.9

     More details

    Language:Japanese   Publisher:(一社)日本脈管学会  

    researchmap

  • テルミサルタンは、beyond AT1R作用により動脈硬化抑制作用を示す

    塩田 あすか, 福田 大受, 佐藤 寛美, 東田 真由子, 榎本 操一郎, 平田 陽一郎, 黒部 裕嗣, 佐田 政隆

    肥満研究   17 ( Suppl. )   170 - 170   2011.9

     More details

    Language:Japanese   Publisher:(一社)日本肥満学会  

    researchmap

  • 脳循環維持目的に補助手段を工夫した人工心肺下の開心術3例

    神原 保, 黒部 裕嗣, 木下 肇, 中山 泰介, 菅野 幹雄, 藤本 鋭貴, 北市 隆, 北川 哲也

    脈管学   51 ( Suppl. )   S155 - S156   2011.9

     More details

    Language:Japanese   Publisher:(一社)日本脈管学会  

    researchmap

  • GLP-1 receptor agonist attenuates vascular remodeling after endovascular injury

    Y. Hirata, H. Kurobe, M. Higashida, Y. Nakaya, T. Kitagawa, M. Sata

    EUROPEAN HEART JOURNAL   32   32 - 32   2011.8

     More details

    Language:English   Publishing type:Research paper, summary (international conference)   Publisher:OXFORD UNIV PRESS  

    Web of Science

    researchmap

  • HMGB1/TLR9 pathway plays a critical role in chronic inflammation and vascular remodeling after endovascular injury

    M. Higashida, Y. Hirata, H. Kurobe, Y. Nakaya, T. Kitagawa, M. Sata

    EUROPEAN HEART JOURNAL   32   35 - 35   2011.8

     More details

    Language:English   Publishing type:Research paper, summary (international conference)   Publisher:OXFORD UNIV PRESS  

    Web of Science

    researchmap

  • EZETIMIBE MONO-THERAPY AMELIORATES VASCULAR FUNCTION IN PATIENTS WITH HYPERCHOLESTEROLEMIA THROUGH DECREASING OXIDATIVE STRESS

    H. Kurobe, K. -I. Aihara, Y. Hirata, T. Motoki, M. Sugano, T. Kanbara, T. Nakayama, T. Kitaichi, M. Akaike, M. Sata, T. Matsumoto, T. Kitagawa

    ATHEROSCLEROSIS SUPPLEMENTS   12 ( 1 )   21 - 21   2011.6

     More details

    Language:English   Publishing type:Research paper, summary (international conference)   Publisher:ELSEVIER IRELAND LTD  

    Web of Science

    researchmap

  • GLP-1 receptor agonistが血管リモデリングに与える影響の検討

    黒部 裕嗣, 平田 陽一郎, 西雄 千佳, 東田 真由子, 松岡 祐貴, 赤池 雅史, 中屋 豊, 北川 哲也, 佐田 政隆

    日本内分泌学会雑誌   87 ( 1 )   349 - 349   2011.4

     More details

    Language:Japanese   Publisher:(一社)日本内分泌学会  

    researchmap

  • 心血管手術後エゼチミブ投与による血管機能改善効果の検討

    黒部 裕嗣, 粟飯原 賢一, 西矢 昌子, 中山 泰介, 元木 達夫, 菅野 幹雄, 神原 保, 北市 隆, 松本 俊夫, 北川 哲也

    日本血管外科学会雑誌   20 ( 2 )   417 - 417   2011.4

     More details

    Language:Japanese   Publisher:(NPO)日本血管外科学会  

    researchmap

  • 胸部下行および胸腹部大動脈瘤手術における脊髄虚血の危険因子(Open repiarとTEVARの比較)

    北市 隆, 神原 保, 黒部 裕嗣, 元木 達夫, 菅野 幹雄, 中山 泰介, 北川 哲也

    日本血管外科学会雑誌   20 ( 2 )   532 - 532   2011.4

     More details

    Language:Japanese   Publisher:(NPO)日本血管外科学会  

    researchmap

  • 遠位弓部瘤に対する積極的debranched TEVARの経験

    元木 達夫, 藤本 鋭貴, 中山 泰介, 菅野 幹雄, 黒部 裕嗣, 神原 保, 北市 隆, 北川 哲也

    日本血管外科学会雑誌   20 ( 2 )   455 - 455   2011.4

     More details

    Language:Japanese   Publisher:(NPO)日本血管外科学会  

    researchmap

  • 早期血栓閉塞型急性A型大動脈解離における保存的治療の検討

    中山 泰介, 菅野 幹雄, 元木 達夫, 黒部 裕嗣, 神原 保, 北市 隆, 石戸谷 浩, 堀 隆樹, 北川 哲也

    日本血管外科学会雑誌   20 ( 2 )   448 - 448   2011.4

     More details

    Language:Japanese   Publisher:(NPO)日本血管外科学会  

    researchmap

  • ステントグラフト内挿術による術後腎機能に及ぼす影響に関する検討

    中山 泰介, 菅野 幹雄, 元木 達夫, 黒部 裕嗣, 神原 保, 北市 隆, 藤本 鋭貴, 北川 哲也

    日本血管外科学会雑誌   20 ( 2 )   429 - 429   2011.4

     More details

    Language:Japanese   Publisher:(NPO)日本血管外科学会  

    researchmap

  • エゼチミブ投与による脂質代謝および血管機能改善効果の検討

    黒部 裕嗣, 粟飯原 賢一, 平田 陽一郎, 西矢 昌子, 中山 泰介, 元木 達夫, 菅野 幹雄, 神原 保, 北市 隆, 赤池 雅史, 佐田 政隆, 北川 哲也, 松本 俊夫

    日本内分泌学会雑誌   87 ( 1 )   292 - 292   2011.4

     More details

    Language:Japanese   Publisher:(一社)日本内分泌学会  

    researchmap

  • 出産後の甲状腺機能亢進症が発見の契機となったLeft Main Coronary Trunk Compression Syndromeの一例

    太田 理絵, 冨田 紀子, 楠瀬 賢也, 坂東 左知子, 久岡 白陽花, 林 修司, 竹内 秀和, 仁木 敏之, 山口 浩司, 竹谷 善雄, 岩瀬 俊, 山田 博胤, 添木 武, 若槻 哲三, 赤池 雅史, 佐田 政隆, 木村 建彦, 西内 健, 黒部 裕嗣, 北川 哲也

    四国医学雑誌   67 ( 1-2 )   97 - 98   2011.4

     More details

    Language:Japanese   Publisher:徳島医学会  

    researchmap

  • 化膿性椎間板炎から波及した腹部大動脈破裂に対してステントグラフト内挿術が奏功した1例

    菅野 幹雄, 吉田 誉, 高柳 友貴, 中山 泰介, 元木 達夫, 黒部 裕嗣, 神原 保, 北市 隆, 藤本 鋭貴, 北川 哲也

    日本血管外科学会雑誌   20 ( 2 )   575 - 575   2011.4

     More details

    Language:Japanese   Publisher:(NPO)日本血管外科学会  

    researchmap

  • Functional restoration of endothelial cells of the cryopreserved heart valve

    FUJIMOTO Eiki, YOSHIZUMI Masanori, KANBARA Tamotsu, KUROBE Hirotsugu, MOTOKI Tatsuo, SUGANO Mikio, NAKAYAMA Taisuke, KITAICHI Takashi, KITAGAWA Tetsuya

    59 ( 3 )   169 - 174   2011.3

     More details

  • Successful early resection of cardiac papillary fibroelastomas

    KUROBE Hirotsugu, KANBARA Tamotsu, YOSHIDA Homare, MOTOKI Tatsuo, SUGANO Mikio, NAKAYAMA Taisuke, KITAICHI Takashi, KITAGAWA Tetsuya

    59 ( 3 )   191 - 194   2011.3

     More details

  • ピオグリタゾン投与による腹部大動脈瘤における抗動脈硬化作用の検討

    元木 達夫, 平田 陽一郎, 黒部 裕嗣, 中山 泰介, 菅野 幹雄, 吉田 誉, 神原 保, 北市 隆, 菅澤 典子, 三木 美枝, 佐田 正隆, 北川 哲也

    日本心臓血管外科学会雑誌   40 ( Suppl. )   392 - 392   2011.1

     More details

    Language:Japanese   Publisher:(NPO)日本心臓血管外科学会  

    researchmap

  • 大動脈瘤モデル作製と臨床応用に向けた病態解明・治療法の検討

    黒部 裕嗣, 平田 陽一郎, 松岡 祐貴, 西雄 千佳, 東田 真由子, 兼松 康久, 菅澤 典子, 永廣 信治, 佐田 正隆, 北川 哲也

    日本心臓血管外科学会雑誌   40 ( Suppl. )   234 - 234   2011.1

     More details

    Language:Japanese   Publisher:(NPO)日本心臓血管外科学会  

    researchmap

  • 血管リモデリングにおけるHMGB1の果たす役割

    東田 真由子, 西雄 千佳, 松岡 祐貴, 平田 陽一郎, 黒部 裕嗣, 中屋 豊, 北川 哲也, 佐田 政隆

    血管   34 ( 1 )   43 - 43   2011.1

     More details

    Language:Japanese   Publisher:日本心脈管作動物質学会  

    researchmap

  • 心臓周囲脂肪組織における炎症性サイトカインの発現と冠動脈病変の関連

    平田 陽一郎, 元木 達夫, 黒部 裕嗣, 赤池 雅史, 田端 実, 高梨 秀一郎, 北川 哲也, 佐田 政隆

    血管   34 ( 1 )   33 - 33   2011.1

     More details

    Language:Japanese   Publisher:日本心脈管作動物質学会  

    researchmap

  • Successful Repair of a Traumatic Aortic Isthmus Pseudoaneurysm Concomitant with Right Diaphragmatic Hernia

    Nakayama Taisuke, Hori Takaki, Kano Masashi, Isshiki Shingo, Tominaga Takashi, Ishitoya Hiroshi, Hiratani Katsuhiko, Sawada Takahiro, Kurobe Hirotsugu, Kitagawa Tetsuya

    Japanese Journal of Cardiovascular Surgery   40 ( 3 )   94 - 97   2011

     More details

    Language:Japanese   Publisher:The Japanese Society for Cardiovascular Surgery  

    A 24-year-old woman underwent successful repair of a traumatic pseudoaneurysm of the aortic isthmus concomitant with right diaphragmatic hernia which developed after a traffic accident, and the steering wheel of the crashed car was considered responsible for both lesions. Due to the right diaphragmatic hernia, she could breathe mainly with the left lung only. The aortic isthmus aneurysm was considered to be a pseudoaneurysm, and because of the potential risk of rupture, we performed urgent aortic surgery. Prior to a left thoracotomy, we anastomosed an 8-mm prosthetic graft to the right axillary artery. When the left lung was collapsed in order to perform a femoro-femoral bypass, the SpO<sub>2</sub> level of her right index finger and her cerebral rSO<sub>2</sub> markedly decreased. Therefore, we administered additional perfusion via the right axillary artery, which provided sufficient oxygen to the upper body and brain. The patient underwent Marlex mesh reinforcement of the right diaphragmatic hernia 30 days after grafting, and is doing well 1 year postoperatively.

    DOI: 10.4326/jjcvs.40.94

    researchmap

    Other Link: https://search.jamas.or.jp/index.php?module=Default&action=Link&pub_year=2011&ichushi_jid=J01122&link_issn=&doc_id=20110601170004&doc_link_id=20110601170005&url=http%3A%2F%2Fsearch.jamas.or.jp%2Flink%2Fbc%2F20110601170005&type=jamaslink&icon=https%3A%2F%2Fjk04.jamas.or.jp%2Ficon%2F99999_1.gif

  • 難治性小児乳び胸に対するオクトレオチドの使用経験

    中山泰介, 菅野幹雄, 元木達夫, 黒部裕嗣, 神原保, 北市隆, 北川哲也, 寺田知正, 大西達也, 阪田美穂, 早渕康信, 今中秀光, 西村匡史

    日本循環器学会中国地方会(Web)   98th   CHUGOKU.SHIKOKU98,O130 (WEB ONLY)   2011

     More details

    Language:Japanese  

    J-GLOBAL

    researchmap

  • 左冠動脈右房瘻の1治験例

    中山泰介, 菅野幹雄, 元木達夫, 黒部裕嗣, 神原保, 北市隆, 北川哲也, 大西達也, 阪田美穂, 早渕康信

    日本冠動脈外科学会学術大会講演抄録集   16th   145   2011

     More details

    Language:Japanese  

    J-GLOBAL

    researchmap

  • 虚血皮弁生存に対するPHD阻害剤の効果

    TAKAKU MITSURU, TOMITA SHUHEI, USHIYAMA AKIRA, KUROBE HIROSHI, TAMAKI TOSHIAKI, HASHIMOTO ICHIRO, NAKANISHI HIDEKI

    日本形成外科学会基礎学術集会プログラム・抄録集   20th   122   2011

     More details

    Language:Japanese  

    J-GLOBAL

    researchmap

  • 気管切開孔を有する症例の上行〜弓部大動脈へのアプローチ

    中山 泰介, 加納 正志, 一色 真吾, 佐々木 英樹, 富永 崇司, 石戸谷 浩, 黒部 裕嗣, 北川 哲也, 平谷 勝彦, 堀 隆樹

    胸部外科   63 ( 13 )   1113 - 1118   2010.12

     More details

    Language:Japanese   Publisher:(株)南江堂  

    開放気管切開孔または永久気管切開孔を有する症例での大動脈基部〜弓部の大動脈治療2例を報告し、その問題点とアプローチの工夫について考察した。症例1は41歳男で、慢性Stanford A型大動脈解離を伴う重症大動脈弁閉鎖不全症と診断され、術前画像で心臓の右方偏位と反時計方向回転を確認できたため、逆L字型アプローチによるBentall手術を行った。症例2は76歳女で、急速に拡大する胸部大動脈瘤に対し、検査結果および永久気管切開孔と手術創の位置関係を検討してcram shellアプローチによる上行弓部置換術を行った。いずれも術後縦隔炎などの合併症なく良好に経過した。個々の症例で術前の画像診断から解剖学的位置関係を正確に把握して適切なアプローチ法を考慮すべきであり、特にcram shellアプローチは大動脈基部〜弓部大動脈手術では推奨できるアプローチ法である。

    researchmap

    Other Link: https://search.jamas.or.jp/index.php?module=Default&action=Link&pub_year=2010&ichushi_jid=J00349&link_issn=&doc_id=20101125080003&doc_link_id=40017389643&url=http%3A%2F%2Fci.nii.ac.jp%2Fnaid%2F40017389643&type=CiNii&icon=https%3A%2F%2Fjk04.jamas.or.jp%2Ficon%2F00003_1.gif

  • 胸部大動脈瘤に対するステントグラフトを用いたハイブリッド手術の有効性

    藤本 鋭貴, 筑後 文雄, 菅野 幹雄, 元木 達夫, 黒部 裕嗣, 中山 泰介, 神原 保, 北市 隆, 北川 哲也

    四国医学雑誌   66 ( 5-6 )   187 - 187   2010.12

     More details

    Language:Japanese   Publisher:徳島医学会  

    researchmap

  • 化膿性椎間板炎に起因する腹部大動脈破裂に対してステントグラフト内挿術が奏功した1例

    菅野 幹雄, 吉田 誉, 藤本 鋭貴, 元木 達夫, 高柳 友貴, 高原 文治, 中山 泰介, 黒部 裕嗣, 神原 保, 北市 隆, 北川 哲也

    日本血管外科学会雑誌   19 ( 6 )   719 - 719   2010.10

     More details

    Language:Japanese   Publisher:(NPO)日本血管外科学会  

    researchmap

  • エゼチミブ投与による脂質代謝および血管機能改善効果の検討

    黒部 裕嗣, 粟飯原 賢一, 西矢 昌子, 佐藤 光代, 西尾 進, 中山 泰介, 元木 達夫, 菅野 幹雄, 神原 保, 北市 隆, 松本 俊夫, 北川 哲也

    脈管学   50 ( Suppl. )   S153 - S153   2010.9

     More details

    Language:Japanese   Publisher:(一社)日本脈管学会  

    researchmap

  • Prelimenary evaluation of preoperative Pioglitazone administration on abdominal aortic aneurysm

    元木 達夫, 黒部 裕嗣, 平田 陽一郎

    Shikoku acta medica   66 ( 3 )   91 - 94   2010.8

     More details

    Language:Japanese   Publisher:徳島医学会  

    Accumulating evidence suggests that inflammatory cytokines secreted from visceral fat tissues potentially promote atherosclerosis progression. Recent reports suggested that pioglitazone, which is an anti-diabetes drug, reduces expression of tumor necrosis factor(TNF)‐α and ameliorates insulin-resistance in diabetic mice. Pioglitazone was also reported to suppress progression of coronary atherosclerosis. The objective of this study is to assess the effect of pioglitazone on inflammatory changes in abdominal aortic aneurysms(AAAs). This study protocol was approved by the medical ethics committee in Tokushima University Hospital. Patients with AAA were randomized into two groups. One was with pioglitazone(Group P). The other was without pioglitazone(Group C). Biopsy specimens were obtained from the abdominal subcutaneous fat, the greater omentum, the retroperitoneal periaortic fat and the aneurysmal wall. Immunohistochemistry of CD 68in those specimens was performed. The number of macrophages in Group P was lower than that in Group C. Expressions of inflammatory cytokines in those specimens were evaluated by real-time quantitative reverse transcription-polymerase chain reaction analysis. Expression of inflammatory cytokines in Group P were reduced, when compaird with those in Group C. Our data may suggest that pioglitazone reduce inflammatory changes in human aortic aneurysm.

    CiNii Books

    researchmap

  • The management of venous thrombosis and pulmonary embolization

    黒部 裕嗣, 北川 哲也

    Shikoku acta medica   66 ( 3 )   81 - 84   2010.8

     More details

    Language:Japanese   Publisher:徳島医学会  

    Virchow triad((1)blood stasis(, 2)changes in the vessel wall, and(3)hypercoagulability)are the major factors responsible for the development of venous thrombosis. This venous thrombosis leads to the pathogenesis of acute pulmonary thrombo-embolism which is known as"Economy Class Syndrome". A series of pathogenesis is widely recognized as"Venous thrombo-embolism syndrome". This syndrome occurs suddenly, and occasionally leads to fatal event. So the basic principle of treatment for this syndrome is to prevent deep vein thrombosis(DVT). The prevention consists of three crucial treatments. Firstly, to recognize high-risk patients of DVT is initial step. Secondary, anticoagulation, elastic stocking and foot pump are well established treatments. Thirdly, venous filter is applicable for the most highest-risk patients. In this review, we would like to introduce the latest knowledge for"Venous thrombo-embolism syndrome".

    CiNii Books

    researchmap

    Other Link: http://repo.lib.tokushima-u.ac.jp/110319

  • The rate of aortic aneurysm repair is increasing: open surgery vs. stent graft treatment

    Shikoku acta medica   66 ( 3 )   77 - 80   2010.8

     More details

    Language:Japanese  

    The treatment of Aortic aneurythm is shifting stent graft treatment from open Surgery. Stent graft treatment is useful for the treatment of thoracic aortic aneurythm if the form is adaptable for the stent graft treatment. Open surgery is useful for the treatment of abdominal aortic aneurythm if the patient have no complication and high operative lisk but if the patint have complication and high operative lisk, Stent graft treatment is very useful because of the quality of life is kept

    CiNii Books

    researchmap

    Other Link: http://repo.lib.tokushima-u.ac.jp/110318

  • 心外膜脂肪組織におけるマクロファージ極性化はヒト冠動脈のアテローム性硬化症を増強する(Macrophage Polarization in Epicardial Adipose Tissue Enhances Atherosclerosis of Human Coronary Arteries)

    平田 陽一郎, 元木 達夫, 黒部 裕嗣, 赤池 雅史, 田端 実, 高梨 秀一郎, 五十嵐 隆, 北川 哲也, 佐田 政隆

    日本心臓病学会誌   5 ( Suppl.I )   212 - 212   2010.8

     More details

    Language:English   Publisher:(一社)日本心臓病学会  

    researchmap

  • 心臓血管外科専門医研修を目的としたAnimal Laboの試み

    黒部 裕嗣, 神原 保, 堀 隆樹, 真鍋 智子, 金丸 知香, 瀬部 寛美, 森本 孝枝, 赤池 雅史, 北川 哲也, 香川 征

    医学教育   41 ( Suppl. )   84 - 84   2010.7

     More details

    Language:Japanese   Publisher:(一社)日本医学教育学会  

    researchmap

  • 先天性心疾患にもとづく活動期右心系感染性心内膜炎について

    元木 達夫, 菅野 幹雄, 黒部 裕嗣, 吉田 誉, 神原 保, 北市 隆, 北川 哲也

    日本小児循環器学会雑誌   26 ( Suppl. )   s331 - s331   2010.6

     More details

    Language:Japanese   Publisher:(NPO)日本小児循環器学会  

    researchmap

  • 思春期-成人女性に対する右室流出路再建術について

    北市 隆, 吉田 誉, 神原 保, 黒部 裕嗣, 元木 達夫, 菅野 幹雄, 中山 泰介, 阪田 美穂, 井上 美紀, 早渕 康信, 北川 哲也

    日本小児循環器学会雑誌   26 ( Suppl. )   s374 - s374   2010.6

     More details

    Language:English   Publisher:(NPO)日本小児循環器学会  

    researchmap

  • 遺伝子異常を伴った心疾患児での開心術後免疫動態の検討

    黒部 裕嗣, 菅野 幹雄, 富永 崇司, 浦田 将久, 北市 隆, 堀 隆樹, 江川 善康, 高浜 洋介, 北川 Tetsuya

    日本小児循環器学会雑誌   26 ( Suppl. )   s364 - s364   2010.6

     More details

    Language:Japanese   Publisher:(NPO)日本小児循環器学会  

    researchmap

  • Parkes Weber症候群様所見を認めた1例

    黒部 裕嗣, 神原 保, 山口 浩司, 元木 達夫, 菅野 幹雄, 中山 泰介, 北市 隆, 佐田 政隆, 北川 哲也

    静脈学   21 ( 2 )   230 - 230   2010.5

     More details

    Language:Japanese   Publisher:日本静脈学会  

    researchmap

  • ストリッピング術後遠隔期の慢性静脈不全症の1治療例

    元木 達夫, 菅野 幹雄, 黒部 裕嗣, 吉田 誉, 神原 保, 北市 隆, 北川 哲也

    静脈学   21 ( 2 )   181 - 181   2010.5

     More details

    Language:Japanese   Publisher:日本静脈学会  

    researchmap

  • 胸部大動脈瘤に対するハイブリッド治療の経験

    菅野 幹雄, 元木 達夫, 黒部 裕嗣, 吉田 誉, 神原 保, 北市 隆, 北川 哲也

    四国医学雑誌   66 ( 1-2 )   47 - 47   2010.4

     More details

    Language:Japanese   Publisher:徳島医学会  

    researchmap

  • ピオグリタゾン投与による腹部大動脈瘤における抗動脈硬化作用の検討

    元木 達夫, 黒部 裕嗣, 寺橋 篤子, 菅野 幹雄, 吉田 誉, 神原 保, 北市 隆, 北川 哲也, 平田 陽一郎, 佐田 政隆

    四国医学雑誌   66 ( 1-2 )   46 - 46   2010.4

     More details

    Language:Japanese   Publisher:徳島医学会  

    researchmap

  • 循環器病診療における最新の診かた、考え方 予防できる下肢のむくみと肺塞栓症 静脈塞栓症候群とは?

    黒部 裕嗣, 神原 保, 菅野 幹雄, 元木 達夫, 吉田 誉, 北市 隆, 北川 哲也

    四国医学雑誌   66 ( 1-2 )   44 - 45   2010.4

     More details

    Language:Japanese   Publisher:徳島医学会  

    researchmap

  • A型急性解離に合併した腹部臓器虚血に対し腹部大動脈真腔内balloon expandable stent留置が奏功した1例

    元木 達夫, 北市 隆, 吉田 誉, 菅野 幹雄, 黒部 裕嗣, 神原 保, 北川 哲也

    日本血管外科学会雑誌   19 ( 2 )   473 - 473   2010.4

     More details

    Language:Japanese   Publisher:(NPO)日本血管外科学会  

    researchmap

  • 術前頸動脈病変評価と術中局所脳内酸素飽和度(rSO2)モニタリングの有用性

    黒部 裕嗣, 神原 保, 吉田 誉, 元木 達夫, 菅野 幹雄, 中山 泰介, 北市 隆, 北川 哲也

    日本血管外科学会雑誌   19 ( 2 )   289 - 289   2010.4

     More details

    Language:Japanese   Publisher:(NPO)日本血管外科学会  

    researchmap

  • OP-267-7 血管リモデリング時の転写因子HIF-1αの役割(血管基礎,一般口演,第110回日本外科学会定期学術集会)

    黒部 裕嗣, 浦田 将久, 福原 弥生, 神原 保, 粟飯原 賢一, 赤池 雅史, 高濱 洋介, 玉置 俊晃, 松本 俊夫, 冨田 修平, 北川 哲也

    日本外科学会雑誌   111 ( 2 )   701 - 701   2010.3

     More details

    Language:Japanese   Publisher:一般社団法人日本外科学会  

    CiNii Books

    researchmap

  • OP-239-2 ファロー四徴症術後遠隔期における肺動脈弁の重要性(心臓-7,一般口演,第110回日本外科学会定期学術集会)

    北市 隆, 吉田 誉, 神原 保, 黒部 裕嗣, 元木 達夫, 菅野 幹雄, 早渕 康信, 井上 美紀, 阪田 美穂, 北川 哲也

    日本外科学会雑誌   111 ( 2 )   655 - 655   2010.3

     More details

    Language:Japanese   Publisher:一般社団法人日本外科学会  

    CiNii Books

    researchmap

  • 思春期以降の女性患者に対する右室流出路再建手術

    吉田 誉, 北市 隆, 菅野 幹雄, 元木 達夫, 黒部 裕嗣, 神原 保, 北川 哲也

    日本心臓血管外科学会雑誌   39 ( Suppl. )   246 - 246   2010.1

     More details

    Language:Japanese   Publisher:(NPO)日本心臓血管外科学会  

    researchmap

  • Successful Implantations of Autologous Peripheral Blood-Derived Mononuclear Cells Pretreated by Erythropoietin and Blood Donation in a Patient with Buerger Disease and Intractable Finger Ulcers

    Kinoshita Hajime, Kitagawa Tetsuya, Kanbara Tamotsu, Kurobe Hirotsugu, Motoki Tatsuo, Sugano Mikio, Yoshida Homare, Kitaichi Takashi, Sata Masataka, Matsumoto Toshio

    Japanese Journal of Cardiovascular Surgery   39 ( 1 )   29 - 33   2010

     More details

    Language:Japanese   Publisher:The Japanese Society for Cardiovascular Surgery  

    A 48-year-old man with Buerger disease and intractable finger ulcers underwent successful transplantation of autologous peripheral blood-derived mononuclear cells pretreated with erythropoietin and blood donation to activate bone marrow function. Clinical symptoms on his finger ulcers improved significantly within 1 month after mononuclear cell transplantation, however, one of the intractable ulcers reappeared 2 months later. In total three transplantations were performed. Every cell transplantation revealed similar effectiveness 1 month later, and the interval of the subsequent disappearance of finger ulcers ranged from 3&ndash;6 months. There were no adverse effects based on this new therapy. These findings suggest that autologous peripheral mononuclear cell transplantation pretreated with erythropoietin and blood donation might be a non-invasive and safe alternatives for patients with Buerger disease and intractable finger ulcers.

    DOI: 10.4326/jjcvs.39.29

    researchmap

  • 冠動脈周囲脂肪組織におけるマクロファージ浸潤の動脈硬化病変形成に与える影響

    平田 陽一郎, 仁木 敏之, 山口 浩司, 楠瀬 賢也, 小柴 邦彦, 八木 秀介, 竹谷 善雄, 岩瀬 俊, 山田 博胤, 添木 武, 若槻 哲三, 赤池 雅史, 佐田 政隆, 黒部 裕嗣, 神原 保, 筑後 文雄, 北川 哲也, 堀 貴樹

    四国医学雑誌   65 ( 5-6 )   199 - 199   2009.12

     More details

    Language:Japanese   Publisher:徳島医学会  

    researchmap

  • 気管切開を伴った患者に対するBentall型手術の1例

    中山 泰介, 加納 正志, 米沢 数馬, 一色 真吾, 富永 崇司, 石戸谷 浩, 黒部 裕嗣, 北川 哲也, 平谷 勝彦, 堀 隆樹

    日本血管外科学会雑誌   18 ( 6 )   652 - 652   2009.10

     More details

    Language:Japanese   Publisher:(NPO)日本血管外科学会  

    researchmap

  • 縦隔鏡下リンパ節生検時に腕頭動脈損傷を来しPCPS使用下に救命し得た1例

    菅野 幹雄, 吉田 誉, 元木 達夫, 北市 隆, 神原 保, 黒部 裕嗣, 北川 哲也

    日本血管外科学会雑誌   18 ( 6 )   653 - 653   2009.10

     More details

    Language:Japanese   Publisher:(NPO)日本血管外科学会  

    researchmap

  • 右室心尖部小切開による乳児期心尖部筋性VSDの閉鎖

    菅野幹雄, 北市隆, 吉田誉, 神原保, 黒部裕嗣, 元木達夫, 阪田美穂, 井上美紀, 早渕康信, 北川哲也

    Gen Thorac Cardiovasc Surg   57 ( Supplement )   543   2009.9

     More details

    Language:Japanese  

    J-GLOBAL

    researchmap

  • 左房後壁転位による心房内血流転換術を行った心臓型総肺静脈還流異常症の中期遠隔期成績

    北市隆, 吉田誉, 神原保, 黒部裕嗣, 元木達夫, 浦田将久, 北川哲也, 阪田美穂, 井上美紀, 早渕康信

    日本小児循環器学会雑誌   25 ( 5 )   712 - 712   2009.9

     More details

    Language:Japanese   Publisher:(NPO)日本小児循環器学会  

    J-GLOBAL

    researchmap

  • 保存的治療にて症状の改善を認めた鎖骨下静脈閉塞の2例

    神原 保, 黒部 裕嗣, 元木 達夫, 菅野 幹雄, 吉田 誉, 北市 隆, 北川 哲也

    脈管学   49 ( Suppl. )   S250 - S250   2009.9

     More details

    Language:Japanese   Publisher:(一社)日本脈管学会  

    researchmap

  • 深部静脈血栓症疑いで紹介されたBaker嚢腫破裂の2例

    神原 保, 北市 隆, 浦田 将久, 元木 達夫, 黒部 裕嗣, 吉田 誉, 北川 哲也

    静脈学   20 ( 2 )   134 - 134   2009.6

     More details

    Language:Japanese   Publisher:日本静脈学会  

    researchmap

  • 転移性後腹膜腫瘍摘出時の超音波凝固切開装置使用の検討

    黒部 裕嗣, 神原 保, 加納 正志, 浦田 将久, 元木 達夫, 吉田 誉, 北市 隆, 北川 哲也

    静脈学   20 ( 2 )   148 - 148   2009.6

     More details

    Language:Japanese   Publisher:日本静脈学会  

    researchmap

  • 右室心尖部小切開による乳児期心尖部筋性VSDの閉鎖

    元木達夫, 北市隆, 吉田誉, 神原保, 黒部裕嗣, 浦田将久, 阪田美穂, 井上美紀, 早渕康信, 北川哲也

    日本小児循環器学会雑誌   25 ( 3 )   558 - 558   2009.5

     More details

    Language:Japanese   Publisher:(NPO)日本小児循環器学会  

    J-GLOBAL

    researchmap

  • 小児期ペースメーカー治療―心外膜電極による治療戦略―

    北市隆, 吉田誉, 神原保, 黒部裕嗣, 元木達夫, 浦田将久, 阪田美穂, 井上美紀, 早渕康信, 北川哲也

    日本小児循環器学会雑誌   25 ( 3 )   434 - 434   2009.5

     More details

    Language:Japanese   Publisher:(NPO)日本小児循環器学会  

    J-GLOBAL

    researchmap

  • Heparin Cofactor II is an Independent Protective Factor against Peripheral Arterial Disease in Elderly Subjects with Cardiovascular Risk Factors Reviewed

    AIHARA Ken-ichi, AZUMA Hiroyuki, AKAIKE Masashi, KUROBE Hirotsugu, TAKAMORI Nobuyuki, IKEDA Yasumasa, SUMITOMO Yuka, YOSHIDA Sumiko, YAGI Shusuke, IWASE Takashi, ISHIKAWA Kazue, SATA Masataka, KITAGAWA Tetsuya, MATSUMOTO Toshio

    J Atheroscler Thromb   16 ( 2 )   127 - 134   2009.4

     More details

    Language:English   Publisher:JAPAN ATHEROSCLEROSIS SOC  

    AIM: Heparin cofactor II (HCII) specifically inactivates thrombin action at the injured vascular wall. We have reported that HCII is a protective factor against coronary in-stent restenosis and carotid atherosclerosis; however, it is unclear whether there is any correlation between plasma HCII levels and the development of peripheral arterial disease (PAD). METHODS: Plasma HCII activity and the ankle brachial pressure index (ABI) were determined in 494 elderly subjects with cardiovascular risk factors. PAD was diagnosed by ABI below 0.9, and 62 subjects were diagnosed with PAD. The relationship between factors that affect cardiovascular events and the prevalence of PAD was statistically evaluated. RESULTS: Mean HCII activity in PAD subjects was significantly lower than in non-PAD subjects (87.5+/-19.7% v.s. 94.6+/-17.8%, p=0.009). Multivariate logistic regression analysis showed that age (odds ratio [OR]: 1.062, p=0.0016), current smoking (OR 3.028, p=0.002) and diabetes mellitus (OR 2.656, p=0.008) were independent and progressive determinants of PAD. In contrast, HCII was an independent inhibitory factor of PAD (OR: 0.982, p=0.048). CONCLUSIONS: Plasma HCII activity is inversely related to the prevalence of PAD. HCII may function as the sole protective factor against PAD in elderly people with cardiovascular risk factors.

    DOI: 10.5551/jat.E695

    Web of Science

    PubMed

    CiNii Books

    researchmap

  • 大動脈炎症候群の治療と問題点について

    元木 達夫, 浦田 将久, 黒部 裕嗣, 吉田 誉, 神原 保, 北市 隆, 北川 哲也

    日本血管外科学会雑誌   18 ( 2 )   367 - 367   2009.4

     More details

    Language:Japanese   Publisher:(NPO)日本血管外科学会  

    researchmap

  • 既製品のステントグラフト導入前後の開腹腹部大動脈瘤手術症例の検討

    神原 保, 北市 隆, 浦田 将久, 元木 達夫, 黒部 裕嗣, 吉田 誉, 藤本 鋭貴, 筑後 文雄, 北川 哲也

    日本血管外科学会雑誌   18 ( 2 )   325 - 325   2009.4

     More details

    Language:Japanese   Publisher:(NPO)日本血管外科学会  

    researchmap

  • 生体間腎移植後患者に併発したCrawford 3型胸腹部大動脈瘤に対する治療経験

    黒部 裕嗣, 堀 隆樹, 中山 泰介, 米沢 数馬, 石戸谷 浩, 藤方 史朗, 岡本 賢二郎, 北川 哲也

    日本血管外科学会雑誌   18 ( 2 )   309 - 309   2009.4

     More details

    Language:Japanese   Publisher:(NPO)日本血管外科学会  

    researchmap

  • 血管奇形の治療戦略 巨大動静脈奇形に対する治療戦略

    北市 隆, 神原 保, 吉田 誉, 黒部 裕嗣, 元木 達夫, 浦田 将久, 北川 哲也

    日本血管外科学会雑誌   18 ( 2 )   189 - 189   2009.4

     More details

    Language:Japanese   Publisher:(NPO)日本血管外科学会  

    researchmap

  • 治療戦略に苦慮した小児感染性心内膜炎

    元木達夫, 吉田誉, 神原保, 黒部裕嗣, 北市隆, 浦田将久, 阪田美穂, 井上美紀, 早渕康信, 北川哲也

    Circ J   73 ( Suppl.II )   999 - 999   2009.4

     More details

    Language:Japanese   Publisher:(一社)日本循環器学会  

    J-GLOBAL

    researchmap

  • DPE-065 A Combination of Erythropoietin Administration with Autologous Blood Donation for Therapeutic Angiogenesis(DPE11,Kidney/Renal Circulation/CKD (H),Digital Poster Session (English),The 73rd Annual Scientific Meeting of The Japanese Circulation Society)

    Iwase Takashi, Kurobe Hirotsugu, Akaike Masashi, Nakano Shunji, Yoshida Sumiko, Sumitomo Yuka, Yagi Shusuke, Aihara Kenichi, Ozaki Shuji, Abe Masahiro, Yasui Natsuo, Matsumoto Toshio, Kitagawa Tetsuya, Sata Masataka

    Circulation journal : official journal of the Japanese Circulation Society   73 ( 0 )   372 - 372   2009.3

     More details

    Language:English   Publisher:Japanese Circulation Society  

    CiNii Books

    researchmap

  • 虚血肢に対するエリスロポエチン誘導自己末梢血単核球移植治療の有用性

    神原 保, 黒部 裕嗣, 浦田 将久, 元木 達夫, 吉田 誉, 北市 隆, 安倍 正博, 岩瀬 俊, 赤池 雅史, 佐田 政隆, 松本 俊夫, 北川 哲也

    日本心臓血管外科学会雑誌   38 ( Suppl. )   317 - 317   2009.3

     More details

    Language:Japanese   Publisher:(NPO)日本心臓血管外科学会  

    researchmap

  • 動脈硬化の病態進展におけるT細胞のHIF-1αの役割

    冨田 修平, 黒部 裕嗣, 浦田 将久, 福原 弥生, 石澤 有紀, 神原 保, 石澤 啓介, 土屋 浩一郎, 北川 哲也, 吉栖 正典, 玉置 俊晃

    日本薬理学雑誌   133 ( 3 )   25P - 25P   2009.3

     More details

    Language:Japanese   Publisher:(公社)日本薬理学会  

    researchmap

  • 成長,発達の観点からみたファロー四徴症に対する乳児期根治術の治療成績

    北市隆, 吉田誉, 神原保, 黒部裕嗣, 元木達夫, 浦田将久, 阪田美穂, 井上美紀, 早渕康信, 北川哲也

    日本心臓血管外科学会雑誌   38 ( Suppl. )   421 - 421   2009.3

     More details

    Language:Japanese   Publisher:(NPO)日本心臓血管外科学会  

    J-GLOBAL

    researchmap

  • 開心術後早期抜管による患者予後と医療コストの有用性

    黒部 裕嗣, 堀 隆樹, 中山 泰介, 米沢 数馬, 石戸谷 浩, 北川 哲也

    日本心臓血管外科学会雑誌   38 ( Suppl. )   436 - 436   2009.3

     More details

    Language:Japanese   Publisher:(NPO)日本心臓血管外科学会  

    researchmap

  • 肺高血圧症モデルマウスにおける血管内皮細胞の低酸素応答転写因子(HIF1-β)の役割

    浦田 将久, 福原 弥生, 冨田 修平, 吉田 誉, 北市 隆, 神原 保, 黒部 裕嗣, 元木 達夫, 玉置 俊晃, 北川 哲也

    日本心臓血管外科学会雑誌   38 ( Suppl. )   413 - 413   2009.3

     More details

    Language:Japanese   Publisher:(NPO)日本心臓血管外科学会  

    researchmap

  • SF-097-4 当院におけるエリスロポイエチン誘導自己末梢幹細胞移植治療の検討(末梢血管1,サージカルフォーラム,第109回日本外科学会定期学術集会)

    神原 保, 黒部 裕嗣, 浦田 将久, 元木 達夫, 吉田 誉, 北市 隆, 安倍 正博, 岩瀬 俊, 赤池 雅史, 佐田 政隆, 松本 俊夫, 北川 哲也

    日本外科学会雑誌   110 ( 2 )   345 - 345   2009.2

     More details

    Language:Japanese   Publisher:一般社団法人日本外科学会  

    CiNii Books

    researchmap

  • HP-116-4 Fontan術後に動脈血酸素飽和度低下を来す因子の検討(心臓・先天性疾患,ハイブリッドポスター,第109回日本外科学会定期学術集会)

    北市 隆, 神原 保, 吉田 誉, 黒部 裕嗣, 元木 達夫, 浦田 将久, 阪田 美穂, 井上 美紀, 早渕 康信, 北川 哲也

    日本外科学会雑誌   110 ( 2 )   594 - 594   2009.2

     More details

    Language:Japanese   Publisher:一般社団法人日本外科学会  

    CiNii Books

    researchmap

  • 肺高血圧症モデルマウスにおける血管内皮細胞の低酸素応答転写因子(HIF1-β)の役割

    浦田 将久, 冨田 修平, 福原 弥生, 宮本 直輝, 黒部 裕嗣, 吉田 誉, 石澤 啓介, 土屋 浩一郎, 北川 哲也, 玉置 俊晃

    血管   32 ( 1 )   23 - 23   2009.1

     More details

    Language:Japanese   Publisher:日本心脈管作動物質学会  

    researchmap

  • Renal Transplantation in a Patient with Uremic Cardiomyopathy Resulting in Marked Improvement of Cardiac Function

    Nakayama Taisuke, Kurobe Hirotsugu, Hori Takaki, Maisawa Kazuma, Ishitoya Hiroshi, Sogabe Hitoshi, Katoh Itsuo, Kitagawa Tetsuya

    Japanese Journal of Cardiovascular Surgery   38 ( 2 )   160 - 164   2009

     More details

    Language:Japanese   Publisher:The Japanese Society for Cardiovascular Surgery  

    A 71-year-old man who had been on peritoneal dialysis for 6 years was referred to our hospital for renal transplantation from a living donor. Preoperative echocardiography revealed diffuse severe hypokinesis, a left ventricular ejection fraction (LVEF) of 25%, and a pedicled floating mass in the right atrium. He had not exhibited positive symptoms of active endocarditis or metastatic malignant tumor, and the causes of cardiomyopathy seemed to be uremic and/or ischemic factors. Renal transplantation was postponed, and the extirpation of the mass in the right atrium was scheduled. LVEF improved to 48% 2 months following the induction of hemodialysis before the cardiac operation. Pathohistological findings of the extirpated intra-atrial mass showed sphachelus and fibrotic thrombus, which meant asymptomatic healed infective endocarditis. He recovered uneventfully, and underwent a living renal transplantation from living donor 5 months after the cardiac operation. LVEF further improved better to 56%, and his performance status was remarkably improved. These results imply that renal transplantation and hemodialysis in peritoneal dialysis patients with uremic cardiomyopathy can achive improvement of cardiac function and enable a safe cardiac operation.

    DOI: 10.4326/jjcvs.38.160

    researchmap

  • 大動脈瘤に対する低侵襲ステントグラフト内挿術について

    木下 肇, 北市 隆, 元木 達夫, 吉田 誉, 浦田 将久, 黒部 裕嗣, 神原 保, 北川 哲也, 藤本 鋭貴, 筑後 文雄

    四国医学雑誌   64 ( 5-6 )   271 - 271   2008.12

     More details

    Language:Japanese   Publisher:徳島医学会  

    researchmap

  • 195) 慢性腎不全管理の変更により心機能の改善を認めた慢性期感染性心内膜炎の1手術例(第92回日本循環器学会中国・四国合同地方会)

    堀 隆樹, 黒部 裕嗣, 石戸 谷浩, 米沢 数馬, 旗 厚, 中井 康成, 高野 信二, 長嶋 光樹

    Circulation journal : official journal of the Japanese Circulation Society   72 ( 0 )   1050 - 1050   2008.10

     More details

    Language:Japanese   Publisher:社団法人日本循環器学会  

    CiNii Books

    researchmap

  • 65) 大動脈弁二尖弁症に併発した上行大動脈瘤に対する手術経験(第92回日本循環器学会中国・四国合同地方会)

    黒部 裕嗣, 米沢 数馬, 石戸 谷浩, 前田 智治, 堀 隆樹

    Circulation journal : official journal of the Japanese Circulation Society   72 ( 0 )   1036 - 1036   2008.10

     More details

    Language:Japanese   Publisher:社団法人日本循環器学会  

    CiNii Books

    researchmap

  • 164) 活動期感染性心内膜炎による三尖弁病変に対する外科治療(第92回日本循環器学会中国・四国合同地方会)

    元木 達夫, 吉田 誉, 浦田 将久, 黒部 裕嗣, 神原 保, 北市 隆, 北川 哲也

    Circulation journal : official journal of the Japanese Circulation Society   72 ( 0 )   1047 - 1047   2008.10

     More details

    Language:Japanese   Publisher:社団法人日本循環器学会  

    CiNii Books

    researchmap

  • Erythropoietin Administration with Autologous Blood Donation - A Novel Strategy to Enhance Mobilization of Circulating Progenitor Cells Reviewed

    Takashi Iwase, Hirotsugu Kurobe, Masashi Akaike, Shunil Nakano, Sumiko Yoshida, Yuka Sumitomo, Shusuke Yagi, Kenchi Aihara, Shuji Ozaki, Masahiro Abe, Natsuo Yasui, Toshio Matsumoto, Masataka Safe

    CIRCULATION   118 ( 18 )   S635 - S635   2008.10

     More details

    Language:English   Publishing type:Research paper, summary (international conference)   Publisher:LIPPINCOTT WILLIAMS & WILKINS  

    Web of Science

    researchmap

  • 新生児期・乳児期早期の心臓手術に伴う胸腺摘除が免疫能に及ぼす影響

    黒部裕嗣, 富永崇司, 元木達夫, 吉田誉, 神原保, 北市隆, 菅野幹雄, 早渕康信, 浦田将久, 川人智久, 長嶋光樹, 江川善康, 高浜洋介, 北川哲也

    Gen Thorac Cardiovasc Surg   56 ( Supplement )   365   2008.9

     More details

  • 乳児期早期のsymptomatic TOFの外科治療―PA with VSD,MAPCAs例も含めて

    北市隆, 吉田誉, 神原保, 黒部裕嗣, 元木達夫, 浦田将久, 阪田美穂, 井上美紀, 早渕康信, 北川哲也

    Gen Thorac Cardiovasc Surg   56 ( Supplement )   237   2008.9

     More details

    Language:Japanese  

    J-GLOBAL

    researchmap

  • Two Cases of Cardiac Surgery for Neonates with Transient Abnormal Myelopoiesis and Down Syndrome

    NAGASHIMA Mitsugi, HIBINO Narutoshi, TAKANO Shinji, HORI Takaki, ISHITOYA Hiroshi, KUROBE Hirotsugu, MAISAWA Kazuma, YAMAMOTO Eiichi, OHTA Masaaki, OHTOH Yoshiko, HIGAKI Takashi

    日本小児循環器学会雑誌 = Acta cardiologica paediatrica Japonica   24 ( 5 )   636 - 639   2008.9

     More details

    Language:Japanese  

    CiNii Books

    researchmap

  • 肺高血圧症モデルマウスにおける血管内皮細胞の低酸素応答転写因子(HIF1-β)の役割

    浦田 将久, 冨田 修平, 黒部 裕嗣, 吉田 誉, 石澤 啓介, Gonzalez Frank, 北川 哲也, 玉置 俊晃

    Inflammation and Regeneration   28 ( 4 )   371 - 371   2008.7

     More details

    Language:Japanese   Publisher:(一社)日本炎症・再生医学会  

    researchmap

  • 腹部大動脈瘤術後、尿路敗血症を発症した1例

    一色 真吾, 平谷 勝彦, 米沢 数馬, 黒部 裕嗣, 高野 信二, 石戸谷 浩, 堀 隆樹, 長嶋 光樹

    愛媛医学   27 ( 2 )   146 - 146   2008.6

     More details

    Language:Japanese   Publisher:愛媛医学会  

    researchmap

  • 経静脈的な同種骨髄単核球細胞移植のmonocrotaline誘発肺高血圧に対する肺血管床改善効果

    吉田 誉, 北市 隆, 浦田 将久, 神原 保, 黒部 裕嗣, 加納 正志, 元木 達夫, 北川 哲也

    日本小児循環器学会雑誌   24 ( 3 )   400 - 400   2008.5

     More details

    Language:Japanese   Publisher:(NPO)日本小児循環器学会  

    researchmap

  • さまざまなPLE発症要因と治療―Fontan術後PLE治療指針解明のために

    吉田誉, 北市隆, 加納正志, 神原保, 黒部裕嗣, 元木達夫, 浦田将久, 早渕康信, 井上美紀, 北川哲也

    日本小児循環器学会雑誌   24 ( 3 )   423 - 423   2008.5

     More details

    Language:Japanese   Publisher:(NPO)日本小児循環器学会  

    J-GLOBAL

    researchmap

  • MAPCAsを伴う乳児期複雑心疾患に対する外科治療の問題点

    北市隆, 吉田誉, 加納正志, 神原保, 黒部裕嗣, 元木達夫, 浦田将久, 早渕康信, 井上美紀, 北川哲也

    日本小児循環器学会雑誌   24 ( 3 )   338 - 338   2008.5

     More details

    Language:Japanese   Publisher:(NPO)日本小児循環器学会  

    J-GLOBAL

    researchmap

  • 55) 冠動脈-肺動脈ろうに発生した巨大仮性動脈留の一治験例(第91回日本循環器学会四国地方会)

    堀 隆樹, 黒部 裕嗣, 松中 豪, 石戸谷 浩, 米沢 数馬, 旗 厚, 高野 信二, 長嶋 光樹, 平谷 勝彦, 一色 真吾

    Circulation journal : official journal of the Japanese Circulation Society   72 ( 0 )   912 - 912   2008.4

     More details

    Language:Japanese   Publisher:社団法人日本循環器学会  

    CiNii Books

    researchmap

  • 84) 大動脈弁瘤を呈した感染性心内膜炎の一例(第91回日本循環器学会四国地方会)

    高木 弥栄美, 中村 陽一, 南立 秀幸, 佐々木 康浩, 西山 明子, 泉 直樹, 川田 好高, 羽原 宏和, 松中 豪, 垣下 幹夫, 鈴木 誠, 風谷 幸男, 堀 隆樹, 黒部 裕嗣

    Circulation journal : official journal of the Japanese Circulation Society   72 ( 0 )   915 - 915   2008.4

     More details

    Language:Japanese   Publisher:社団法人日本循環器学会  

    CiNii Books

    researchmap

  • 65) 右室梗塞を合併した急性大動脈解離に対しBentall手術,弓部置換術,冠動脈バイパス術を施行した1例(第91回日本循環器学会四国地方会)

    米沢 数馬, 石戸谷 浩, 黒部 裕嗣, 堀 隆樹, 一色 真吾, 高野 信二, 平谷 勝彦, 長嶋 光樹

    Circulation journal : official journal of the Japanese Circulation Society   72 ( 0 )   913 - 913   2008.4

     More details

    Language:Japanese   Publisher:社団法人日本循環器学会  

    CiNii Books

    researchmap

  • FRS-026 HIF-1α in T cells pathway plays a crucial role in the progression of arteriosclerosis(Novel Mechanisms in Atherosclerosis (IHD),Featured Research Session,The 72nd Annual Scientific Meeting of the Japanese Circulation Society)

    Kurobe Hirotsugu, Urata Masahisa, Ishizawa Yuki, Fukuhara Yayoi, Kanbara Tamotsu, Aihara Kenichi, Akaike Masashi, Frank Gonzalez, Matsumoto Toshio, Tamaki Toshiaki, Matsumoto Toshio, Kitagawa Tetsuya, Yoshizumi Masanori, Tomita Shuhei

    Circulation journal : official journal of the Japanese Circulation Society   72 ( 0 )   148 - 148   2008.3

     More details

    Language:English   Publisher:Japanese Circulation Society  

    CiNii Books

    researchmap

  • 右室梗塞を合併した急性解離性大動脈瘤に対しBentall,CABG、弓部置換術を施行し救命しえた一例

    米沢 数馬, 石戸谷 浩, 黒部 裕嗣, 堀 隆樹, 一色 真吾, 平谷 勝彦, 高野 信二, 長嶋 光樹

    日本血管外科学会雑誌   17 ( 2 )   408 - 408   2008.3

     More details

    Language:Japanese   Publisher:(NPO)日本血管外科学会  

    researchmap

  • 術前より臓器灌流障害を合併する急性A型大動脈解離の検討

    石戸谷 浩, 米沢 数馬, 黒部 裕嗣, 堀 隆樹, 一色 真吾, 平谷 勝彦, 高野 信二, 長嶋 光樹

    日本血管外科学会雑誌   17 ( 2 )   324 - 324   2008.3

     More details

    Language:Japanese   Publisher:(NPO)日本血管外科学会  

    researchmap

  • 腹部大動脈瘤術後、尿路敗血症を発症した一例

    一色 真吾, 平谷 勝彦, 米沢 数馬, 黒部 裕嗣, 高野 信二, 石戸谷 浩, 堀 隆樹, 長嶋 光樹

    日本血管外科学会雑誌   17 ( 2 )   426 - 426   2008.3

     More details

    Language:Japanese   Publisher:(NPO)日本血管外科学会  

    researchmap

  • A型大動脈解離術後の遠隔期再手術適応症例の検討

    堀 隆樹, 黒部 裕嗣, 旗 厚, 石戸谷 浩, 米沢 数馬, 平谷 勝彦, 一色 真吾, 高野 信二, 長嶋 光樹

    日本血管外科学会雑誌   17 ( 2 )   410 - 410   2008.3

     More details

    Language:Japanese   Publisher:(NPO)日本血管外科学会  

    researchmap

  • 小児開心術後デクスメデトミジンの血行動態、鎮静効果への影響の検討

    長嶋 光樹, 高野 信二, 米沢 数馬, 黒部 裕嗣, 石戸谷 浩, 堀 隆樹, 一色 真吾, 平谷 勝彦

    日本心臓血管外科学会雑誌   37 ( Suppl. )   391 - 391   2008.1

     More details

    Language:Japanese   Publisher:(NPO)日本心臓血管外科学会  

    researchmap

  • 周術期管理におけるナロキソンの有用性

    黒部 裕嗣, 米沢 数馬, 石戸谷 浩, 高野 信二, 長嶋 光樹, 堀 隆樹

    日本心臓血管外科学会雑誌   37 ( Suppl. )   304 - 304   2008.1

     More details

    Language:Japanese   Publisher:(NPO)日本心臓血管外科学会  

    researchmap

  • 大動脈弁瘤を呈した感染性心内膜炎の1例

    高木 弥栄美, 中村 陽一, 南立 秀幸, 佐々木 康浩, 泉 直樹, 西山 明子, 川田 好高, 羽原 宏和, 松中 豪, 垣下 幹夫, 鈴木 誠, 風谷 幸男, 堀 隆樹, 黒部 裕嗣

    超音波医学   35 ( 1 )   87 - 87   2008.1

     More details

    Language:Japanese   Publisher:(公社)日本超音波医学会  

    researchmap

  • 12. 胸部大動脈瘤術後の気管狭窄に対して,デュモンステントおよびウルトラフレックスステントの両者を挿入し,人工呼吸器から離脱可能となった1例(第16回日本呼吸器内視鏡学会中国四国支部会)

    塩尻 正明, 岡田 昌浩, 森高 智典, 橋本 明子, 難波 千佳, 井上 孝司, 中西 徳彦, 上田 暢男, 堀 隆樹, 黒部 裕嗣

    気管支学   30 ( 3 )   159 - 159   2008

     More details

    Language:Japanese   Publisher:特定非営利活動法人 日本呼吸器内視鏡学会  

    DOI: 10.18907/jjsre.30.3_159_1

    researchmap

  • 永久気管孔を有する上行弓部大動脈瘤に対する両側第4肋間開胸による上行弓部人工血管置換術を行った1治験例

    堀 隆樹, 黒部 裕嗣, 米沢 数馬, 石戸谷 浩, 旗 厚, 高野 信二, 長嶋 光樹, 一色 真吾, 平谷 勝彦

    日本血管外科学会雑誌   16 ( 7 )   831 - 831   2007.12

     More details

    Language:Japanese   Publisher:(NPO)日本血管外科学会  

    researchmap

  • 下肢の亜急性動脈閉塞症に対し、血栓除去術を行った3例の検討

    一色 真吾, 平谷 勝彦, 黒部 裕嗣, 米沢 数馬, 石戸谷 浩, 旗 厚, 高野 信二, 堀 隆樹, 長嶋 光樹

    日本血管外科学会雑誌   16 ( 7 )   833 - 833   2007.12

     More details

    Language:Japanese   Publisher:(NPO)日本血管外科学会  

    researchmap

  • 184)低心機能の虚血性心筋症患者に合併した僧帽弁閉鎖不全に対する心拍動下僧帽弁形成術を施行した1例(第90回日本循環器学会中国・四国合同地方会)

    米沢 数馬, 黒部 裕嗣, 高野 信二, 石戸谷 浩, 堀 隆樹, 長嶋 光樹, 佐藤 晴瑞

    Circulation journal : official journal of the Japanese Circulation Society   71 ( 0 )   977 - 977   2007.10

     More details

    Language:Japanese   Publisher:社団法人日本循環器学会  

    CiNii Books

    researchmap

  • 心房中隔膜様部に腫瘍を認めた感染性心内膜炎の一例

    森 あい子, 佐伯 秀幸, 泉 直樹, 西山 明子, 松中 豪, 羽原 宏和, 垣下 幹夫, 平松 伸一, 中村 陽一, 鈴木 誠, 風谷 幸男, 黒部 裕嗣, 米沢 数馬, 石戸谷 浩, 堀 隆樹, 長嶋 光樹

    Circulation Journal   71 ( Suppl.III )   970 - 970   2007.10

     More details

    Language:Japanese   Publisher:(一社)日本循環器学会  

    researchmap

  • Hif-1 alpha in T cells pathway plays a crucial role in the progression of arteriosclerosis and artery intimal thickening Reviewed

    Hirotsugu Kurobe, Masahisa Urata, Yuki Izawa, Yayoi Fukuhara, Tamotsu Kanbara, Kenichi Aihara, Masashi Akaike, Frank Gonzalez, Toshio Matsumoto, Toshiaki Tamaki, Tetsuya Kitagawa, Masanori Yoshizumi, Shuhei Tomita

    CIRCULATION   116 ( 16 )   246 - 246   2007.10

     More details

    Language:English   Publishing type:Research paper, summary (international conference)   Publisher:LIPPINCOTT WILLIAMS & WILKINS  

    Web of Science

    researchmap

  • 乳児期早期心臓・大血管手術時の胸腺摘除が免疫機能に及ぼす影響

    黒部裕嗣, 富永崇司, 来島敦史, 北市隆, 早渕康信, 長嶋光樹, 冨田修平, 江川善康, 高浜洋介, 北川哲也

    Gen Thorac Cardiovasc Surg   55 ( Supplement )   248   2007.9

     More details

    Language:Japanese  

    J-GLOBAL

    researchmap

  • 心室中隔欠損症を伴う右室流出路狭窄病変疾患群に対する外科治療

    高野 信二, 長嶋 光樹, 一色 真吾, 米沢 数馬, 黒部 裕嗣, 石戸谷 浩, 籏 厚, 堀 隆樹, 平谷 勝彦

    日本小児科学会雑誌   111 ( 9 )   1218 - 1218   2007.9

     More details

    Language:Japanese   Publisher:(公社)日本小児科学会  

    researchmap

  • 心房中隔膜様部に膿瘍を認めた感染性心内膜炎の一例

    森 あい子, 佐伯 秀幸, 泉 直樹, 西山 明子, 松中 豪, 羽原 宏和, 垣下 幹夫, 平松 伸一, 中村 陽一, 鈴木 誠, 風谷 幸男, 黒部 裕嗣, 米沢 数馬, 石戸谷 浩, 堀 隆樹, 長嶋 光樹

    Journal of Cardiology   50 ( Suppl.I )   264 - 264   2007.8

     More details

    Language:Japanese   Publisher:(一社)日本心臓病学会  

    researchmap

  • HIF-1 signaling pathway plays a crucial role in the progression of atherosclerosis

    H. Kurobe, M. Urata, Y. Izawa, Y. Fukuhara, T. Kanbara, K. Aihara, T. Tamaki, T. Matsumoto, T. Kitagawa, M. Yoshizumi, S. Tomita

    ATHEROSCLEROSIS SUPPLEMENTS   8 ( 1 )   216 - 216   2007.6

     More details

    Language:English   Publishing type:Research paper, summary (international conference)   Publisher:ELSEVIER IRELAND LTD  

    Web of Science

    researchmap

  • Significance of Peritoneal Fluid Drainage in Management After Repair of Complex Heart Defects in Infancy : Cytokine Dynamics In Vivo

    KUROBE Hirotsugu, KITAICHI Takashi, SHIMAHARA Yusuke, KANEMURA Takeyuki, KANBARA Tamotsu, KURUSHIMA Atsushi, KANO Masashi, HORI Takaki, YOSHIDA Homare, URATA Masahiro, KITAGAWA Tetsuya

    Circulation Journal   71 ( 6 )   941 - 947   2007.5

     More details

    Language:English   Publisher:Japanese Circulation Society  

    <b>Background</b> In vivo redundancy of pro-inflammatory cytokines results in a vicious cycle of systemic inflammatory response syndrome and low cardiac output syndrome (LOS). The purpose of this study was to elucidate the influence of peritoneal fluid (PF) drainage on cytokine dynamics in vivo and the significance of early induction for infants with LOS. <b>Methods and Results</b> Seven infants, who underwent early PF drainage to manage LOS after repair of complex heart defects under cardiopulmonary bypass, were enrolled. The serum and PF levels of the pro- and antiinflammatory cytokines, interleukin (IL)-6, -8, -10 and tumor necrosis factor (TNF)-&alpha;, were measured during the perioperative period. Clinical outcomes were observed simultaneously. There were no cases of early or late death, or infectious complications. Drainage volume of PF peaked just after operation, and decreased completely. The amount of proinflammatory cytokines in the PF increased for 3 days after operation. Of the proinflammatory cytokines in the PF IL-6 increased the earliest and cleared the fastest. The amount of cleared IL-8 and TNF-&alpha; peaked on the 3rd postoperative day and resembled the course of C-reactive protein (CRP). Serum levels of CRP and proinflammatory cytokines in patients with PF drainage decreased significantly more than those without PF drainage. <b>Conclusions</b> Early initiation of PF drainage is useful in the postoperative critical care of infants with LOS by improving cytokine dynamics in vivo, although there are differences between the severity of patients undergoing PF drainage and those who do not. (<i>Circ J</i> 2007; <b>71:</b> 941 - 947)<br>

    DOI: 10.1253/circj.71.941

    Web of Science

    CiNii Books

    researchmap

  • 53)ショック状態のため,搬送途中の病院にてPCPS装着,救命し得た血栓弁の1例(第89回日本循環器学会四国地方会)

    久米 悠太, 石戸谷 浩, 堀 隆樹, 長嶋 光樹, 平谷 勝彦, 黒部 裕嗣, 米沢 数馬, 一色 真吾, 佐藤 晴瑞

    Circulation journal : official journal of the Japanese Circulation Society   71 ( 0 )   883 - 883   2007.4

     More details

    Language:Japanese   Publisher:社団法人日本循環器学会  

    CiNii Books

    researchmap

  • 52)術後20年目に発症した大動脈血栓弁(B-S弁)の1手術症例(第89回日本循環器学会四国地方会)

    黒部 裕嗣, 山本 恵子, 堀 隆樹, 石戸谷 浩, 長嶋 光樹, 米沢 数馬, 一色 真吾, 平谷 勝彦, 佐藤 晴瑞

    Circulation journal : official journal of the Japanese Circulation Society   71 ( 0 )   883 - 883   2007.4

     More details

    Language:Japanese   Publisher:社団法人日本循環器学会  

    CiNii Books

    researchmap

  • 88)B型大動脈解離破裂術後吻合部動脈瘤に対しオープンステントを併用した弓部下行大動脈置換術を行った一例(第89回日本循環器学会四国地方会)

    堀 隆樹, 長嶋 光樹, 石戸谷 浩, 日比野 成俊, 黒部 裕嗣, 米沢 数馬, 清家 愛幹, 久米 悠太, 平谷 勝彦, 一色 真吾, 佐藤 晴瑞

    Circulation journal : official journal of the Japanese Circulation Society   71 ( 0 )   887 - 887   2007.4

     More details

    Language:Japanese   Publisher:社団法人日本循環器学会  

    CiNii Books

    researchmap

  • 腹部大動脈intimal sarcomaの1例

    一色 真吾, 平谷 勝彦, 米沢 数馬, 黒部 裕嗣, 石戸谷 浩, 堀 隆樹

    日本血管外科学会雑誌   16 ( 2 )   532 - 532   2007.4

     More details

    Language:Japanese   Publisher:(NPO)日本血管外科学会  

    researchmap

  • 遠位弓部から胸部下行大動脈瘤に対する外科的ステントグラフト留置術の工夫

    米沢 数馬, 堀 隆樹, 石戸谷 浩, 平谷 勝彦, 黒部 裕嗣, 一色 真吾

    日本血管外科学会雑誌   16 ( 2 )   300 - 300   2007.4

     More details

    Language:Japanese   Publisher:(NPO)日本血管外科学会  

    researchmap

  • 大動脈縮窄症および離断症を合併した先天性心疾患に対する外科治療成績

    長嶋 光樹, 堀 隆樹, 石戸谷 浩, 黒部 裕嗣, 米沢 数馬, 平谷 勝彦, 一色 真吾, 佐藤 晴瑞

    日本小児科学会雑誌   111 ( 4 )   632 - 632   2007.4

     More details

    Language:Japanese   Publisher:(公社)日本小児科学会  

    researchmap

  • PE-570 Therapeutic Angiogenesis by Transplantation of Atologous Peripheral-blood Mononuclear Cells Mobilized by Human Recombinant Erythropoietin in Patients with Severe Limb Ischemia(Regeneration (angiogenesis/myocardial regeneration)-4, The 71st Annual Scientific Meeting of the Japanese Circulation Society)

    Iwase Takashi, Kurobe Hirotsugu, Akaike Masashi, Yagi Shusuke, Sumitomo Yuka, Ikeda Yasumasa, Aihara Kenichi, Masuda Yutaka, Azuma Hiroyuki, Matsumoto Toshio, Kitagawa Tetsuya

    Circulation journal : official journal of the Japanese Circulation Society   71 ( 0 )   466 - 466   2007.3

     More details

    Language:English   Publisher:Japanese Circulation Society  

    CiNii Books

    researchmap

  • A successful transatrial repair in redo surgery of postinfarction inferoposterior ventricular septal rupture. Reviewed

    Takashi Tominaga, Hirotsugu Kurobe, Tamotsu Kanbara, Takeyuki Kanemura, Takashi Kitaichi, Tetsuya Kitagawa

    The journal of medical investigation : JMI   54 ( 1-2 )   184 - 6   2007.2

     More details

    Language:English   Publisher:The University of Tokushima  

    A successful transatrial repair in redo surgery of postinfarction posterior ventricular septal rupture (VSR) was performed after an infarct exclusion technique through left ventriculotomy incision of the infarcted area. For the infarct lesion, this approach provides excellent results with sufficient closure of the VSR and prevention of the ventricular remodeling for five years. A right atrial approach for postinfarction posterior VSR is very useful for avoiding any further ventriculotomy in an already impaired ventricle, securing a stable suture, and preserving the left ventricular geometry and function.

    DOI: 10.2152/jmi.54.184

    PubMed

    researchmap

  • 脱細胞化肺動脈弁再細胞化の検討 ミニブタ移植モデルでの検討

    来島 敦史, 増田 裕, 北市 隆, 加納 正志, 吉田 誉, 黒部 裕嗣, 浦田 将久, 北川 哲也, 川人 伸次

    日本心臓血管外科学会雑誌   36 ( Suppl. )   236 - 236   2007.1

     More details

    Language:Japanese   Publisher:(NPO)日本心臓血管外科学会  

    researchmap

  • 周術期管理におけるシベレスタットの有用性

    黒部 裕嗣, 富永 崇司, 神原 保, 元木 達夫, 菅野 幹夫, 来島 敦, 北市 隆, 増田 裕, 堀 隆樹, 北川 哲也

    日本心臓血管外科学会雑誌   36 ( Suppl. )   230 - 230   2007.1

     More details

    Language:Japanese   Publisher:(NPO)日本心臓血管外科学会  

    researchmap

  • 虚血肢に対するエリスロポイエチン誘導自己末梢幹細胞移植治療の検討

    増田 裕, 黒部 裕嗣, 北市 隆, 加納 正志, 来島 敦史, 吉田 誉, 浦田 将久, 北川 哲也, 赤池 雅史, 岩瀬 俊, 安倍 正博, 松本 俊夫, 瀧脇 弘嗣

    日本心臓血管外科学会雑誌   36 ( Suppl. )   272 - 272   2007.1

     More details

    Language:Japanese   Publisher:(NPO)日本心臓血管外科学会  

    researchmap

  • 33)カテーテル後止血デバイスに合併した大腿動脈感染性仮性瘤の2例(第88回日本循環器学会中国・四国合同地方会)

    来島 敦史, 浦田 将久, 黒部 裕嗣, 吉田 誉, 加納 正志, 北市 隆, 増田 裕, 北川 哲也

    Circulation journal : official journal of the Japanese Circulation Society   70 ( 0 )   1152 - 1152   2006.10

     More details

    Language:Japanese   Publisher:社団法人日本循環器学会  

    CiNii Books

    researchmap

  • 白血病類似疾患を合併するDown症候群に対する心臓手術2例

    長嶋 光樹, 日比野 成俊, 堀 隆樹, 石戸谷 浩, 黒部 裕嗣, 門脇 輔, 佐藤 晴瑞, 山本 英一, 大藤 佳子, 藤澤 由樹

    日本小児科学会雑誌   110 ( 9 )   1306 - 1306   2006.9

     More details

    Language:Japanese   Publisher:(公社)日本小児科学会  

    researchmap

  • Peripheral blood-derived mononuclear cell implantation for therapeutic angiogenesis in patients with peripheral arterial disease

    Shikoku acta medica   62 ( 3 )   137 - 141   2006.8

     More details

    Language:Japanese  

    Earlier studies have shown that bone marrow-derived mononuclear cell(BM-MNC)implantation induces therapeutic angiogenesis in patients with peripheral arterial disease(PAD). However, the invasiveness of bone marrow collection limits clinical application of BM-MNC implantation.We performed peripheral blood-derived mononuclear cell(PB-MNC)implantation in ischemic limbs of five patients with PAD. After implantation, clinical symptoms such as rest pain and numbness were relieved in four patients. Maximal walking distance markedly increased from 160 m to 915 m in one patient. Non-healing ulcers were cured after repeated cell implantation in one patient with Burger disease. There was no adverse event. These findings suggest that PB-MNC implantation is a safe and noninvasive strategy for therapeutic angiogenesis for the treatment of severe PAD.

    CiNii Books

    researchmap

    Other Link: http://repo.lib.tokushima-u.ac.jp/49311

  • エリスロポエチン併用末梢単核球細胞移植による血管新生療法の試み

    岩瀬 俊, 八木 秀介, 藤村 光則, 赤池 雅史, 安倍 正博, 東 博之, 松本 俊夫, 黒部 裕嗣, 増田 裕, 北川 哲也

    日本動脈硬化学会総会プログラム・抄録集   38回   267 - 267   2006.7

     More details

    Language:Japanese   Publisher:(一社)日本動脈硬化学会  

    researchmap

  • HIF1alpha-arnt transcriptional system of T lymphocytes may regulate the vascular inflammation and remodeling in the arteriosclerosis disease

    H. Kurobe, Y. Isawa, Y. Fukuhara, K. Aihara, M. Akaike, T. Kitagawa, T. Matsumoto, T. Tamaki, S. Tomita, M. Yoshizumi

    ATHEROSCLEROSIS SUPPLEMENTS   7 ( 3 )   235 - 235   2006.6

     More details

    Language:English   Publishing type:Research paper, summary (international conference)   Publisher:ELSEVIER IRELAND LTD  

    Web of Science

    researchmap

  • Plasma heparin cofactor II activity is a predictor for incidence of peripheral arterial disease in patients with cardiovascular risk factors

    K. Aihara, H. Azuma, M. Akaike, H. Kurobe, M. Fujimura, S. Hashizume, Y. Ikeda, S. Yagi, T. Kitagawa, T. Matsumoto

    ATHEROSCLEROSIS SUPPLEMENTS   7 ( 3 )   106 - 106   2006.6

     More details

    Language:English   Publishing type:Research paper, summary (international conference)   Publisher:ELSEVIER IRELAND LTD  

    Web of Science

    researchmap

  • MAPCAsを伴う乳児期PA/VSDに対する外科治療の問題点

    来島 敦史, 北市 隆, 加納 正志, 黒部 裕嗣, 吉田 誉, 浦田 将久, 増田 裕, 鈴木 光二郎, 早淵 康信, 森 一博, 北川 哲也

    日本小児循環器学会雑誌   22 ( 3 )   323 - 323   2006.5

     More details

    Language:Japanese   Publisher:(NPO)日本小児循環器学会  

    researchmap

  • 新生時期胸腺摘除が免疫形成に与える影響

    黒部 裕嗣, 富永 崇司, 来島 敦史, 加納 正志, 北市 隆, 江川 善康, 長嶋 光樹, 増田 裕, 高濱 洋介, 北川 哲也

    日本小児循環器学会雑誌   22 ( 3 )   430 - 430   2006.5

     More details

    Language:Japanese   Publisher:(NPO)日本小児循環器学会  

    researchmap

  • 小児における上室性頻拍に対する外科治療

    北市 隆, 増田 裕, 加納 正志, 来島 敦史, 黒部 裕嗣, 森 一博, 早淵 康信, 鈴木 光二郎, 北川 哲也

    日本小児循環器学会雑誌   22 ( 3 )   360 - 360   2006.5

     More details

    Language:Japanese   Publisher:(NPO)日本小児循環器学会  

    researchmap

  • 243)HITを呈した感染性心内膜炎症例に対しアルガトロバン(スロンノン)を用いた体外循環の一例(第87回日本循環器学会中国・四国合同地方会)

    来島 敦史, 黒部 裕嗣, 加納 正志, 北市 隆, 増田 裕, 北川 哲也, 森 一博, 早渕 康信, 樋口 精一

    Circulation journal : official journal of the Japanese Circulation Society   70 ( 0 )   1078 - 1078   2006.4

     More details

    Language:Japanese   Publisher:社団法人日本循環器学会  

    CiNii Books

    researchmap

  • 大動脈弓部全置換術後のMRSA人工血管感染に対する一治験例

    加納 正志, 黒部 裕嗣, 来島 敦史, 北市 隆, 増田 裕, 北川 哲也

    日本血管外科学会雑誌   15 ( 2 )   361 - 361   2006.4

     More details

    Language:Japanese   Publisher:(NPO)日本血管外科学会  

    researchmap

  • OE-138 Plasma Heparin Cofactor II Activity is Inversely Associated with Prevalence of Peripheral Arterial Disease in Elderly individuals(Peripheral circulation-1 (H) OE23,Oral Presentation (English),The 70th Anniversary Annual Scientific Meeting of the Japanese Circulation Society)

    Aihara Ken-ichi, Azuma Hiroyuki, Akaike Masashi, Kurobe Hirotsugu, Fujimura Mitsunori, Yagi Shusuke, Hashizume Shunji, Ikeda Yasumasa, Iwase Takashi, Takamori Nobuyuki, Kitagawa Tetsuya, Matsumoto Toshio

    Circulation journal : official journal of the Japanese Circulation Society   70 ( 0 )   183 - 183   2006.3

     More details

    Language:English   Publisher:Japanese Circulation Society  

    CiNii Books

    researchmap

  • OJ-211 HIF-ARNT Transcriptional System in T Cells Has a Pivotal Role in Vascular Inflammation and Remodeling(Atherosclerosis, basic-2 (H) OJ36,Oral Presentation (Japanese),The 70th Anniversary Annual Scientific Meeting of the Japanese Circulation Society)

    Kurobe Hirotsugu, Izawa Yuki, Fukuhara Yayoi, Kanbara Tamotsu, Kurushima Atsushi, Aihara Ken-ichi, Akaike Masashi, Kano Masashi, Kitaichi Takashi, Masuda Yutaka, Azuma Hiroyuki, Tamaki Toshiaki, Matsumoto Toshio, Kitagawa Tetsuya, Tomita Shuhei, Yoshizumi Masanori

    Circulation journal : official journal of the Japanese Circulation Society   70 ( 0 )   287 - 287   2006.3

     More details

    Language:English   Publisher:Japanese Circulation Society  

    CiNii Books

    researchmap

  • 【リンパ球の動態とケモカイン・接着分子】胸腺内Tリンパ球の移動制御とケモカイン

    黒部 裕嗣, 上野 智雄, 北川 哲也, 高濱 洋介

    臨床免疫   45 ( 2 )   117 - 122   2006.2

     More details

    Language:Japanese   Publisher:(有)科学評論社  

    researchmap

  • 胸腺内Tリンパ球の異動制御とケモカイン

    黒部裕嗣, 上野智雄, 北川哲也, 高濱洋介

    臨床免疫   45 ( 2 )   165 - 177   2006

     More details

  • Perioperative thyroid storm: a case of urgent coronary artery bypass grafting

    Kano Masashi, Wakatsuki Tetsuzo, Kurobe Hirotsugu, Kurushimal Atsushi, Kitaichi Takashi, Masuda Yutaka, Kitagawa Tetsuya, Yamaguchi Koji, Koshiba Kunihiko, Kawano Tomohito

    Shinzo   38 ( 11 )   1089 - 1092   2006

     More details

    Language:Japanese   Publisher:Japan Heart Foundation  

    DOI: 10.11281/shinzo1969.38.11_1089

    researchmap

  • ステントグラフト留置術(TPEG)の検討

    来島 敦史, 黒部 裕嗣, 加納 正志, 北市 隆, 増田 裕, 北川 哲也

    四国医学雑誌   61 ( 5〜6 )   209 - 210   2005.12

     More details

    Language:Japanese   Publisher:徳島医学会  

    researchmap

  • 右室心尖部切開による乳児期apical muscular VSDsの閉鎖

    来島 敦史, 速水 朋彦, 黒部 裕嗣, 濱本 貴子, 市川 洋一, 神原 保, 北市 隆, 増田 裕, 北川 哲也

    日本小児循環器学会雑誌   21 ( 6 )   699 - 699   2005.11

     More details

    Language:Japanese   Publisher:(NPO)日本小児循環器学会  

    researchmap

  • Chronic contained rupture 2症例の検討(第86回日本循環器学会四国地方会)

    松岡 英子, 北市 隆, 神原 保, 市川 洋一, 黒部 裕嗣, 来島 敦史, 増田 裕, 北川 哲也

    Circulation journal : official journal of the Japanese Circulation Society   69 ( 0 )   939 - 939   2005.10

     More details

    Language:Japanese   Publisher:社団法人日本循環器学会  

    CiNii Books

    researchmap

  • T cell-specific HIF-1alpha-deficient mice, but not ARNT-deficient mice, exhibit exacerbated inflammation and vascular remodeling in response to cuff injury

    H Kurobe, Y Izawa, Y Fukuhara, T Kanbara, K Aihara, M Akaike, H Azuma, T Kitagawa, T Tamaki, T Matsumoto, M Ueno, S Tomita, M Yoshizumi

    CIRCULATION   112 ( 17 )   U73 - U74   2005.10

     More details

    Language:English   Publishing type:Research paper, summary (international conference)   Publisher:LIPPINCOTT WILLIAMS & WILKINS  

    Web of Science

    researchmap

  • ヘパリンコファクターIIは末梢動脈閉塞症に対する独立した防御因子である

    粟飯原 賢一, 東 博之, 赤池 雅史, 黒部 裕嗣, 藤村 光則, 八木 秀介, 橋詰 俊二, 池田 康将, 岩瀬 俊, 北川 哲也, 松本 俊夫

    日本血栓止血学会誌   16 ( 5 )   548 - 548   2005.10

     More details

    Language:Japanese   Publisher:(一社)日本血栓止血学会  

    researchmap

  • 脊髄虚血防止のための周術期管理 胸部下行および胸腹部大動脈瘤手術における対麻痺の危険因子とその対策

    北市 隆, 増田 裕, 神原 保, 市川 洋一, 来島 敦史, 濱本 貴子, 黒部 裕嗣, 速水 朋彦, 北川 哲也

    日本血管外科学会雑誌   14 ( 3 )   339 - 339   2005.6

     More details

    Language:Japanese   Publisher:(NPO)日本血管外科学会  

    researchmap

  • 悪性腫瘍に伴う下大静脈内血栓腫瘍栓の外科的摘出術と術中肺塞栓の予防

    濱本 貴子, 速水 朋彦, 黒部 裕嗣, 来島 敦史, 市川 洋一, 神原 保, 北市 隆, 増田 裕, 北川 哲也

    静脈学   16 ( 3 )   215 - 215   2005.6

     More details

    Language:Japanese   Publisher:日本静脈学会  

    researchmap

  • 当科における非解剖学的バイパス術の検討適応・術式・グラフト開存・生命予後について

    増田 裕, 北市 隆, 神原 保, 市川 洋一, 黒部 裕嗣, 来島 敦史, 速水 朋彦, 濱本 貴子, 北川 哲也

    日本血管外科学会雑誌   14 ( 3 )   481 - 481   2005.6

     More details

    Language:Japanese   Publisher:(NPO)日本血管外科学会  

    researchmap

  • 有茎自己心膜を使用した右室流出露見再建術

    北市 隆, 神原 保, 市川 洋一, 来島 敦史, 濱本 貴子, 黒部 裕嗣, 速水 朋彦, 増田 裕, 森 一博, 枝川 卓二

    日本小児循環器学会雑誌   21 ( 3 )   411 - 411   2005.5

     More details

    Language:Japanese   Publisher:(NPO)日本小児循環器学会  

    researchmap

  • 段階的 Fontan 手術における心室形態と体心室ジオメトリー変化の検討(第105回日本外科学会定期学術集会)

    北市 隆, 増田 裕, 神原 保, 市川 洋一, 来島 敦史, 黒部 裕嗣, 速水 朋彦, 枝川 卓二, 森 一博, 北川 哲也

    日本外科学会雑誌   106 ( 0 )   348 - 348   2005.4

     More details

    Language:Japanese   Publisher:一般社団法人日本外科学会  

    CiNii Books

    researchmap

  • 15年後の静脈グラフト不全による狭心症に対しre-do CABGを施行した一例

    速水 朋彦, 北市 隆, 神原 保, 市川 洋一, 黒部 裕嗣, 来島 敦史, 増田 裕, 北川 哲也

    Circulation Journal   69 ( Suppl.II )   801 - 801   2005.4

     More details

    Language:Japanese   Publisher:(一社)日本循環器学会  

    researchmap

  • 解離性大動脈瘤に対する下行大動脈へのステントグラフト留置術後に一時的late paraplegiaを認めた一例

    神原 保, 北市 隆, 浦田 将久, 元木 達夫, 黒部 裕嗣, 市川 洋一, 富永 崇司, 増田 裕, 北川 哲也

    The Japanese Journal of THORACIC AND CARDIOVASCULAR SURGERY   53 ( Suppl.I )   44 - 44   2005.3

     More details

    Language:Japanese   Publisher:シュプリンガー・ジャパン(株)  

    researchmap

  • 高度肝硬変を伴う狭立症症例に対しoff-pump冠動脈バイパス術(OPCAB)が有用であった一例

    元木 達夫, 富永 崇司, 市川 洋一, 神原 保, 黒部 裕嗣, 浦田 将久, 北市 隆, 増田 裕, 北川 哲也

    The Japanese Journal of THORACIC AND CARDIOVASCULAR SURGERY   53 ( Suppl.I )   65 - 65   2005.3

     More details

    Language:Japanese   Publisher:シュプリンガー・ジャパン(株)  

    researchmap

  • 左右冠動脈単一バルサルバ洞起始を伴ったTGA類似症例に対する動脈スイッチ手術の経験

    黒部 裕嗣, 北市 隆, 富永 崇司, 神原 保, 市川 洋一, 元木 達夫, 浦田 将久, 増田 裕, 北川 哲也

    The Japanese Journal of THORACIC AND CARDIOVASCULAR SURGERY   53 ( Suppl.I )   53 - 53   2005.3

     More details

    Language:Japanese   Publisher:シュプリンガー・ジャパン(株)  

    researchmap

  • ヘパリンコファクターIIは末梢動脈閉塞性病変進展に対する新規抑制因子である

    粟飯原 賢一, 東 博之, 赤池 雅史, 黒部 裕嗣, 藤村 光則, 八木 秀介, 橋詰 俊二, 池田 康将, 北川 哲也, 松本 俊夫

    日本内科学会雑誌   94 ( Suppl. )   228 - 228   2005.2

     More details

    Language:Japanese   Publisher:(一社)日本内科学会  

    researchmap

  • T細胞特異的HIF1αKOマウスではカフモデルにて血管リモデリングが促進される

    黒部裕嗣, 黒部裕嗣, 冨田修平, 井澤有紀, 福原弥生, 粟飯原賢一, 赤池雅史, 神原保, 松本俊夫, 北川哲也, 吉栖正典, 玉置俊晃

    日本循環薬理学会口演要旨集   15th   2005

  • 成体胸腺の皮質は正の選択をうけたTリンパ球を循環に放出できる

    黒部 裕嗣, 上野 智雄, 斉藤 ふみ, 劉 村蘭, 北川 哲也, 高濱 洋介

    日本免疫学会総会・学術集会記録   34   37 - 37   2004.11

     More details

    Language:Japanese   Publisher:(NPO)日本免疫学会  

    researchmap

  • 62) 椎体固定器具により腹部大動脈に仮性動脈瘤が生じた一例(第84回日本循環器学会四国地方会)

    神原 保, 北市 隆, 速水 朋彦, 黒部 裕嗣, 来島 敦史, 市川 洋一, 増田 裕, 北川 哲也, 加藤 真介, 東野 恒作, 安井 夏生

    Circulation journal : official journal of the Japanese Circulation Society   68 ( 0 )   959 - 959   2004.10

     More details

    Language:Japanese   Publisher:社団法人日本循環器学会  

    CiNii Books

    researchmap

  • 両側内腸骨動脈と下腸間膜動脈からのmeandering arteryを伴った腹部大動脈瘤の一手術例

    市川 洋一, 北市 隆, 速水 朋彦, 来島 敦史, 神原 保, 黒部 裕嗣, 増田 裕, 北川 哲也

    日本血管外科学会雑誌   13 ( 6 )   635 - 635   2004.10

     More details

    Language:Japanese   Publisher:(NPO)日本血管外科学会  

    researchmap

  • 慢性期DeBakeyIIIb型大動脈解離に対するステントグラフト治療について

    市川 洋一, 北市 隆, 富永 崇司, 神原 保, 黒部 裕嗣, 浦田 将久, 北川 哲也

    日本血管外科学会雑誌   13 ( 6 )   628 - 628   2004.10

     More details

    Language:Japanese   Publisher:(NPO)日本血管外科学会  

    researchmap

  • 乳児期VSD,PAの治療戦略

    黒部 裕嗣, 北市 隆, 神原 保, 市川 洋一, 来島 敦史, 速水 朋彦, 増田 裕, 北川 哲也

    The Japanese Journal of THORACIC AND CARDIOVASCULAR SURGERY   52 ( Suppl. )   369 - 369   2004.9

     More details

    Language:Japanese   Publisher:シュプリンガー・ジャパン(株)  

    researchmap

  • Ebstein奇形の外科治療における弁機能を正常弁輪へ移動させることの重要性

    神原 保, 北市 隆, 浦田 将久, 元木 達夫, 黒部 裕嗣, 市川 洋一, 富永 崇司, 増田 裕, 森 一博, 北川 哲也

    日本小児循環器学会雑誌   20 ( 3 )   356 - 356   2004.5

     More details

    Language:Japanese   Publisher:(NPO)日本小児循環器学会  

    researchmap

  • 先天性心疾患に対する開心術後急性期における低濃度NO吸入療法の効果

    北市 隆, 増田 裕, 富永 崇司, 神原 保, 市川 洋一, 黒部 裕嗣, 元木 達夫, 浦田 将久, 福田 靖, 北川 哲也

    日本小児循環器学会雑誌   20 ( 3 )   363 - 363   2004.5

     More details

    Language:Japanese   Publisher:(NPO)日本小児循環器学会  

    researchmap

  • 一時留置型静脈フィルターに捕獲された塞栓の診断と対処 静脈造影法と経食道エコー法の検討

    黒部 裕嗣, 北市 隆, 富永 崇司, 金村 賦之, 神原 保, 市川 洋一, 島原 祐介, 元木 達夫, 菅野 幹夫, 浦田 将久, 増田 裕, 堀 隆樹, 北川 哲也

    静脈学   15 ( 3 )   253 - 258   2004.5

     More details

    Language:Japanese   Publisher:日本静脈学会  

    2002年1月から7月の間に一時留置型下大静脈フィルター(t-IVCF)を挿入した14例を対象とし,抜去時の捕獲塞栓の評価法と対処についてretrospectiveに検討した.捕獲塞栓の診断のため,10例で術翌日に静脈造影法,2例で術中経食道エコー法による評価を施行した.全例で臨床上問題となるような急性肺塞栓症を予防できた.一時型下大静脈フイルターは処置や手術時の急性肺塞栓症予防に極めて有用であり,捕獲塞栓の評価に,経食道エコー法と静脈造影法を症例に応じて使い分けることが安全で推奨される.捕獲塞栓が15mm径以下で,かつ赤色血栓が予想される場合には,シース内に収納可能で,30mm径以上の捕獲塞栓や,15mm径以下でもフィルター収納時に抵抗がある場合,及び腫瘍栓が予測される場合には,速やかに全身麻酔下に内頸静脈からのフィルターと塞栓の同時除去術を施行すべきである

    researchmap

  • 119) 重症急性肺塞栓症に対する血栓溶解療法の3経験(第83回日本循環器学会中国・四国合同地方会)

    神原 保, 浦田 将久, 元木 達夫, 黒部 裕嗣, 市川 洋一, 富永 崇司, 北市 隆, 増田 裕, 北川 哲也

    Circulation journal : official journal of the Japanese Circulation Society   68 ( 0 )   836 - 836   2004.4

     More details

    Language:Japanese   Publisher:社団法人日本循環器学会  

    CiNii Books

    researchmap

  • 117) 腹部大動脈瘤に対するステントグラフト治療について(第83回日本循環器学会中国・四国合同地方会)

    浦田 将久, 増田 裕, 北市 隆, 富永 崇司, 神原 保, 市川 洋一, 黒部 裕嗣, 元木 達夫, 宮谷 知彦, 北川 哲也

    Circulation journal : official journal of the Japanese Circulation Society   68 ( 0 )   836 - 836   2004.4

     More details

    Language:Japanese   Publisher:社団法人日本循環器学会  

    CiNii Books

    researchmap

  • 86) 著明なporcelain aortaを合併した大動脈弁閉鎖不全症に対する一手術例(第83回日本循環器学会中国・四国合同地方会)

    市川 洋一, 北市 隆, 富永 崇司, 神原 保, 黒部 裕嗣, 浦田 将久, 増田 裕, 北川 哲也

    Circulation journal : official journal of the Japanese Circulation Society   68 ( 0 )   832 - 832   2004.4

     More details

    Language:Japanese   Publisher:社団法人日本循環器学会  

    CiNii Books

    researchmap

  • 125) 徳島ACLSコースを開催して : 循環器医としてのかかわりについて(第83回日本循環器学会中国・四国合同地方会)

    福田 靖, 黒田 泰弘, 浦田 将久, 黒部 裕嗣, 市川 洋一, 神原 保, 富永 崇司, 北市 隆, 増田 裕, 北川 哲也

    Circulation journal : official journal of the Japanese Circulation Society   68 ( 0 )   837 - 837   2004.4

     More details

    Language:Japanese   Publisher:社団法人日本循環器学会  

    CiNii Books

    researchmap

  • 腹部大動脈瘤に対する術中・術後シベレスタット投与が術後に及ぼす影響

    黒部 裕嗣, 富永 崇司, 神原 保, 市川 洋一, 元木 達夫, 浦田 将久, 北市 隆, 増田 裕, 北川 哲也

    日本血管外科学会雑誌   13 ( 2 )   303 - 303   2004.4

     More details

    Language:Japanese   Publisher:(NPO)日本血管外科学会  

    researchmap

  • 胸部ステントグラフト内挿術におけるESP変化の検討

    市川 洋一, 北市 隆, 富永 崇司, 神原 保, 黒部 裕嗣, 元木 達夫, 浦田 将久, 増田 裕, 北川 哲也

    日本血管外科学会雑誌   13 ( 2 )   281 - 281   2004.4

     More details

    Language:Japanese   Publisher:(NPO)日本血管外科学会  

    researchmap

  • 重症肺動脈塞栓症に対する治療方針(血栓溶解療法と外科的摘除術)の検討

    浦田 将久, 神原 保, 元木 達夫, 黒部 裕嗣, 市川 洋一, 富永 崇司, 北市 隆, 増田 裕, 北川 哲也

    静脈学   15 ( 2 )   194 - 194   2004.4

     More details

    Language:Japanese   Publisher:日本静脈学会  

    researchmap

  • PS-069-5 複雑心奇形根治術後低心拍出量症候群に対する腹腔ドレナージの有用性 : 体内炎症性サイトカインの動向から

    黒部 裕嗣, 北市 隆, 富永 崇司, 神原 保, 市川 洋一, 元木 達夫, 浦田 将久, 増田 裕, 樋口 精一, 北川 哲也

    日本外科学会雑誌   105 ( 0 )   447 - 447   2004.3

     More details

    Language:Japanese   Publisher:一般社団法人日本外科学会  

    CiNii Books

    researchmap

  • 3b型解離性大動脈瘤に対するステントグラフト内挿術の経験

    堀 隆樹, 北市 隆, 富永 崇司, 金村 賦之, 神原 保, 黒部 裕嗣, 島原 佑介, 速水 朋彦, 菅野 幹雄, 元木 達夫, 北川 哲也

    The Japanese Journal of THORACIC AND CARDIOVASCULAR SURGERY   52 ( Suppl. )   107 - 107   2004.3

     More details

    Language:Japanese   Publisher:シュプリンガー・ジャパン(株)  

    researchmap

  • 単心室リモデリングの推移からみた段階的Fontan手術の妥当性

    北市 隆, 堀 隆樹, 富永 崇司, 金村 賦之, 神原 保, 黒部 裕嗣, 島原 佑介, 速水 朋彦, 菅野 幹雄, 元木 達夫, 森 一博, 枝川 卓二, 北川 哲也

    The Japanese Journal of THORACIC AND CARDIOVASCULAR SURGERY   52 ( Suppl. )   99 - 99   2004.3

     More details

    Language:Japanese   Publisher:シュプリンガー・ジャパン(株)  

    researchmap

  • 成人期ファロー四徴症根治手術症例の長期遠隔期におけるQOL評価

    北市 隆, 増田 裕, 富永 崇司, 神原 保, 市川 洋一, 黒部 裕嗣, 元木 達夫, 浦田 将久, 深田 義夫, 北川 哲也

    日本心臓血管外科学会雑誌   33 ( Suppl. )   264 - 264   2004.2

     More details

    Language:Japanese   Publisher:(NPO)日本心臓血管外科学会  

    researchmap

  • 肺高血圧症を伴う乳児期心室中隔欠損症におけるミルリノンの有用性

    黒部 裕嗣, 北市 隆, 富永 崇司, 藤本 鋭貴, 金村 賦之, 神原 保, 市川 洋一, 元木 達夫

    日本心臓血管外科学会雑誌   33 ( Suppl. )   326 - 326   2004.2

     More details

    Language:Japanese   Publisher:(NPO)日本心臓血管外科学会  

    researchmap

  • Assessment and management of thrombus captured in a temporary vena cava filter : venography and transesophageal echocardiography

    KUROBE H

    Jpn J Phlebol   15   253 - 258   2004

     More details

  • 生体内胸腺のタイムラプス細胞動態解析

    黒部 裕嗣, 戸村 道夫, 斉藤 ふみ, 臼井 健二, 北川 哲也, 高浜 洋介

    日本免疫学会総会・学術集会記録   33   235 - 235   2003.11

     More details

    Language:Japanese   Publisher:(NPO)日本免疫学会  

    researchmap

  • 胸腺組織のタイムラプス可視化による胸腺内細胞動態の解析

    臼井 健司, 戸村 道夫, 黒部 裕嗣, 北川 哲也, 斉藤 ふみ, 五十嵐 英哉, 阪口 薫雄, 高浜 洋介

    日本免疫学会総会・学術集会記録   33   239 - 239   2003.11

     More details

    Language:Japanese   Publisher:(NPO)日本免疫学会  

    researchmap

  • 肝不全を伴った三尖弁閉鎖不全症に対する人工弁置換術の一例(第82回日本循環器学会四国地方会)

    神原 保, 元木 達夫, 菅野 幹雄, 島原 祐介, 速水 朋彦, 黒部 裕嗣, 金村 賦之, 富永 嵩司, 北市 隆, 堀 隆樹, 北川 哲也

    Circulation journal : official journal of the Japanese Circulation Society   67 ( 0 )   1014 - 1014   2003.10

     More details

    Language:Japanese   Publisher:社団法人日本循環器学会  

    CiNii Books

    researchmap

  • 段階的Fontan手術後の体心室壁厚・容積比の変化に影響を与える因子の検討

    北市 隆, 堀 隆樹, 富永 崇司, 金村 賦之, 神原 保, 黒部 裕嗣, 島原 佑介, 速水 朋彦, 森 一博, 北川 哲也

    日本小児循環器学会雑誌   19 ( 3 )   297 - 297   2003.5

     More details

    Language:Japanese   Publisher:(NPO)日本小児循環器学会  

    researchmap

  • 心臓・血管疾患における脈波解析の検討

    堀 隆樹, 北市 隆, 富永 崇司, 金村 賦之, 神原 保, 黒部 裕嗣, 島原 佑介, 速水 朋彦, 菅野 幹雄, 元木 達夫, 北川 哲也

    日本外科学会雑誌   104 ( 0 )   665 - 665   2003.4

     More details

    Language:Japanese   Publisher:一般社団法人日本外科学会  

    CiNii Books

    researchmap

  • 64)Intramural hematomaからDeBakeyII型へ移行したCT画像上興味ある経過をとった大動脈解離の1治験例

    金村 賦之, 堀 隆樹, 北市 隆, 富永 崇司, 神原 保, 黒部 裕嗣, 島原 佑介, 北川 哲也

    Circulation journal : official journal of the Japanese Circulation Society   67 ( 0 )   841 - 841   2003.4

     More details

    Language:Japanese   Publisher:社団法人日本循環器学会  

    CiNii Books

    researchmap

  • 172)他科手術時の一時留置型下大静脈フィルター留置は肺塞栓症予防に有用か?

    元木 達夫, 堀 隆樹, 北市 隆, 富永 崇, 金村 賦之, 神原 保, 黒部 裕嗣, 島原 祐介, 速水 朋彦, 菅野 幹雄, 北川 哲也

    Circulation journal : official journal of the Japanese Circulation Society   67 ( 0 )   864 - 864   2003.4

     More details

    Language:Japanese   Publisher:社団法人日本循環器学会  

    CiNii Books

    researchmap

  • 胸部大動脈瘤に対するTPEG時の脊髄障害予防にステロイドが有効であった症例の検討

    堀 隆樹, 北市 隆, 富永 崇司, 金村 賦之, 神原 保, 黒部 裕嗣, 島原 佑介, 速水 朋彦, 菅野 幹雄, 元木 達夫, 北川 哲也

    日本心臓血管外科学会雑誌   32 ( Suppl. )   160 - 160   2003.4

     More details

    Language:Japanese   Publisher:(NPO)日本心臓血管外科学会  

    researchmap

  • 上腸間膜動脈性十二指腸閉塞症(SMA syndrome)に対する腹腔鏡下十二指腸空腸吻合術

    八木 淑之, 藤野 良三, 高井 茂治, 三木 仁司, 住友 正幸, 松山 和男, 尾形 頼彦, 中川 靖士, 金村 晋史, 兼田 裕司, 黒部 裕嗣, 寺内 明子

    四国医学雑誌   59 ( 1〜2 )   68 - 73   2003.4

     More details

    Language:Japanese   Publisher:徳島医学会  

    17歳女.嘔吐,摂食不良を主訴とした.乳児期から嘔吐の頻度が多かった.上部消化管透視,造影後腹部X線検査,腹部造影CT検査,腹部3D-CT検査の所見と経過から,長期にわたる極端な内臓下垂を伴った上腸間膜動脈性十二指腸閉塞症(SMA症候群)と診断した.手術適応と考えられ,腹腔鏡下に十二指腸第3部と空腸を経横行結腸間膜的に側々に吻合した.術後経過良好で,術後第5週の透視においても通過は良好であった.本症には術式も簡単で手術侵襲が少なく美容的にも優れている,経横行結腸間膜的腹腔鏡下十二指腸空腸吻合術がより適応と考えられた

    researchmap

    Other Link: https://search.jamas.or.jp/index.php?module=Default&action=Link&pub_year=2003&ichushi_jid=J00548&link_issn=&doc_id=20030602390013&doc_link_id=http%3A%2F%2Frepo.lib.tokushima-u.ac.jp%2F110590&url=http%3A%2F%2Frepo.lib.tokushima-u.ac.jp%2F110590&type=%93%BF%93%87%91%E5%8Aw%81F%93%BF%93%87%91%E5%8Aw%8B%40%8A%D6%83%8A%83%7C%83W%83g%83%8A&icon=https%3A%2F%2Fjk04.jamas.or.jp%2Ficon%2F80037_3.gif

  • 膵海綿状リンパ管腫(cavernous lymphangioma of the pancreas)に対して腹腔鏡下腫瘍摘出術を行った1例

    八木 淑之, 藤野 良三, 高井 茂治, 三木 仁司, 住友 正幸, 松山 和男, 尾形 頼彦, 中川 靖士, 金村 晋史, 兼田 裕司, 黒部 裕嗣

    四国医学雑誌   59 ( 1〜2 )   57 - 62   2003.4

     More details

    Language:Japanese   Publisher:徳島医学会  

    49歳男.膵体尾部腫瘤を主訴とした.人間ドックで膵体尾部腫瘤を指摘されたが腹痛等の症状はなかった.画像診断から膵体尾部の嚢胞腺腫あるいは同部周辺のリンパ管腫を疑った.経過観察中に腫瘤の増大傾向を認めたため,malignant potentialを有する膵嚢胞性腫瘍も否定できず,腹腔鏡下腫瘍摘出術を施行した.摘出された腫瘤は7.0×5.5×3.0cmの,結合織で囲まれた多房性腫瘍であった.悪性所見は認めず,膵海綿状リンパ管腫と診断された.術後経過は良好で,術後4年の現在,再発なく無症状で経過している.膵海綿状リンパ管腫は極めて稀な膵非上皮性腫瘍であり,検索し得た限り自験例を含め15例の報告があるのみであった

    researchmap

    Other Link: https://search.jamas.or.jp/index.php?module=Default&action=Link&pub_year=2003&ichushi_jid=J00548&link_issn=&doc_id=20030602390011&doc_link_id=http%3A%2F%2Frepo.lib.tokushima-u.ac.jp%2F110588&url=http%3A%2F%2Frepo.lib.tokushima-u.ac.jp%2F110588&type=%93%BF%93%87%91%E5%8Aw%81F%93%BF%93%87%91%E5%8Aw%8B%40%8A%D6%83%8A%83%7C%83W%83g%83%8A&icon=https%3A%2F%2Fjk04.jamas.or.jp%2Ficon%2F80037_3.gif

  • 弓部大動脈手術時の脳合併症と脳保護法について

    神原 保, 北川 哲也, 堀 隆樹, 北市 隆, 富永 崇司, 金村 賦之, 黒部 裕嗣, 島原 佑介, 速水 朋彦, 菅野 幹雄, 元木 達夫

    日本心臓血管外科学会雑誌   32 ( Suppl. )   308 - 308   2003.4

     More details

    Language:Japanese   Publisher:(NPO)日本心臓血管外科学会  

    researchmap

  • 冠動脈病変,腹部大動脈瘤を合併した症例に対する治療戦略

    金村 賦之, 堀 隆樹, 北市 隆, 藤本 鋭貴, 黒部 裕嗣, 速水 朋彦, 島原 佑介, 北川 哲也

    The Japanese Journal of THORACIC AND CARDIOVASCULAR SURGERY   51 ( Suppl. )   122 - 122   2003.3

     More details

    Language:Japanese   Publisher:シュプリンガー・ジャパン(株)  

    researchmap

  • 重症三尖弁閉鎖不全症を合併する乳児期WPW症候群に対する手術療法

    島原 佑介, 堀 隆樹, 北市 隆, 藤本 鋭貴, 金村 賦之, 黒部 裕嗣, 速水 朋彦, 北川 哲也, 森 一博

    The Japanese Journal of THORACIC AND CARDIOVASCULAR SURGERY   51 ( Suppl. )   108 - 108   2003.3

     More details

    Language:Japanese   Publisher:シュプリンガー・ジャパン(株)  

    researchmap

  • 一時留置型下大静脈フィルターによる術後捕獲塞栓の診断 血管造影と経食道エコーの有効性について

    黒部 裕嗣, 堀 隆樹, 北市 隆, 富永 崇司, 金村 賦之, 神原 保, 島原 祐介, 速水 朋彦, 菅野 幹雄, 元木 達夫

    静脈学   14 ( 2 )   137 - 137   2003.3

     More details

    Language:Japanese   Publisher:日本静脈学会  

    researchmap

  • 血栓閉塞型解離とintramural hematoma(IMH)の関連性について

    金村 賦之, 堀 隆樹, 北市 隆, 富永 崇司, 神原 保, 黒部 裕嗣, 菅野 幹雄, 元木 達夫, 北川 哲也

    日本血管外科学会雑誌   11 ( 7 )   717 - 717   2002.12

     More details

    Language:Japanese   Publisher:(NPO)日本血管外科学会  

    researchmap

  • Fontan手術後の容量負荷軽減に対する段階的Fontan手術の緩衝効果

    北市 隆, 堀 隆樹, 金村 賦之, 神原 保, 黒部 裕嗣, 島原 佑介, 速水 朋彦, 森 一博, 北川 哲也

    The Japanese Journal of THORACIC AND CARDIOVASCULAR SURGERY   50 ( Suppl. )   282 - 282   2002.9

     More details

    Language:Japanese   Publisher:シュプリンガー・ジャパン(株)  

    researchmap

  • 凍結保存弁の解凍後の組織培養により弁機能を回復させうるか?

    藤本 鋭貴, 吉栖 正典, 増田 裕, 富永 崇司, 金村 賦之, 神原 保, 黒部 裕嗣, 島原 佑介, 速水 朋彦, 北市 隆, 堀 隆樹, 北川 哲也

    The Japanese Journal of THORACIC AND CARDIOVASCULAR SURGERY   50 ( Suppl. )   424 - 424   2002.9

     More details

    Language:Japanese   Publisher:シュプリンガー・ジャパン(株)  

    researchmap

  • 片側深部静脈血栓症発症にて発見された両側巨大膝窩動脈瘤の一例

    速水 朋彦, 堀 隆樹, 北市 隆, 藤本 鋭貴, 金村 賦之, 黒部 裕嗣, 島原 佑介, 北川 哲也

    四国医学雑誌   58 ( 1〜2 )   74 - 74   2002.4

     More details

    Language:Japanese   Publisher:徳島医学会  

    researchmap

  • 乳児期早期肺静脈狭窄症の外科治療における一考察

    黒部 裕嗣, 堀 隆樹, 北市 隆, 藤本 鋭貴, 金村 賦之, 島原 祐介, 速水 朋彦, 北川 哲也

    日本小児循環器学会雑誌   18 ( 2 )   342 - 342   2002.4

     More details

    Language:Japanese   Publisher:(NPO)日本小児循環器学会  

    researchmap

  • 血栓溶解療法が著効した急性肺血栓塞栓症の2例

    島原 佑介, 堀 隆樹, 北市 隆, 藤本 鋭貴, 金村 賦之, 黒部 裕嗣, 速水 朋彦, 北川 哲也

    四国医学雑誌   58 ( 1〜2 )   73 - 74   2002.4

     More details

    Language:Japanese   Publisher:徳島医学会  

    researchmap

  • 段階的Fontan手術における肺動脈径及び体心室壁厚・容積比の推移に対する検討

    北市 隆, 堀 隆樹, 藤本 鋭貴, 金村 賦之, 黒部 裕嗣, 島原 佑介, 速水 朋彦, 森 一博, 北川 哲也

    日本小児循環器学会雑誌   18 ( 2 )   204 - 204   2002.4

     More details

    Language:Japanese   Publisher:(NPO)日本小児循環器学会  

    researchmap

  • Isolated myocardial perfusion下の弓部置換術 心肥大からみたその適応についての検討

    黒部 裕嗣, 堀 隆樹, 増田 裕, 北市 隆, 藤本 鋭貴, 金村 賦之, 島原 祐介, 速水 朋彦, 北川 哲也

    日本血管外科学会雑誌   11 ( 2 )   343 - 343   2002.4

     More details

    Language:Japanese   Publisher:(NPO)日本血管外科学会  

    researchmap

  • 乳児期早期ペースメーカー植え込み術の検討

    島原 佑介, 堀 隆樹, 北市 隆, 藤本 鋭貴, 金村 賦之, 黒部 裕嗣, 速水 朋彦, 北川 哲也

    日本小児循環器学会雑誌   18 ( 2 )   354 - 354   2002.4

     More details

    Language:Japanese   Publisher:(NPO)日本小児循環器学会  

    researchmap

  • 急性下肢動脈閉塞を発症した膝窩動脈瘤の2症例

    吉田 誉, 黒部 裕嗣, 筑後 文雄, 黒上 和義

    日本血管外科学会雑誌   11 ( 3 )   504 - 504   2002.4

     More details

    Language:Japanese   Publisher:(NPO)日本血管外科学会  

    researchmap

  • 腹部大動脈瘤に重症冠動脈病変を合併した症例に対する治療戦略

    金村 賦之, 堀 隆樹, 北市 隆, 藤本 鋭貴, 黒部 裕嗣, 速水 朋彦, 島原 佑介, 北川 哲也

    日本血管外科学会雑誌   11 ( 2 )   351 - 351   2002.4

     More details

    Language:Japanese   Publisher:(NPO)日本血管外科学会  

    researchmap

  • 脳内組織酸素化率から見た選択的脳分離体外循環中の灌流条件の検討

    堀 隆樹, 北市 隆, 藤本 鋭貴, 金村 賦之, 黒部 裕嗣, 島原 佑介, 速水 朋彦, 北川 哲也

    日本血管外科学会雑誌   11 ( 2 )   340 - 340   2002.4

     More details

    Language:Japanese   Publisher:(NPO)日本血管外科学会  

    researchmap

  • 一側肺動脈で根治術を施行したTOF,PA,MAPCAsの一例

    北市 隆, 堀 隆樹, 増田 裕, 脇坂 佳成, 大谷 享史, 藤本 鋭貴, 濱本 貴子, 黒部 裕嗣, 森 一博, 北川 哲也

    The Japanese Journal of THORACIC AND CARDIOVASCULAR SURGERY   50 ( Suppl. )   128 - 128   2002.3

     More details

    Language:Japanese   Publisher:シュプリンガー・ジャパン(株)  

    researchmap

  • 大動脈弁輪周囲膿瘍を合併した活動期感染性心内膜炎の一例

    大谷 享史, 堀 隆樹, 増田 裕, 北市 隆, 脇坂 佳成, 藤本 鋭貴, 濱本 貴子, 黒部 裕嗣, 赤池 雅史, 北川 哲也

    The Japanese Journal of THORACIC AND CARDIOVASCULAR SURGERY   50 ( Suppl. )   118 - 118   2002.3

     More details

    Language:Japanese   Publisher:シュプリンガー・ジャパン(株)  

    researchmap

  • 重症感染性心内膜炎術後のエンドトキシン類似炎症性物質除去を目的としたblood apheresisの経験

    堀 隆樹, 増田 裕, 北市 隆, 脇坂 佳成, 大谷 享史, 藤本 鋭樹, 浜本 貴子, 黒部 裕嗣, 北川 哲也, 岡久 稔也

    The Japanese Journal of THORACIC AND CARDIOVASCULAR SURGERY   50 ( Suppl. )   110 - 110   2002.3

     More details

    Language:Japanese   Publisher:シュプリンガー・ジャパン(株)  

    researchmap

  • 36) エンドトキシン吸着療法が奏功したDIC状態の感染性心内膜炎の一例(日本循環器学会 第78回四国地方会)

    黒部 裕嗣, 堀 隆樹, 増田 裕, 北市 隆, 大谷 享史, 藤本 鋭貴, 濱本 貴子, 北川 哲也

    Japanese circulation journal   65 ( 0 )   813 - 813   2001.10

     More details

    Language:Japanese   Publisher:社団法人日本循環器学会  

    CiNii Books

    researchmap

  • 入浴中の高齢者心肺停止症例の検討

    田尾 佳代子, 三村 誠二, 渡部 智紀, 兼田 裕司, 木下 弾, 黒部 裕嗣, 細川 亜裕, 渡部 豪, 上山 裕二, 橋本 拓也

    四国医学雑誌   57 ( 4〜5 )   150 - 150   2001.10

     More details

    Language:Japanese   Publisher:徳島医学会  

    researchmap

  • 地方都市の救命救急センターにおける熱傷患者症例の実態について

    上山 裕二, 三村 誠二, 渡部 智紀, 田尾 佳代子, 兼田 裕司, 木下 弾, 黒部 裕嗣, 細川 亜裕, 渡部 豪, 橋本 拓也

    四国医学雑誌   57 ( 4〜5 )   150 - 150   2001.10

     More details

    Language:Japanese   Publisher:徳島医学会  

    researchmap

  • 下肢静脈瘤治療が末梢循環に与える効果について Air Plethysmography及び近赤外線分光法による検討

    渡辺 美恵, 増田 裕, 堀 隆樹, 北市 隆, 小川 佳宏, 富永 崇司, 大谷 享史, 藤本 鋭貴, 濱本 貴子, 黒部 裕嗣, 北川 哲也

    Therapeutic Research   22 ( 9 )   1995 - 1999   2001.9

     More details

    Language:Japanese   Publisher:ライフサイエンス出版(株)  

    下肢静脈瘤治療が末梢循環に与える効果について,APGによる静脈機能検査とNIRSによる組織血流検査を用いて検討した.対象は大伏在静脈型一次性下肢静脈瘤7例で臨床的には末梢動脈閉塞性疾患を合併しない症例であった.大伏静脈型一次性下肢静脈瘤に対する高位結紮術により,患肢静脈機能は著明に改善し,トレッドミル負荷NIRS検査による検討では,動脈血流入の改善,静脈鬱滞の減少,更に組織流入動脈血キャパシタンスの改善が認められた

    researchmap

  • 肺動脈閉鎖を伴う心室中隔欠損症の乳児期primary complete repairについて preliminary report

    北川 哲也, 北市 隆, 堀 隆樹, 増田 裕, 大谷 享史, 藤本 鋭貴, 濱本 貴子, 黒部 裕嗣, 真鍋 哲也, 森 一博

    The Japanese Journal of THORACIC AND CARDIOVASCULAR SURGERY   49 ( Suppl. )   311 - 311   2001.9

     More details

    Language:Japanese   Publisher:シュプリンガー・ジャパン(株)  

    researchmap

  • 無侵襲脳内酸素飽和度からみたOff Pump CABG(OPCAB)の有用性

    堀 隆樹, 増田 裕, 北市 隆, 富永 崇司, 大谷 享史, 藤本 鋭貴, 濱本 貴子, 黒部 裕嗣, 北川 哲也

    Therapeutic Research   22 ( 9 )   2021 - 2024   2001.9

     More details

    Language:Japanese   Publisher:ライフサイエンス出版(株)  

    体外循環が脳循環に及ぼす影響について無侵襲脳内酸素飽和度測定法により検討した.対象はoff pump CABG6例(A群)と人工心肺下に行った心臓手術15例(B群)とし,無侵襲脳内酸素飽和度監視装置インボス4100を用いて,専用センサーを両前額部に装着し,麻酔導入時より手術室搬出時まで連続記録し,脳内酸素飽和度の最高値,最低値,変動域,左右差の最大値,最小値,左右差の変動域について両群間で比較検討した.脳内酸素飽和度の最低値において有意差を認めた.off pump CABGは脳循環に及ぼす影響が有意に少なく,周術期脳合併症の発生を減少させる可能性があることが示唆された

    researchmap

  • 興味ある経過を示した早期血栓閉鎖型大動脈解離(closing aortic dissection:CAD)の2例

    北市 隆, 堀 隆樹, 増田 裕, 富永 崇司, 大谷 享史, 藤本 鋭貴, 濱本 貴子, 黒部 裕嗣, 北川 哲也

    日本血管外科学会雑誌   10 ( 4 )   513 - 513   2001.6

     More details

    Language:Japanese   Publisher:(NPO)日本血管外科学会  

    researchmap

  • 急性肺血栓塞栓症の予防を目的とした一時留置型下大静脈フィルターの有用性

    濱本 貴子, 堀 隆樹, 増田 裕, 北市 隆, 富永 崇司, 大谷 亨史, 藤本 鋭貴, 黒部 裕嗣, 北川 哲也, 福田 靖

    静脈学   12 ( 2 )   186 - 186   2001.5

     More details

    Language:Japanese   Publisher:日本静脈学会  

    researchmap

  • 下大静脈内腫瘍栓を伴う悪性腫瘍の外科治療の検討

    藤本 鋭貴, 堀 隆樹, 増田 裕, 北市 隆, 脇坂 佳成, 大谷 享史, 濱本 貴子, 黒部 裕嗣, 香川 征, 青野 敏博

    静脈学   12 ( 2 )   165 - 165   2001.5

     More details

    Language:Japanese   Publisher:日本静脈学会  

    researchmap

  • 167) 心房中隔欠損症術後遠隔期に拡大した肺動脈の圧排によりLMT狭窄をきたした一例

    濱本 貴子, 堀 隆樹, 増田 裕, 北市 隆, 富永 崇司, 大谷 亨史, 藤本 鋭貴, 黒部 裕嗣, 北川 哲也, 若槻 哲三, 山田 廣胤, 渡部 智紀, 北畑 洋

    Japanese circulation journal   65 ( 0 )   678 - 678   2001.4

     More details

    Language:Japanese   Publisher:社団法人日本循環器学会  

    CiNii Books

    researchmap

  • DICを合併した腹部大動脈瘤症例

    大谷 享史, 堀 隆樹, 増田 裕, 北市 隆, 脇坂 佳成, 藤本 鋭貴, 濱本 貴子, 黒部 裕嗣, 北川 哲也

    日本血管外科学会雑誌   10 ( 2 )   260 - 260   2001.4

     More details

    Language:Japanese   Publisher:(NPO)日本血管外科学会  

    researchmap

  • 胸部下行大動脈瘤,胸腹部大動脈瘤人工血管置換術時における脊髄保護の工夫

    堀 隆樹, 増田 裕, 北市 隆, 大谷 享史, 藤本 鋭貴, 濱本 貴子, 黒部 裕嗣, 北川 哲也

    日本血管外科学会雑誌   10 ( 2 )   312 - 312   2001.4

     More details

    Language:Japanese   Publisher:(NPO)日本血管外科学会  

    researchmap

  • 永久型ペースメーカー植込み術後感染症例についての検討

    堀 隆樹, 増田 裕, 北市 隆, 脇坂 佳成, 大谷 享史, 藤本 鋭貴, 濱本 貴子, 黒部 裕嗣, 北川 哲也

    不整脈   17 ( 2 )   308 - 308   2001.4

     More details

    Language:Japanese   Publisher:(NPO)日本不整脈学会  

    researchmap

  • 腎障害を伴う腹部大動脈瘤の術後腎機能についての検討

    黒部 裕嗣, 堀 隆貴, 増田 裕, 北市 隆, 脇坂 佳成, 大谷 享史, 藤本 鋭貴, 濱本 貴子, 北川 哲也

    日本血管外科学会雑誌   10 ( 2 )   262 - 262   2001.4

     More details

    Language:Japanese   Publisher:(NPO)日本血管外科学会  

    researchmap

  • PP136 ファロー四徴症根術後の長期遠隔期運動機能について-手術時期および手技の改善を目的として

    北川 哲也, 松岡 優, 多田羅 勝義, 森 一博, 堀 隆樹, 増田 裕, 北市 隆, 富永 崇司, 大谷 享史, 藤本 鋭貴, 濱本 貴子, 黒部 裕嗣

    日本外科学会雑誌   102 ( 0 )   257 - 257   2001.3

     More details

    Language:Japanese   Publisher:一般社団法人日本外科学会  

    CiNii Books

    researchmap

  • 遠隔期大動脈弁機能からみた大動脈弁尖逸脱を伴うVSDの治療と工夫

    北市 隆, 堀 隆樹, 増田 裕, 脇坂 佳成, 大谷 享史, 藤本 鋭貴, 濱本 貴子, 黒部 裕嗣, 森 一博, 北川 哲也

    日本小児循環器学会雑誌   17 ( 2 )   295 - 295   2001.3

     More details

    Language:Japanese   Publisher:(NPO)日本小児循環器学会  

    researchmap

  • Hemi-Fontan手術-Fontan手術の段階的治療後の遠隔期の問題点

    北川 哲也, 北市 隆, 堀 隆樹, 増田 裕, 大谷 享史, 藤本 鋭貴, 濱本 貴子, 黒部 裕嗣, 真鍋 哲也, 森 一博

    日本小児循環器学会雑誌   17 ( 2 )   292 - 292   2001.3

     More details

    Language:Japanese   Publisher:(NPO)日本小児循環器学会  

    researchmap

  • 急性肺血栓塞栓症の予防を目的とした一時留置型下大静脈フィルターの有用性

    濱本 貴子, 堀 隆樹, 増田 裕, 北市 隆, 富永 崇司, 大谷 亨史, 藤本 鋭貴, 黒部 裕嗣, 北川 哲也, 福田 靖

    四国医学雑誌   57 ( 1 )   18 - 18   2001.2

     More details

    Language:Japanese   Publisher:徳島医学会  

    researchmap

  • 下咽頭癌および食道癌根治術における遊離空腸移植術の経験

    藤本 鋭貴, 堀 隆樹, 増田 裕, 北市 隆, 富永 崇司, 大谷 亨史, 濱本 貴子, 黒部 裕嗣, 北川 哲也, 武田 憲昭

    四国医学雑誌   57 ( 1 )   18 - 18   2001.2

     More details

    Language:Japanese   Publisher:徳島医学会  

    researchmap

  • 右室流出路再建に有茎自己心膜を用いたRoss手術

    北市 隆, 堀 隆樹, 増田 裕, 富永 崇司, 大谷 享史, 藤本 鋭貴, 濱本 貴子, 黒部 裕嗣, 森 一博, 北川 哲也

    日本心臓血管外科学会雑誌   31 ( Suppl. )   218 - 218   2001.1

     More details

    Language:Japanese   Publisher:(NPO)日本心臓血管外科学会  

    researchmap

  • 先天性凝固線溶異常を伴った心臓血管外科手術症例の検討

    大谷 享史, 堀 隆樹, 増田 裕, 北市 隆, 富永 崇司, 藤本 鋭貴, 濱本 貴子, 黒部 裕嗣, 赤池 雅史, 北川 哲也

    日本心臓血管外科学会雑誌   31 ( Suppl. )   374 - 374   2001.1

     More details

    Language:Japanese   Publisher:(NPO)日本心臓血管外科学会  

    researchmap

  • 連続縫合によるVSD閉鎖の検討

    北市 隆, 堀 隆樹, 増田 裕, 富永 崇司, 大谷 享史, 藤本 鋭貴, 濱本 貴子, 黒部 裕嗣, 森 一博, 北川 哲也

    日本心臓血管外科学会雑誌   31 ( Suppl. )   273 - 273   2001.1

     More details

    Language:Japanese   Publisher:(NPO)日本心臓血管外科学会  

    researchmap

  • 無侵襲脳内酸素飽和度からみたOFF PUMP CABGの有用性

    堀 隆樹, 増田 裕, 北市 隆, 富永 崇司, 大谷 享史, 藤本 鋭貴, 濱本 貴子, 黒部 裕嗣, 北川 哲也

    日本心臓血管外科学会雑誌   31 ( Suppl. )   46 - 46   2001.1

     More details

    Language:Japanese   Publisher:(NPO)日本心臓血管外科学会  

    researchmap

  • 当院におけるステントグラフト内挿術の経験

    濱本 貴子, 堀 隆樹, 増田 裕, 北市 隆, 富永 崇司, 大谷 亨史, 藤本 鋭貴, 黒部 裕嗣, 北川 哲也

    四国医学雑誌   56 ( 5 )   198 - 198   2000.10

     More details

    Language:Japanese   Publisher:徳島医学会  

    researchmap

  • 当科におけるOff pump CABGのpreliminary report

    大谷 享史, 堀 隆樹, 増田 裕, 北市 隆, 富永 崇司, 藤本 鋭貴, 濱本 貴子, 黒部 裕嗣, 北川 哲也

    四国医学雑誌   56 ( 5 )   198 - 198   2000.10

     More details

    Language:Japanese   Publisher:徳島医学会  

    researchmap

  • Transcriptional regulation of fatty acid cyclooxygenases-1 and -2

    S. Yamamoto, K. Yamamoto, H. Kurobe, R. Yamashita, H. Yamaguchi, N. Ueda

    International Journal of Tissue Reactions   20 ( 1 )   17 - 22   1998

     More details

    Publishing type:Book review, literature introduction, etc.  

    Transcriptional regulation of fatty acid cyclooxygenase isozymes (COX-1 and COX-2) were studied using two cell lines. A rapid and transient induction of COX-2 was observed by the addition of tumor necrosis factor α (TNFα) to murine osteoblastic cells MC3T3-E1. Possible involvement of NFκB and NF-IL6 as transcription factors was shown by deletion experiments using a luciferase reporter gene. COX-1 induction by a phorbol ester was demonstrated along with differentiation of human megakaryoblastic cells CMK to megakaryocytes.

    Scopus

    PubMed

    researchmap

▼display all

Industrial property rights

  • Materials for medical devices

     More details

    Applicant:Gunze Limited

    Application no:特願2019-181505  Date applied:2019.10

    Announcement no:特開2021-53267  Date announced:2021.4

    Country of applicant:Domestic   Country of acquisition:Domestic , Foreign country

    【国際特許分類】
    A61B 17/00 20060101AFI20210312BHJP

    researchmap

  • Materials for medical devices

     More details

    Applicant:Gunze Limited

    Application no:特願2019-132833  Date applied:2019.7

    Announcement no:特開2021-16478  Date announced:2021.2

    Country of applicant:Domestic   Country of acquisition:Domestic , Foreign country

    【国際特許分類】
    A61B 17/00 20060101AFI20210118BHJP

    researchmap

  • Materials for medical devices

     More details

    Applicant:Gunze Limited, The University of Tokushima

    Application no:特願2017-140003  Date applied:2017.7

    Announcement no:特開2019-017795  Date announced:2019.2

    Country of applicant:Domestic   Country of acquisition:Domestic , Foreign country

    researchmap

  • 【再公表特許(A1)】医療用材料

    坂元悠紀, 新岡俊治, 黒部裕嗣

     More details

    Applicant:グンゼ株式会社

    Application no:特願2017-515441  Date applied:2016.3

    Announcement no:特開WO2016/174972  Date announced:2016.11

    Country of applicant:Domestic   Country of acquisition:Domestic , Foreign country

    心房中隔欠損症に対して、遠隔期の不具合の可能性がほとんどない、低侵襲の治療を実現する欠損孔閉鎖材を提供する。
    欠損孔閉鎖材(100)は、生体吸収性材料の編み目状組織の2つの筒体(第1の筒部(110)および第2の筒部(120))により形成され、砂時計型、8の字型、2連の紡錘型またはピーナッツ型の形状を備え、第1の端部(112)と第2の端部(122)とにそれぞれ両端が係合され、第1の端部(112)側から略中央部(130)を介して第2の端部(122)側まで第1の筒部(110)および第2の筒部(120)の内部に通されたコイルばね(140)を備える。カテーテル(300)から欠損孔閉鎖材(100)を押し出すと、コイルばね(140)の作用により略中央部(130)を中心にして第1の筒部(110)と第2の筒部(120)とが接近して筒径が拡張される。

    researchmap

  • Materials for medical devices

     More details

    Applicant:Gunze Limited

    Application no:特願2014-234767  Date applied:2014.11

    Announcement no:特開2016-96917  Date announced:2016.5

    Country of applicant:Domestic   Country of acquisition:Domestic , Foreign country

    researchmap

  • Materials for medical devices

     More details

    Applicant:Gunze Limited

    Application no:特願2013-166967  Date applied:2013.8

    Announcement no:特開2015-33555  Date announced:2015.2

    Country of applicant:Domestic   Country of acquisition:Domestic , Foreign country

    researchmap

  • Materials for medical devices

     More details

    Applicant:Gunze Limited

    Application no:特願2017-533080 

    Announcement no:特開WO2017/022750  Date announced:2017.2

    Country of applicant:Domestic   Country of acquisition:Domestic , Foreign country

    researchmap

▼display all

Awards

  • Banyu fellow Ship Program

    2011   Banyu Life Science Foundation International  

    Hirotsugu KUROBE

     More details

  • Miki-Kouraku Award

    2010   Miki Korakukai Foundation  

    Hirotsugu KUROBE

     More details

  • Plenary session

    2010   Japanese Association for Thoracic Surgery  

    Hirotsugu KUROBE

     More details

  • Excellent presenting Award

    2010   Japanese College of Angiology  

    Hirotsugu KUROBE

     More details

  • Research award, School of Medicine, the University of TOKUSHIMA

    2005   School of Medicine, the University of TOKUSHIMA  

    Hirotsugu KUROBE

     More details

  • Young Investigator Award

    2005   Japanese Society of Phlebology  

    Hirotsugu KUROBE

     More details

  • Melchers’ Travel Award

    2004   Japanese Society for immunology  

    Hirotsugu KUROBE

     More details

  • MIKI-KOURAKU Award

    1999   Miki Korakukai Foundation  

    Hirotsugu KUROBE

     More details

▼display all

Research Projects

  • 心臓血管外科治療で用いる生体材料の石灰化メカニズムの包括的理解

    2024.4 - 2028.3

    日本学術振興会  科学研究費助成事業  基盤研究(B)

    泉谷 裕則, 杉本 愛, 坂上 倫久, 薦田 宗則, 黒部 裕嗣, 倉田 美恵

      More details

    Grant amount:\18590000 ( Direct Cost: \14300000 、 Indirect Cost:\4290000 )

    researchmap

  • High Functionalization of Silk Fibroin for Cardiovascular Devices and Its Application to Novel Artificial Heart Valves

    2024.4 - 2028.3

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (B)

      More details

    Grant amount:\18460000 ( Direct Cost: \14200000 、 Indirect Cost:\4260000 )

    researchmap

  • International translational research for clinical applications of novel biodegradable ASD occluder device using large animals

    2021.10 - 2025.3

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Fund for the Promotion of Joint International Research (Fostering Joint International Research (B))

      More details

    Grant amount:\18980000 ( Direct Cost: \14600000 、 Indirect Cost:\4380000 )

    researchmap

  • 生体吸収性素材を用いた経カテーテル心房中隔閉鎖術の移植後組織再生に関する検討

    2020.4 - 2023.3

    日本学術振興会  科学研究費助成事業 基盤研究(C)  基盤研究(C)

    黒部 裕嗣, 平田 陽一郎, 坂上 倫久

      More details

    Grant amount:\4290000 ( Direct Cost: \3300000 、 Indirect Cost:\990000 )

    生体吸収性ASD閉鎖デバイスを用いて、福島県の動物実験施設で豚を用いた心房中隔壁へ経カテーテル的移植後解析を行い、その性能に問題無いことを確認した。
    具体的には埋植後の大動物、3ヶ月、6ヶ月、1年でSacrificeさせ、臓器(心臓・肺臓・脳)を摘出し、肉眼評価(マクロ評価)をまず施行した。デバイス状態評価と残存孔の有無・梗塞(脳・肺など)所見の有無をマクロ的に確認したところ、デバイスとそ れに迷入している自己組織によりASD孔はシャントなく閉鎖され、表面は内皮化しており、またデバイスは中心部のバネ部を除いては吸収が進んでいることを確認した。
    ミクロ的な評価である組織染色(HE)実験でも自己組織の再生が順調に進み、拒絶反応等を認める所見は無いことを現時点で確認している。
    これらデーターを確認した上で、デバイス性能および操作性の改良を行うべく、コロナ禍で厳しい環境にあったものの、可能な限り定期的に共同研究者・協力企業と打合せをおこない、 デバイスへの改良に努めている。

    researchmap

  • analysis of calcification process in implanted arterial artificial-graft.

    2016.4 - 2018.3

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research Grant-in-Aid for Challenging Exploratory Research  Grant-in-Aid for Challenging Exploratory Research

    KUROBE Hirotsugu

      More details

    Grant amount:\3380000 ( Direct Cost: \2600000 、 Indirect Cost:\780000 )

    Purpose of his study clarify the of calcification process in implanted arterial artificial-graft. Artificial arterial graft was implanted to abdominal aorta in 49 mice, and we explanted the implanted grafts from 39 mice at 2 months after implantation. By X-ray analysis, 14 explanted grafts occurred calcification. We divided 2 groups; Group C in 14 grafts with calcification, and Group N is 25 grafts without calcification.
    By microarray analysis with both groups, we picked up genes which was more than 2 fold in Fold Change analysis. And, by real time PCR was done in these picked up 22 genes, we think 4 genes (collagen X、osx、win3a、ankrd2) were associated with calcification process. We are doing more analysis to clarify the relation of these 4 genes for calcification process after graft-implanting.

    researchmap

  • Contributing Factors for Optimal Remodeling of Tissue Engineered Vascular Graft

    2015.4 - 2019.3

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research Grant-in-Aid for Scientific Research (C)  Grant-in-Aid for Scientific Research (C)

    Naito Yuji

      More details

    Grant amount:\4680000 ( Direct Cost: \3600000 、 Indirect Cost:\1080000 )

    Tissue Engineered Vascular Graft (TEVG) emerged to solve inherent problem of biomaterial used for surgical repair of congenital heart disease. TEVG requires in vivo remodeling in which TEVG sometimes encounters unexpected tissue overgrowth. The study investigated contributing factors for optimal remodeling of TEVG. Initially, biodegradable scaffold material was used in this study, however, its availability was limited, new method was employed. Yokoyama U et al. described novel method in which arterial graft was fabricated by vascular cells periodically exposed to extremely high hydrostatic pressure (eHHP). This novel method was assembled to analyze extracellular matrix (ECM), therefore, we have employed this method for further analysis. TEVG fabricated by eHHP showed well organized ECM consistent with native vessels without unexpected tissue overgrowth. TEVG fabricated by eHHP has potential to remodel to mimic native vessels in vivo by controlled quality in vitro.

    researchmap

  • Clarification of structure-function correlation of silk fibroin for Next Generation Heart Valve

    2015.4 - 2018.3

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research Grant-in-Aid for Scientific Research (B)  Grant-in-Aid for Scientific Research (B)

    NAKAZAWA Yasumoto, KUROBE Hirotsugu, ASANO Atsushi, MURAKAMI Tomoaki, TARA Shuhei

      More details

    Grant amount:\17290000 ( Direct Cost: \13300000 、 Indirect Cost:\3990000 )

    Silk fibroin (SF) is a biodegradable material, however, it lacks the elasticity required for a artificial heart valves. Polyurethane (PU) and polycarbonate(PC) are well-known for elastomer so this study focused on a SF-PU or SF-PC composite materials for tissue engineering materials, especially regeneration heart valves.
    As a result, we succeeded in nano-fiber sheets material. And each materials were able to exhibit good results in terms of improvement in physical properties, inhibition of inflammation and calcification, and tissue regeneration. However, it was found that infiltration of cells and tissues into the interior of the sheet was slight by animal implantation experiments.Continuing this research, we aim to propose new materials applicable to absorbable heart valves in the future.

    researchmap

  • Fundamental research for Biodegradable ASD closure system

    2014.4 - 2016.3

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research Grant-in-Aid for Challenging Exploratory Research  Grant-in-Aid for Challenging Exploratory Research

    KUROBE Hirotsugu, HIRATA Yoichirou, KITAGAWA Tetsuya, KINOSHITA Hajime

      More details

    Grant amount:\3640000 ( Direct Cost: \2800000 、 Indirect Cost:\840000 )

    Biodegradable device for ASD closure was made by using the biodegradable materials (PLA and PGA). After then, we assessed these devices in vitro and in vivo environments to clarify the it’s safety of devices and materials after implantation.
    In results, we clarified these devices are safe. More experiments will be done more for assessment in future.

    researchmap

  • 生体内分解性素材を用いた国産治療デバイスの開発-経カテーテル的心房中隔欠損孔閉鎖デバイスの開発- International coauthorship

    2014.4 - 2016.3

    厚生労働省、日本医療研究開発機構(AMED)  厚生労働科学研究費補助金 

    黒部裕嗣, 平田陽一郎, 中山泰介, 木下肇北川哲也

      More details

    Authorship:Principal investigator  Grant type:Competitive

    Grant amount:\93940000

    researchmap

  • Role of macrophage-derived hypoxia-inducible factor (HIF)-1alpha as a mediator of

    2012.4 - 2015.3

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research Grant-in-Aid for Scientific Research (C)  Grant-in-Aid for Scientific Research (C)

    KINOSHITA Hajime, KITAGAWA Tetsuya, KITAICHI Takashi, SUGANO Mikio, NAKAYAMA Taisuke, KUROBE Hirotsugu, FUJIMOTO Eiki

      More details

    Grant amount:\5330000 ( Direct Cost: \4100000 、 Indirect Cost:\1230000 )

    In this study, we clarified the role of macrophage-derived hypoxia-inducible factor (HIF-1α) in vascular remodeling. Wire-induced femoral arterial injury was inflicted in mice lacking the macrophage-specific HIF-1α gene and in their wild-type counterparts. The mutant mice showed both suppressed wire-induced neointimal thickening and decreased infiltration of inflammatory cells in the adventitia, compared to wild-type mice. Studies to clarify the mechanism of restrained vascular remodeling in the mutant mice revealed decreased production of pro-inflammatory cytokines by the activated macrophages and suppressed macrophage migration activity in the mutant mice. Gene expressions of the HIF-1α-deficient macrophages positively correlated with the phenotypic profile of M2 macrophages and negatively correlated with that of M1 macrophages. Our results show that HIF-1α in macrophages plays a crucial role in promoting vascular inflammation and remodeling.

    researchmap

  • Effects of Transplanted Human Cord Blood-Mononuclear Cells on Pulmonary Hypertension in Immunodeficient Mice and Their Distribution

    2012.4 - 2015.3

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research Grant-in-Aid for Scientific Research (B)  Grant-in-Aid for Scientific Research (B)

    KITAGAWA Tetsuya, KITAICHI Takashi, NAKAGAWA Ryuji, MAEDA Kazuhisa, SUGANO Mikio, NAKAYAMA Taisuke, KUROBE Hirotsugu, KINOSHITA Hajime

      More details

    Grant amount:\18330000 ( Direct Cost: \14100000 、 Indirect Cost:\4230000 )

    Objectives: To investigate the effects of human umbilical cord blood-derived mononuclear cell (hUCB-MNC) transplantation on pulmonary hypertension (PH) induced by monocrotaline (MCT) in immunodeficient mice and their distribution. Methods: Fresh hUCB-MNCs harvested from a human donor after her delivery were injected intravenously into those PH mice (BALB/c Slc-nu/nu) 4 weeks after MCT induction. To reveal the incorporation into the lung, CMTMR-labeled hUCB-MNCs were observed in the lung. DiR-labeled hUCB-MNCs were detected in the lung and other organs by bioimaging. Results: PH was significantly improved 4 weeks after hUCB-MNC transplantation. CMTMR-positive hUCB-MNCs were observed in the lung 3 hours after transplantation. Bioluminescence signals were detected more strongly in the lung than in other organs for 24 hours after transplantation. Conclusions: The results indicate that hUCB-MNCs are incorporated into the lung early after hUCB-MNC transplantation and improve MCT-induced PH.

    researchmap

  • Lymphangiogenesis with transplantation of mononuclear cells for lymphedema

    2011 - 2013

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research Grant-in-Aid for Scientific Research (C)  Grant-in-Aid for Scientific Research (C)

    KITAICHI Takashi, KITAGAWA Tetsuya, KUROBE Hirotsugu, SUGANO Mikio, NAKAYAMA Taisuke

      More details

    Authorship:Collaborating Investigator(s) (not designated on Grant-in-Aid)  Grant type:Competitive

    Grant amount:\5200000 ( Direct Cost: \4000000 、 Indirect Cost:\1200000 )

    Is it possible transplantation of mononuclear cells induce anatomical and functional lymphangiogenisis for lymphedema ? We create the secondary lymphedema models of mouse tails and hind legs, but could not get the good chronic lymphedema models, because their lymphedema improved naturally in a few weeks.

    researchmap

  • Role of ARNT-Hypoxia Inducible Factor 1 in development of pulmonary arterial hypertension

    2011 - 2013

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research Grant-in-Aid for Scientific Research (C)  Grant-in-Aid for Scientific Research (C)

    SUGANO Mikio, KITAGAWA Tetsuya, KUROBE Hirotsugu, NAKAYAMA Taisuke, FUJIMOTO Eiki

      More details

    Authorship:Collaborating Investigator(s) (not designated on Grant-in-Aid)  Grant type:Competitive

    Grant amount:\5200000 ( Direct Cost: \4000000 、 Indirect Cost:\1200000 )

    Hypoxia-inducible factor (HIF) specifically in endothelial cells of the pulmonary artery seems to play an important role in development of pulmonary arterial hypertension. Role of HIF was investigated using monocrotaline-induced pulmonary arterial hypertension model mice lacking Hif-1 beta. The endothelin upregulation through HIF may be one of the potential pathways for the pulmonary artery remodeling in the lung tissue.

    researchmap

  • Elucidation of molecular mechanism of plaque destabilization and identification of predictable factors for acute coronary syndrome

    2010 - 2012

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research Grant-in-Aid for Scientific Research (B)  Grant-in-Aid for Scientific Research (B)

    SATA Masataka, SOEKI Takeshi, HIRATA Yasunobu

      More details

    Authorship:Collaborating Investigator(s) (not designated on Grant-in-Aid)  Grant type:Competitive

    Grant amount:\18720000 ( Direct Cost: \14400000 、 Indirect Cost:\4320000 )

    We tried to elucidate molecular mechanism of plaque destabilization by analyzing clinical samples and utilizing animal models. The concentration of HMGB1, a non-histone nuclear protein, increased at coronary sinus in patients with coronary artery disease. Particularly, acute coronary syndrome, such as acute myocardial infarction or unstable angina pectoris, was associated with ten times elevated HMGB1 level. Animal experiments revealed that HMGB1-DNA complex signal contributed destabilization of vessel wall by activating Toll-like receptor 9 in the bone marrow-derived cells.

    researchmap

  • 長期予後改善を目的とした新たな新生児心臓手術手技の確立

    2010 - 2011

    日本学術振興会  科学研究費助成事業 基盤研究(C)  基盤研究(C)

    黒部 裕嗣, 北川 哲也, 菅野 幹雄, 中山 泰介

      More details

    Authorship:Principal investigator  Grant type:Competitive

    Grant amount:\2210000 ( Direct Cost: \1700000 、 Indirect Cost:\510000 )

    徳島大学・香川小児病院・愛媛県立中央病院で心臓・大血管手術を行った遺伝性疾患を除く3ヶ月未満齢児(29.4±27.2,3-90日齢)を対象に本研究へのエントリーを行い、胸腺の全摘群(Group E)と温存・部分摘出群(Group P)に分類した。手術時より3年間の予定で、半年毎に、外来診察と全血・白血球分類・免疫細胞分画の推移と、術後3年時には麻疹・風疹抗体産生能とリンパ球刺激によるリンパ球機能検査を予定している。現時点で31例(TGA9例,VSD6例,TAPVC4例,PTA2例,IAA2例,その他8例)が対象となっている。これら両群において、術後の臨床経渦を解析したところ、感染症状による外来受診回数と入院回数ともに胸腺全摘群で増加傾向にあることがわかった。その主な診断としては、外来では急性気管支炎、入院では肺炎の頻度が高いことがわかった。血液検査では、白血球数・リンパ球数・全T細胞数、helper T細胞数、killer T細胞数、制御性T細胞数ともに、胸腺全摘群では著しい低下を示した。これら途中解析ではあるが、新生児期の胸腺全摘は、術後の患児における細胞性免疫機能発達に著しい影響を及ぼし、かつ術後易感染性の可能性が示唆される。これらデーターは、来年度アメリカ胸部外科学会で発表予定である。

    researchmap

  • 周囲脂肪組織を標的とした新規血管保護療法の開発

    2010

    日本学術振興会  科学研究費助成事業 挑戦的萌芽研究  挑戦的萌芽研究

    佐田 政隆, 黒部 裕嗣

      More details

    Authorship:Collaborating Investigator(s) (not designated on Grant-in-Aid)  Grant type:Competitive

    Grant amount:\3000000 ( Direct Cost: \3000000 )

    血管のホメオスターシス維持と病変形成過程における、血管周囲脂肪組織の役割について検討した。痩せたマウスの血管外膜周囲に豊富に存在する脂肪組織の形質を、皮下脂肪、内臓脂肪と比較したところ、血管外脂肪組織は通常は皮下脂肪に近いものの、血管傷害を契機に内臓脂肪型に形質を転換することが明らかとなった。血管外膜周囲の毛細血管をMelcox樹脂を用いて走査型電子顕微鏡で観察した。外膜脂肪細胞が血管と解剖学的に近接関係にあり、外膜液性因子が粥腫に直接アクセスする経路が示された。血管外膜脂肪組織周囲と血管壁との外膜微小血管によって、物理的、機能的に相互作用していることが明らかとなった。
    また、痩せたマウスの血管外膜周囲脂肪組織を残した場合と、除去した場合で、血管傷害を加えて病変の形成の程度を比較検討した。外膜脂肪組織の除去により病変形成が加速された。また、その後、痩せた別のマウス由来の皮下脂肪を移植すると、病変形成は内因性の血管周囲脂肪組織がある場合と同程度まで抑制された。一方、太ったマウスの内臓脂肪を移植すると逆に病変形成は加速された。以上より、外膜周囲脂肪組織は病的血管リモデリングを抑制する作用があることがわかった。
    外膜周囲脂肪組織は、通常病的血管リモデリングに対して防御的に機能することが明らかとなった,また、冠動脈疾患患者では、心臓周囲脂肪組織に炎症が生じ、動脈硬化の進展と破綻に大きな役割を担っていることが明らかとなった。バイパス手術を施行する場合に、炎症に富む心臓周囲脂肪組織を取り除き、健全な皮下脂肪を移植する新規抗動脈硬化治療手術を現在ブタを用いて検討している。

    researchmap

  • Human Umbilical Cord Blood-derived Mononuclear Cell Transplantation Improves Pulmonary Arterial Hypertension in Immunodeficiency Mouse

    2009 - 2011

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research Grant-in-Aid for Scientific Research (B)  Grant-in-Aid for Scientific Research (B)

    KITAGWA Tetsuya, KITAICHI Takashi, NAKAGAWA Ryuji, MAEDA Kazutoshi, SUGANO Mikio, KANBARA Tamotsu, KUROBE Hirotsugu, YOSHIDA Homare

      More details

    Authorship:Collaborating Investigator(s) (not designated on Grant-in-Aid)  Grant type:Competitive

    Grant amount:\17030000 ( Direct Cost: \13100000 、 Indirect Cost:\3930000 )

    Backgrounds and Objectives. The purpose of this study is to investigate whether human umbilical cord blood-derived mononuclear cell(hUCB-MNC) transplantation improves the development of pulmonary arterial hypertension(PAH) in monocrotaline(MCT)-treated mice. HUCB-MNC transplantation may have a new therapeutic potential for several congenital heart defects with primitive pulmonary vasculatures. Methods. MCT-induced PAH model was made using BALB/ c Slc-nu immunodeficiency mouse. HUCB-MNCs were adjusted to 1 x 107/ 0. 25 mL of concentration, and injected intravenously into those mice 4 weeks after MCT administration. The mice were divided into five groups :(1) vehicle-injected mice ;(2) MCT-treated mice ;(3) hUCB-MNC transplantation for PAH mice ;(4) hUCB-MNC+ plasma transplantation for PAH mice ;(5) plasma transplantation for PAH mice. Assessment of PAH were performed by the ratio of right ventricular to ventricular septum plus left ventricular weight(RV/ S+ LV), medial thickness of small pulmonary arteries, and pulmonary acceleration time/ ejection time(PAT/ ET) of the main pulmonary artery by echocardiography. Results. RV/ S+ LV ratio, medial thickness of small pulmonary arteries and PAT/ ET were significantly improved by hUCB-MNC transplantation with or without plasma, respectively. Conclusions. Our data shows that hUCB-MNC transplantation improves MCT-induced PAH and its efficacy is dependent on hUCB-MNCs themselves

    researchmap

  • Recellularization of small artery graft by cellular adhesion factor coating techniques.

    2008 - 2010

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research Grant-in-Aid for Scientific Research (C)  Grant-in-Aid for Scientific Research (C)

    KANBARA Tamotsu, KITAGAWA Tetsuya, KAWAHITO Shinji, KUROBE Hirotsugu, URATA Masahisa

      More details

    Authorship:Collaborating Investigator(s) (not designated on Grant-in-Aid)  Grant type:Competitive

    Grant amount:\4550000 ( Direct Cost: \3500000 、 Indirect Cost:\1050000 )

    We made the vascular scaffold of 3 mm in diameter made from plant fiber, and implant these to cervical artery or femoral artery in pig. But the patency of these at one month after implantation was 25% of all. The reasons of obstruction were indicated below. One is due to spasm of artery in pig. And another is due to acute thrombosis.
    So we need to resolve these problem in near future, and try to make small artificial artery graft, which we can use in vascular suregery.

    researchmap

  • The effects and possible mechanism of syngeneic bone marrow mononuclear cell transplantation on pulmonary arterial hypertension

    2008 - 2010

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research Grant-in-Aid for Scientific Research (C)  Grant-in-Aid for Scientific Research (C)

    KITAICHI Takashi, KITAGAWA Tetsuya, KUROBE Hirotsugu

      More details

    Authorship:Collaborating Investigator(s) (not designated on Grant-in-Aid)  Grant type:Competitive

    Grant amount:\3510000 ( Direct Cost: \2700000 、 Indirect Cost:\810000 )

    We investigated the effects and possible mechanism of syngeneic bone marrow mononuclear cell (BM-MNC) transplantation on pulmonary arterial hypertension induced by monocrotaline. Monocrotaline-injected mice improved significantly after BM-MNC transplantation compared with those of mice after monocrotaline injection. However, BM-MNCs were not incorporated into the lung at1week after transplantation, and significant vascular endothelial growth factor (VEGF) upregulation and without receptor expression was observed in lung tissue after transplantation. Improvement of pulmonary arterial hypertension was inhibited by simultaneous administration of VEGF receptor-2inhibitor with BM-MNC transplantation. These results indicate that syngeneic BMMNC transplantation improves monocrotaline-induced pulmonary arterial hypertension by favorable pulmonary artery remodeling through VEGF upregulation.

    researchmap

▼display all

Teaching Experience

  • Surgery

    Institution:Faculty of Dentistry, University of Tokushima

     More details

  • Cardiovascular Surgery

    Institution:Faculty of Medicine, University of Tokushima

     More details

  • 外科学

     More details

  • 心臓血管外科学

     More details